Human stem cell metabolomics; headspace volatile gas analysis as an indicator of self-renewal and differentiation status by Al-Zubaidi, Mohammed Abdulridha
This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 
quote extensively from the work, permission must be obtained from the 
copyright holder/s. 
Human stem cell metabolomics; headspace 
volatile gas analysis as an indicator of self-
renewal and differentiation status 
 
Mohammed Abdulridha Al-Zubaidi 
Thesis submitted to Keele University for the Degree of Doctor of Philosophy 
 
March 2018  
 
 
Keele University 
 
 
 
  
SUBMISSION OF THESIS FOR A RESEARCH DEGREE 
Part I. DECLARATION by the candidate for a research degree. To be bound in the thesis 
Degree for which thesis being submitted Doctor of Philosophy  
Title of thesis  Human stem cell metabolomics; headspace volatile gas analysis as an indicator of 
self-renewal and differentiation status 
 This thesis contains confidential information and is subject to the protocol set down for 
the submission and examination of such a thesis.                  NO  
Date of submission 15.12.2017  Original registration date 06.01.2014 
(Date of submission must comply with Regulation 2D) 
Name of candidate  Mohammed Abdulridha Al-Zubaidi  
Research Institute  Institute for Science and Technology in Medicine   
Name of Lead Supervisor Professor Nicholas R Forsyth    
I certify that: 
(a) The thesis being submitted for examination is my own account of my own research 
(b) My research has been conducted ethically. Where relevant a letter from the approving 
body confirming that ethical approval has been given has been bound in the thesis as an 
Annex 
(c) The data and results presented are the genuine data and results actually obtained by 
me during the conduct of the research 
(d) Where I have drawn on the work, ideas and results of others this has been 
appropriately acknowledged in the thesis 
(e) Where any collaboration has taken place with one or more other researchers, I have 
included within an ‘Acknowledgments’ section in the thesis a clear statement of their 
contributions, in line with the relevant statement in the Code of Practice (see Note 
overleaf). 
(f) The greater portion of the work described in the thesis has been undertaken 
subsequent to my registration for the higher degree for which I am submitting for 
examination 
(g) Where part of the work described in the thesis has previously been incorporated in 
another thesis submitted by me for a higher degree (if any), this has been identified and 
acknowledged in the thesis 
(h) The thesis submitted is within the required word limit as specified in the Regulations 
Total words in submitted thesis (including text and footnotes, but excluding references and 
appendices) ……………… 
Signature of candidate ………..………………………………..            Date……………………
I 
 
Abstract 
Self-renewal and an ability to differentiate are key hallmarks of stem cells. Pluripotent 
stem cells (PSC) have the capacity to differentiate into all cell types found within the three 
germ layers; ectoderm, endoderm, mesoderm. Multipotent stem cells including 
mesenchymal stem cells (MSC) customarily differentiate into cell types representative of 
one germ layer only. 
Metabolomics focusses on characterising the low molecular weight organic compounds 
which are by-products of protein-protein interactions and metabolic enzymatic processes; 
volatile organic compounds (VOCs) emitted from or consumed by cells can be correlated 
with metabolic status. Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) has been 
used to identify and discriminate between metabolites (VOCs) from both undifferentiated 
and differentiated stem cells in specific cell culture oxygen conditions (air (21% O2) and 
physiological oxygen (2% O2)). 
The suitability of SIFT-MS for detecting and identifying VOCs from hPSCs was evaluated 
with SIFT-MS spectral data analysed via OPLS-DA. hPSCs cultured in 2% O2 displayed a 
distinct metabolic profile to those cultured in 21% O2. Metabolite markers differing 
between culture conditions for undifferentiated hPSCs included ethanol and acetaldehyde. 
Inhibition of ethanol/acetaldehyde conversion enzymes revealed mechanistic control of 
ethanol and acetaldehyde levels linked to environmental oxygen. hPSC differentiation-
linked differences in metabolic profiles included immediate reductions in acetaldehyde and 
DMS/ethanethiol levels upon onset of differentiation. 
For hMSCs, OPLS-DA score plots indicated that hMSCs cultured in a controlled, 
hermetic, workstation maintained at 2% O2 were distinct to those cultured in either 2% O2 
II 
 
or 21% O2. The VOC profile of hMSCs varied with oxygen condition and degree of 
differentiation during osteogenic differentiation. 
In summary, this thesis demonstrates that SIFT-MS can detect and discriminate VOC 
profiles in two distinct stem cell populations. These profiles are sensitive to oxygen and 
differentiation status and therefore provide a potential valuable tool for non-invasive 
explorations of stem cell biology.
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Chapter 1-Introduction
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1.1 Stem cells 
Stem cells are defined as undifferentiated or unspecialised cells from the embryo (i.e. 
embryonic stem cells) or from adult tissue (i.e. adult stem cells). Embryonic stem cells 
have two important characteristics; the ability to divide and generate new identical copies 
of themselves (i.e. self-renewal) and under the proper physiological or experimental 
condition, can specialise or differentiate into a diverse range of cell types found in the body 
(Evans and Kaufman, 1981; Martin, 1981; Thomson et al., 1998). Like embryonic stem 
cells, some adult stem cells are capable of self-renewal and differentiation into various cell 
types. Conversely, unlike embryonic stem cells, adult stem cells are not pluripotent (i.e. 
multipotent) as well as having a limited self-renewal ability. Self-renewal and potency to 
differentiate into specialised cells allow them to serve as building blocks in developmental 
processes. (Ullah et al., 2015). 
Stem cells are classified based on their potential for differentiation (Figure 1.1). 
Accordingly, they can be defined as: 
 Totipotent stem cells are the most primitive and have the potential to develop into 
trophectoderm cell lineages in addition to the three germ layers; ectoderm, 
mesoderm and endoderm. These cells are yielded at the moment of fertilization of 
the egg (early progeny of the zygote) and remain until the embryo reaches the 4 to 
8 cell stage (Mitalipov and Wolf, 2009). 
 Pluripotent stem cells can differentiate into cells of all three germ layers, ectoderm, 
mesoderm and endoderm; e.g. embryonic stem cells and induced pluripotent stem 
cells (Mitalipov and Wolf, 2009). 
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 Multipotent stem cells can differentiate into multiple cell types in germ layer; e.g. 
mesenchymal stem cells and haematopoietic stem cells. (Bianco, 2011). 
Currently, all mammalian stem cells can be classified based on their origin into two 
categories: embryonic stem cells (ESCs) and adult or somatic stem cells (e.g. mesenchymal 
stem cells (MSCs)) (Lodi et al., 2011). Recently, new stem cells have been added to the list 
of stem cells and were named induced pluripotent stem cells (iPSCs). (Mitalipov and Wolf, 
2009). 
 
Figure 1.1. Types of stem cells. The formation of totipotent zygote following fusion of 
egg and sperm to form the inner cell mass (ICM) and trophoblast of the blastocyst. 
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Following ICM isolation from blastocyst, the cells of the inner cell mass (ICM) can be 
maintained in culture as pluripotent (i.e. embryonic stem cells). During the development of 
the embryo, the pluripotent stem cells in the inner cell mass (ICM) become multipotent 
stem cells and generate tissue-specific. These include epidermal stem cells (bulge cells) 
and mesenchymal stem cells. Eckfeldt et al., 2005. 
1.2 Human pluripotent stem cells: 
As mentioned above, due to their unique ability to differentiate into cells of all three germ 
layers and their unlimited self-renewal capacity, human PSCs hold a huge potential for a 
number of different scientific and clinical applications, including new drugs screening and 
cell-based therapies and regenerative medicine. Currently, two types of pluripotent stem 
cells have been described; embryonic stem cells (ESCs) and induced pluripotent stem cells 
(iPSCs) (Avior et al., 2016). 
1.2.1 Human embryonic stem cells: 
The first type of identified and isolated human pluripotent stem cells, hESCs are valuable 
tools in the area of biological development and regenerative medicine. Prior to the 
derivation of ESCs, embryonal carcinoma cells (ECCs) were isolated from 
teratocarcinomas formed following the implantation of early stage mouse embryos and 
used as a model for developing embryo in vitro (Martin, 1981). After a number of efforts, a 
breakthrough evolved and arose in 1981 when ESCs were isolated from murine embryos 
(Evans and Kaufman, 1981; Martin, 1981), before isolation of ESCs from non-human 
primate embryo’s in 1995 (Thomson et al., 1995). In 1998, Thomson and colleagues 
isolated and cultured the first derivation of human ESCs from human embryos produced by 
in vitro fertilisation (IVF). These cells were isolated by immunosurgery from the inner cell 
mass (ICM) of the blastocyst stage embryo and cultured on irradiated mouse embryonic 
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fibroblasts. The resulting cells were grown as colonies and individual undifferentiated 
colonies were dissociated into clumps until the cell line was established. Five different 
hESC lines were derived, three of them had a normal XY karyotype (H1, H13 and H14) 
and two had a normal XX karyotype (H7 and H7) (Thomson et al., 1998). Both human 
embryonic stem cells and mouse embryonic stem cells have various signalling features and 
culture conditions, but they both maintain pluripotency via the expression of the same core 
transcription factors (Pera et al., 2000). Nowadays, those hESCs generated in 1998 are still 
utilized in research and regarded as the gold standard hESC lines. 
A large number of hESC lines have now been generated besides the original five lines. 
There is a considerable heterogeneity between lines in addition to the differences in gene 
expression signatures (Abeyta et al., 2004), differentiation propensity (Osafune et al., 
2008) and population doubling time; this variation possibly reflecting differences in 
derivation methods and timing, initial culture conditions, or original genetics of the source 
embryo. hESC lines must meet a number of criteria (Hoffman and Carpenter, 2005), 
including expression of a number of cell surface antigens and internal transcription factors 
associated with pluripotency for example stage specific antigens 3 and 4 (SSEA3 and 
SSEA4), tumour receptor antigens 1-60 and 1-81 (TRA1-60 and TRA1-81), octamer-
binding transcription factor 4 (OCT4), Nanog and SRY-box 2 (SOX2). Another definition 
of pluripotency in hESC is being able to form all three germ layers derivatives in 
immunocompromised mice in vivo (Allegrucci and Young, 2006). Moreover, hESCs must 
possess the capacity for unlimited self-renewal and normal karyotype. 
In spite of their promise, there are numerous issues to be considered before any strategy for 
use in routine clinical applications. Firstly, there are a number of ethical issues, which must 
be taken into account when deriving hESCs, including the destruction of fertilised 
embryos. Secondly, it is essential to confirm that all pluripotent stem cells are removed 
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from the transplanted cell population, as the presence of these cells increases the prospect 
of teratoma formation. The potential of immunogenicity also presents an issue for 
consideration (Wert and Mummery, 2003). 
1.2.2 Induced pluripotent stem cells: 
The best way to overcome the issue of hESCs immunorejection is by using autologous 
cells. Yamanaka and colleagues reprogrammed both mouse and human adult fibroblast to 
pluripotency via transduction of four defined factors, including Oct4, Sox2, Klf4 and c-
Myc (Takahashi and Yamanaka, 2006; Takahashi et al., 2007) (figure 1.2). The generated 
pluripotent cells were known as induced pluripotent stem cells (iPSCs) which are similar to 
hESCs in morphology, proliferation capacity, expression of hESCs specific cell surface 
antigens (SSEA3, SSEA4, TRA1-60 and TRA1-81) and endogenous genes (Oct4, Nanog, 
Sox2), and the ability to generate any cell from all three germ layers in vitro and teratoma 
formation in vivo. 
 
Figure 1.2. Schematic diagram represent stages of hiPSC generation. Following 
isolation, fibroblasts or other somatic cells are cultured in vitro and transduced with four 
pluripotent factors (OCT-4, SOX2, KLF4, and c-MYC). Adapted from Yamanaka and 
Blau, 2010. 
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1.3 Adult stem cells: 
Adult stem cells are undifferentiated cells found in various tissues of the human body 
which are capable of differentiating into more mature cell of that tissue (Fujimaki et al., 
2013). Adult stem cells can be classified depending on the germ layer they come from: the 
ectoderm layer of an early embryo lead to the nervous system, mammary glands, hair and 
skin; the endoderm layer give rise to the intestine, pancreas, liver and lung. Circulatory 
system muscle and mesenchymal stem cells come from the mesodermal layer (Haasters et 
al., 2009). Unlike ES cells, adult stem cells are only multipotent and are not derived by 
destruction of an embryo; consequently, avoiding many of the ethical issues involved in 
the research of embryonic stem cells. The clinical use of adult stem cells e.g. 
transplantation of bone marrow for treating blood disorder, has been used for decades 
(Kinner et al., 2002) and therefore holds great opportunity for regenerative medicine. 
The bone marrow introduces several adult stem cell populations that serve to maintain the 
tissue homeostasis by generate new cell types in adult human body; haematopoietic stem 
cells (HSCs), mesenchymal stem cells (MSCs), multipotent adult progenitor cells and 
endothelial progenitor cells (EPCs). These cells differentiate into cells of the vascular and 
musculoskeletal systems (Saeed et al., 2016). 
1.3.1 Mesenchymal stem cells: 
The first evidence supporting the presence of distinct stem cell populations within the bone 
marrow was in 1968, when Friedenstein and colleagues found a set of cells that were tissue 
culture plastic adherent, colonogenic, nonphagocytic, and fibroblastic that were coined 
Colony Forming Unit-Fibroblast (CFU-F) (Friedenstein et al., 1968). Since then, a number 
of research groups have discovered MSCs and their particular properties that raised the 
need to establish general agreement on their definition (Dominici et al., 2006). The study 
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of hMSCs is dependent, in some part, on the morphology and expression of surface 
antigens. The cells are constituted of a heterogeneous population; three cell types 
commonly observed are rapidly self-renewing cells, slowly replicating, large, cuboidal or 
flattened cells and elongated fibroblastic-like, spindle shaped cells (Haasters et al., 2009).  
There is no single marker for the detection and recognition of mesenchymal stem cells, 
therefore the Mesenchymal and Tissue Stem Cell Committee of the International Society 
for Cellular Therapy suggested a minimum set of criteria to define this population, based 
on the adherence to tissue culture plastic when cultured in standard culture condition, 
positive expression for several surface markers including CD105, CD90 and CD73, and 
negative surface marker expression for CD14, CD45, CD34, CD11b, CD79α, CD19 and 
HLA-DR, and multipotent differentiation potential (Dominici et al., 2006). 
Human mesenchymal stem cells can be isolated from several tissues. The most popular are 
bone marrow (Friedenstein et al., 1968), adipose tissue (Zuk et al., 2001), placenta (In’T 
Anker et al., 2004) and umbilical cord structure or blood (Erices et al., 2000; Kim et al., 
2004). Other adult tissue or organ sources of this population or similar ones are synovium 
(Fickert et al., 2003), cartilage (Alsalameh et al., 2004), dermis (Riekstina et al., 2009). 
MSCs might also be found during the fetal development in the lung, liver and spleen (In’T 
Anker et al., 2003). Although MSCs present in all above tissues, they appear to have some 
differences in their differentiation potential in accordance to their source (Cavallo et al., 
2011; Peng et al., 2008). 
The first reported source of MSCs was bone marrow (Friedenstein et al., 1968), which is 
considered to be the gold standard source, even though the frequency of MSCs is only 
1/10000-1/100000 of nucleated cells (Peng et al., 2008). The harvesting of mesenchymal 
stem cells from bone marrow is painful and usually requires anaesthesia (Zuk et al., 2001) 
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as well as the low frequency of MSCs which decline with age (Penge et al., 2008) suggest 
an expansion step in vitro (Zuk et al., 2001). The expansion step is time consuming, 
expensive, and subject to cell contamination risk and loss (Zuk et al., 2001). Adipose tissue 
seems to be an alternative to the standard source of MSCs, which is usually discarded from 
abdominoplasties and lipoaspirations as a medical waste (Bourin et al., 2013), easily 
accessible with less invasive method (Cavallo et al., 2011; Peng et al., 2008), and richer in 
stem cells when compared to bone marrow (~ 500 fold) (Hass et al., 2011), which might 
result in reducing the expansion time of cells in vitro (Richardson et al., 2013). 
Osteoprogenitors, chondrogenic progenitors and adipocyte progenitors are amongst a 
mixture of isolated MSCs from bone marrow that can be observed as partially defined in 
terms of their stem cell fate (Muraglia et al., 2000). MSCs have been reported to 
differentiate into adipocyte, osteoblast, chondrocyte, myoblast and fibroblast cells 
(Pittenger et al., 1999; Barry et al., 2001; Gang et al., 2004). However, in recent years 
some controversial studies reported cases of transdifferentiation across tissue types, for 
example neuronal cells and hepatocytes (Song and Tuan, 2004; Sato et al., 2005). 
Therefore MSCs offer great therapeutic potential for use in clinical applications, which is 
dependent on further understanding the regulation between self-renewal and lineage 
commitment. 
1.4 Stem cell niche: 
The stem cell niche concept was suggested by Schofield over 30 years ago to characterize 
the particular microenvironment where a stem cell resides in vivo (Wang and Wagers, 
2011). The niche is basically a tissue microenvironment (Morrison and Spradling, 2008), 
including cells (including stem cells), the extracellular matrix, and soluble molecules 
present around the stem cells (Kolf et al., 2007). The niche is essential to give stem cells 
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cues to maintain them in an undifferentiated state and external cues to induce their 
differentiation whenever needed to replace and repair injured tissue (Kolf et al., 2007). 
Therefore, the niche will regulate stem cell behaviour and function via a balance between 
protection and interaction (Wang and Wagers, 2011). One of the important components of 
the niche is a group of proteins called cadherins, which are responsible for cell-cell 
adhesion, migration, differentiation, polarity and interaction with the mammalian 
homologue of Drosophila wingless (Wnts), which are believed to be involved in the 
maintenance of undifferentiated state and the differentiation paths of MSCs (Kolf et al., 
2007). 
Stem cell niches can be divided into three types based on the specific function; simple cell 
niches, complex cell niches and storage cell niches. The simple cell niche is a 
microenvironment which contains one stem cell type which is locked to the extracellular 
matrix via adhesion junctions and integrin mediated interactions. In this niche, paracrine 
signals promote stem cell growth while inhibiting differentiation. The complex niches 
contain two or more different stem cells that are supported by one or more different partner 
cells. The activity of the complex niches is controlled by regulatory signals to produce 
multiple progeny cells. Storage niches are specific locations in which stem cells are 
maintained until external signals are received to repair injured tissue (Ohlstein et al., 2004). 
The compositions of extracellular matrix are fibres, laminin polymer, cell adhesion protein 
(e.g. fibronectin, proteoglycans) and growth factors (Chen, 2010). There are two types of 
extracellular matrix which exist together in the bone, the calcified bone matrix that is 
created by osteoblasts, and the marrow extracellular matrix that is created by MSCs (Chen, 
2010). Datta and colleagues showed that the extracellular matrix is very important for 
MSCs differentiation (Datta et al., 2005). They observed that deposited extracellular matrix 
produced by osteoblastic cells on decellularized scaffold displayed higher proliferation of 
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MSCs, higher deposition of calcium and increased levels of osteopontin, indicating stem 
cells differentiation into bone progenitor cells (Datta et al., 2005). 
The central and epiphysis region of bone is the bone marrow region where haematopoiesis 
occurs comprising extracellular matrix and a meshwork of thin walled capillaries (Zhao et 
al., 2012). The niche within this structure contains both haematopoietic stem/progenitor 
cells and mesenchymal stem cells along with adipocytes and stromal cells (Chen, 2010). 
MSCs are perivascular and usually present in the central area of the bone marrow, and they 
are also found at lower frequency in the vicinity of the endosteum (Krause et al., 2013) 
(Figure 1.3). The bone marrow niche is physioxic, and this low oxygen level, ranging from 
1% in the niche itself to 6% in the sinusoidal cavity (Eliasson and Jonsson, 2010), 
participates in increasing the proliferation capacity, as well as maintaining the naïve state 
and the plasticity of mesenchymal stem cells (Makino et al., 1999). The physioxic 
environment of haematopoietic cells is associated with a more quiescent state because it 
occurs far away from blood capillaries and closer to bone surface (Eliasson and Jonsson, 
2010). 
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Figure 1.3. MSCs niche in bone marrow. The bone marrow cells including stromal cells, 
adipocyte and osteoblasts are derived from MSCs, while HSCs have the ability to 
differentiate into all haematopoietic cells including monocyte-derived osteoclasts. Adapted 
from Schraufstatter et al., 2011. 
1.5 Oxygen and stem cells: 
Oxygen is crucial for life with almost all organisms relying on oxygen for energy 
production. In humans, it is recognized as playing a key role as a vital electron acceptor 
during ATP production (Konigsberg et al., 2013). Although tissue specific oxygen tension 
is dependent on the distance away from the vasculature, 1% - 8% O2 has been recognized 
as a general estimate for most tissues (Jez et al., 2015). In the early stages of human’s 
pregnancy (6-7 days post fertilisation), in which the blastocyst can be explanted for 
development of hESC lines (Camarasa et al., 2012), the intrauterine fluid has an oxygen 
concentration far lower than that found at atmospheric condition. Direct measurements of 
oxygen concentration in human uterine fluids are difficult due to the invasive technique of 
the electrodes and catheters used to quantify its concentration but the mid-point of the 
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menstrual cycle has been assessed to reside at about 3% O2 (Ottosen et al., 2006). 
Furthermore, the dissolved oxygen in the peripheral maternal venous blood was measured 
and showed a gradual increase in parallel with advancing pregnancy due to the 
establishment of circulatory system (Rodesch et al., 1992; Simon and Keith, 2008). Under 
low oxygen tension, the alterations to embryonic and fetal development have often been 
related to the actions of a family of transcriptional regulators (i.e. Hypoxic Inducible 
Factors (HIFs)), which are hypothesised to regulate critical phases of normal embryonic 
development under low oxygen. In vitro, the physioxic condition was investigated by 
Ezashi and colleagues, in order to maintain human embryonic stem cells in 
undifferentiated state. They showed that human embryonic stem cells cultured in the 
physioxic condition (3%-5%) O2 contained less differentiated cells. Furthermore, air 
oxygen cultured cells had produced more chorionic gonadotropin after day five and 
progesterone after day nine in the media, indicating further differentiation (Ezashi et al. 
2005). Additionally, Forsyth and colleagues reported that culture in 2% O2 increased 
hESCs clonal recovery, and flow cytometry analysis showed that physioxia cultured cells 
were smaller and less granular than those in air oxygen condition. Moreover, they reported 
that the early and late passage culture reduced the spontaneous chromosomal aberration of 
hESCs in physioxic culture (Forsyth et al. 2006). 
In vivo, mesenchymal stem cells reside in perivascular niches that associate closely with 
blood vessels in virtually all tissues. The various tissues where mesenchymal stem cells 
reside exhibit low oxygen tensions, even though these stem cells are located close to the 
blood vessels (Mohyeldin et al. 2010). For example, mesenchymal stem cells, found within 
the bone marrow, reside under 1-7% of oxygen level (Sheehy et al. 2012; Holzwarth et al. 
2010) which is lower than the oxygen level in peripheral blood of healthy people (Jing et 
al. 2012). 
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In vitro, mesenchymal stem are traditionally expanded in air culture condition where 5% 
CO2 is used to help buffer the medium’s pH and for cellular metabolism. However, it was 
shown that expansion of stem cells in a low oxygen environment leads to more population 
doublings while maintaining the potential of stem cell differentiation (Moussavi-Harami et 
al 2004; Dellatore et al. 2008; Ma et al. 2009; Cicione et al. 2013). It was also shown that 
their growth rate could be improved by culturing under a hypoxic condition (5% O2). In 
addition, the multipotency of mesenchymal stem cells was maintained and less apoptosis 
was observed (Hung et al. 2007). 
It is suggested that more population doublings are obtained at low oxygen concentration as 
a result of less and delayed cellular senescence (DiGirolamo et al. 1999; Moussavi-Harami 
et al. 2004). Cell death or senescence is induced by DNA damage and/or by shortening of 
telomeres (Herbig et al. 2004; Bakkenist et al. 2004; Nakamura et al. 2008), which may 
happen via oxidative stress (Tchirkov and Lansdorp, 2003; Boesten et al. 2013). Reactive 
oxygen species (ROS), such as oxygen free radicals (O2
-) and hydrogen peroxide (H2O2) 
are produced by oxidative phosphorylation when cells produce energy (Kondoh et al. 
2007). Usually, cells have the ability to protect themselves against reactive oxygen species 
through cellular antioxidants. However, cells can be damaged by reactive oxygen species 
production if there is insufficient antioxidant. Premature aging of the cell can occur as a 
result of the production of ROS. However, when less ROS are produced by redirecting the 
metabolism of cells with lower oxygen concentration in the cell culture, the cellular 
senescence can be reduced and cell expansion is prolonged (Kondoh et al. 2005). 
1.6 Metabolomics: 
Metabolomics comprises both qualitative and quantitative analysis of all metabolites 
present in a biological system (Fiehn, 2001). Metabonomics was coined by Nicholson and 
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colleagues, and defined as the quantitative measurement of the dynamic multiparametric 
response of a biological system to pathophysiological stimuli or genetic modification 
(Nicholson et al., 1999). Practically, both terms overlap by a large degree and are 
frequently utilized interchangeably. The whole set of intracellular and extracellular 
metabolites produced by cells are known as the metabolome (Oliver et al., 1998). While 
metabolites are the downstream products of other omics (e.g. transcriptomics and 
proteomics), metabolomics of the biological system under study provides complementary 
knowledge for a better understanding of the cellular process (Villas-Boas et al., 2005). 
Metabolomics analyses have been divided into two major approaches: targeted and 
untargeted methods. Targeted metabolomics is a quantitative approach wherein a number 
of pre-determined metabolites belonging to a particular set of compounds (e.g. 
carbohydrates, lipids, amino acids) or to specific metabolic pathway (e.g. glycolysis) are 
quantitated (Roberts et al., 2012). Usually, this approach is hypothesis-driven study and 
needs a priori knowledge of the biological system under study. An example of this strategy 
was the analysis of 20 amino acids in cancer cells (Tomita et al., 2016). Because 
researchers concentrated on the measurement of the amino acids other metabolites present 
in the cell extracts were neglected. Targeted methods provide quantitative information 
about the selected number of metabolites. 
The untargeted metabolomics approach (also known as global metabolomics or metabolite 
profile), on the other hand, aims to detect all metabolites in a biological sample, including 
unknown compounds. Usually, the untargeted approach compares the metabolite profile of 
the studied groups (control and altered groups) allowing the identification of the interesting 
metabolites which are the further investigated with a targeted approach (Leon et al., 2013). 
Therefore, untargeted and targeted metabolomics approaches can complement each other 
and if utilized in combination can provide more details about the metabolic events 
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occurring in the biological system. Untargeted metabolomics has been applied in the 
discovery of potential biomarkers in Alzheimer’s disease (Li et al., 2010), cancer (Lin et 
al., 2011; Xie et al., 2012), onchocerciasis (Denery et al., 2010) and metabolic disorders 
(e.g. diabetes and obesity) (Zhang et al., 2009; Kim et al., 2010), amongst other conditions. 
Additionally, untargeted metabolomics can be sub-divided into: metabolomics 
fingerprinting, which aims to analyse all the intracellular metabolites (endo-metabolome) 
(Fiehn, 2001) and metabolomics footprinting, which aims to analyse all extracellular 
metabolites (exo-metabolome) (Allen et al., 2003) (Figure 1.4). Footprinting analysis is 
technically simple when compared with metabolomics fingerprinting because it requires 
minimal sample preparation, only filtration or centrifugation to separate culture media 
from cells before the analysis. Metabolomics fingerprinting requires a much more technical 
procedure to extract the metabolites from cells and the protocols are also extensively 
improved in order to obtain suitable metabolite recoveries (Leon et al., 2013). 
 
Figure 1.4. Untargeted metabolomics strategies for the analysis of extra- and intra-
cellular metabolites. The figure shows the site of the extracellular (outside the cell) and 
intracellular (inside the cell) metabolites. Circles, diamonds and triangles represent 
metabolites. 
17 
 
Metabolites are intermediate products of catabolic and anabolic pathways and build the 
linkage between utilisation of nutrients and the production of cellular components, energy 
and waste products (Ussher et al., 2016). Metabolites are generally labile species, their 
chemical nature is very diverse, and they exist in a wide dynamic range (Hollywood et al., 
2006). The diverse chemical properties and concentration ranges in living systems make all 
metabolites measurement hard to achieve. Hence, most of untargeted approaches are well-
matched for a specific subset of compounds based on their chemical properties and 
concentration ranges. 
Any biological system produces both volatile and non-volatile compounds (Whittle et al., 
2007). In recent years, volatile organic compounds have received considerable interest 
(Filipiak et al., 2016). Hence, volatile organic compounds released from living cells are 
able to provide crucial information about different metabolic processes or pathways as well 
as the physiological condition of the cells (Pasini et al. 2004). Therefore, the concept arises 
of using volatile organic compounds or metabolite characteristics, which are a class of 
biomarkers, to establish metabolic changes due to different diseases, particularly cancer 
(Abaffy et al. 2013). Importantly, there are a wide range of volatile organic compounds 
present in trace amounts across a range of samples, including breath, urine and blood 
samples of human (Rudnicka et al., 2011; Silva et al., 2011; Xue et al., 2008). Generally 
volatile compounds are defined by a molecular weight range between 50-200 Daltons and 
have an appreciable vapour pressure under ambient conditions (Rowan, 2011). The 
advantages of volatile organic compounds are the fact that they are easily and non-
invasively obtainable, and the analysis of VOC profiling is relatively inexpensive (Filipiak 
et al., 2016; Wang et al., 2016). However, the main drawback of VOCs in comparison to 
other markers e.g. nucleic acid and protein-based markers is the current incomplete 
information on the total number of volatile organic compounds produced by human cells. 
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Furthermore, many of the biochemical pathways leading to VOCs production and 
degradation within human cells are missing (Filipiak et al., 2016). In many and various 
cancer states, for example, lung and breast cancer, breath sample analysis has been used in 
several studies to determine which volatile organic compounds (metabolites) can serve as 
potential biomarkers. Additionally, other studies on cancers such as ovarian, liver, stomach 
and prostate cancers have been investigated using chemical analysis of exhaled breath 
(Abaffy et al. 2013). It has been reported in a recent study that there are nine urinary 
volatile organic compounds presented in patients with lung cancer at higher concentrations 
than those in control groups (Hanai et al 2012). In addition, studies have demonstrated that 
the concentration of hexanal and heptanal, which are volatile organic compounds, in the 
blood of patients suffering from lung cancer are elevated as compared with those in the 
control group (Deng et al. 2004). 
Smith and colleagues showed that acetaldehyde is present in the headspace of the cell 
cultures of SK-MES and CALU-1 lung cancer cells lines in a proportion to the cells 
number (Smith et al. 2003). Acetaldehyde level was also found to be higher in a 3D model 
containing CALU-1 cancer cells line and non-malignant lung cells NL20 when compared 
to that of the same cells grown in 2D model (Rutter e al. 2013). High concentrations of 
acetone were also found in the headspace of lung cancer cells as compared to the growth 
medium (Filipiak et al. 2010). 
1.7 Metabolomics and enzyme function identification: 
Stem cells are the basic of all multicellular organisms. Several factors, from transcriptional 
to epigenetic, have been shown to play a role in fate determination; in addition, increasing 
consideration is being given to the responsibility of metabolism as a regulator of stem cell 
fate (Arnold et al., 2015). The research for novel enzymes is one of the tasks in functional 
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genomics. Metabolites can be used to assign or validate the function of enzyme activities 
because they are often the ultimate downstream products of gene expression (Baran et al., 
2009). The chemical reactions that are processed by enzymes in all process of life are 
organised in response to the environment; in addition, the abundance of each metabolite 
depends on the specific physiological and state of a cell. Therefore, the intermediate 
metabolites reflect the phenotype of a cell, resulting in response to various environmental 
or genetic influences (Arnold et al., 2015). 
Most of the traditional enzyme assays are used to establish enzyme activity, but a major 
drawback of this technique is that the enzyme function has to be known (Liesener and 
Karst, 2005). Integrated metabolomic and transcriptomic approaches can be used to assist 
identification of unknown enzymes (Fridman and Pichersky, 2005), however, pre-
knowledge of the biochemical reaction was still necessary. Recent development in Mass 
spectrometry-based techniques in the analysis of intermediate metabolites has become a 
valuable technique for enzyme discovery and validation of their functional assignment 
(Baran et al., 2009). 
1.8 Volatile organic compound sampling and extraction: 
As with metabolomics, the measurement of the profile of volatiles generated by a living 
system needs an alteration of the analysis from the selective quantitative analysis of 
particular metabolite, which has been the core of analytical chemistry, to the measurement 
of several metabolites with corresponding balance in the precision, accuracy and sensitivity 
with single metabolites measurement. As different metabolites within a volatile profile will 
vary in their physical and chemical properties, the efficiency of extraction of these volatiles 
from the sample will also differ and will be extremely dependent on the sampling methods 
used. Thus, the choice of the most suitable strategy for volatile sampling and extraction is 
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the most important step. In general, a complete sample needs to be in an enclosed system 
with air circulation (dynamic headspace collection) and without air circulation (static 
headspace collection) (Rowan, 2011). 
In a dynamic (purge and trap) headspace sampling method, a known volume of ultra-
purified air is passed over the biological sample and the entrained volatiles are 
concentrated onto an adsorbent trapping graphite or organic polymer such as Tenax. VOCs 
may then be extracted from the adsorbent trap by elution with organic solvent transferred 
directly to instrument for analysis by rapid heating of the adsorbent material in a flow of 
inert gas (Rowan, 2011). 
In static headspace analysis, air is not circulated and the volatiles in the sample are allowed 
to equilibrate with the air in an enclosed container. After the equilibration, a known 
volume of air is collected from the headspace of the sample using a needle and introduced 
to the instrument for analysis (Rowan, 2011). 
1.9 Analytical platforms for metabolomics: 
At present, there is no single analytical platform that can fully achieve the analysis of all 
metabolites in a given sample. Amongst the analytical platforms, both mass spectrometry 
(MS) (e.g., GC-MS) and nuclear magnetic resonance (NMR) are advanced analytical tools 
applied to metabolomic investigations. However, both techniques have different analytical 
advantages and disadvantages (Dunn et al., 2011). Each analytical platform has specific 
characterisation features, which enables analysis and detection of a specific range of 
metabolites (Zhang et al., 2012). Amongst the analytical techniques used for analysis of 
volatile metabolites is selected ion flow tube-mass spectrometry (SIFT-MS). 
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1.9.1 Overview of the SIFT-MS technique: 
In 1976, Smith and Adam conceived and developed the Selected Ion Flow Tube (SIFT) to 
study the chemical reactions between ions and molecules at thermal energies (Adams and 
Smith, 1976; Smith and Adams, 1988), this was basic to the development of interstellar ion 
chemistry and developing an understanding of reactions that happen in the ionized 
terrestrial atmosphere (Smith and Adams, 1980; Smith and Spanel, 1995). The analytical 
method for the SIFT-MS technique was born as a direct mass spectrometric analysis of 
volatile compounds in the air and/or vapour samples by chemical ionisation (Smith and 
Spanel, 2005) (Figure 1.5). 
 
Figure 1.5. Schematic diagram of the SIFT-MS. The diagram showing the microwave 
resonator, injection quadrupole mass filter and three orifices through which (1) ions pass 
from ion source into the injection quadrupole mass filter, (2) mass selected precursor ions 
enter flow tube reactor, (3) product and precursor ions pass from flow tube reactor into the 
detection quadrupole mass spectrometer. Adapted from Smith et al.,1999.  
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A precursor ion is selected according to the mass to charge ratio (m/z) by an upstream 
quadrupole mass filter after formation of a mixture of positive ions in a microwave 
discharge source, the precursor ions are injected into flowing inert carrier gas (helium) at a 
pressure of ~ 100 Pa through a venture-type inlet (diameter 1 mm) where they are 
converted as a thermalized swarm along the flow tube (Smith and Spanel, 2005). The 
chosen precursor ions (H3O
+, NO+ and O2
+) are utilised to ionize the trace gases in either 
air or vapour samples. These precursor ions are injected into flowing helium carrier gas, 
and the gas/vapour from the sample of interest is introduced at high speed via the heated 
sample inlet port; the capillary within the inlet port is heated to 80 oC to prevent water 
vapour condensation. The flow speed of helium gas transporting the ion swarm and the 
flow tube length determines the reaction time of the analyte molecules with the precursor 
ions. The chemical reaction occurs when a specific precursor ion reacts with the trace 
compounds in the introduced sample, a small fraction of reagent ions converting into 
product ions that are specific of the analytes (Smith and Spanel, 2005). The large fraction 
of the reagent ions (residual) together with the distinctive product ions travel from the 
flowing swarm through a pinhole orifice (diameter of ~ 0.3 mm) located at the downstream 
quadrupole mass spectrometer. Following mass analysis, quantification of the volatile 
compounds is accomplished by detection and counting at the channeltron multiplier/pulse 
counting system (Smith and Spanel, 2005). 
In the methods utilized to ionize gaseous compounds, chemical ionisation (soft ionisation) 
in combination with mass spectrometry was developed to reduce the fragmentation of 
analyte molecules, leading to simpler distinct product ions thus helping the analyte 
compound identification and quantification. However, not many precursor ions are 
appropriate for ambient gas analysis as these precursors must be relatively unreactive with 
the major components of air (N2, O2, H2O, CO2 and Ar) but very reactive with the trace 
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gases being quantified (Smith and Spanel, 2005). The only appropriate precursor ions for 
SIFT-MS are H3O
+, NO+ and O2
+; these ions do not undergo biomolecular reactions with 
the major components of air while reacting only very slowly with these neutrals via slow 
termolecular association (Spanel and Smith, 1995; Spanel and Smith, 1996a; Smith and 
Spanel, 1996; Spanel and Smith, 1996b). The availability of these ions in SIFT-MS 
provides advanced accuracy for identification of compounds, where important isobaric 
product ions are formed. Furthermore, the ability to rapidly switch between these reagent 
ions within milliseconds allows one to obtain data for each precursor ion without delay, 
which is valuable in the analysis of transient gaseous samples. In addition, the efficient 
generation of these reagent ions is from simple discharge ion sources (Spanel et al., 2004). 
The potential use of anions has been previously explored as precursor ions for SIFT-MS, 
but the reactivity of OH- was found to be far less in comparison with H3O
+ and the 
difficulty in obtaining a large sufficient current of OH- ions; thus negative ions would 
restrict the level of analytical sensitivity of SIFT-MS (Spanel et al., 1995). 
In 1997, SIFT-MS had developed to be a transportable SIFT-MS instrument, MK1, which 
weighed 350 Kg. This mobility allowed it to be worked for the first time outside of the 
analytical chemistry laboratory. Online gas analysis was performed for exhaled breath 
samples of pre and post haemodialysis patients in hospital (Davies et al., 2001). In 2001, 
SIFT-MS became the first commercial SIFT-MS instrument, MK2, and consisted of the 
latest pump and quadrupole mass spectrometers with improved specifications (Spanel and 
Smith, 2011). This allowed for a moderation in critical parameters such as orifice 
diameters and improved the limit of detection for the samples of exhaled breath to 2 parts 
per billion by volume (ppbv) for a 1 second integration time (Spanel and Smith, 2011). The 
thinking and continuous efforts of Professors Smith and Spanel regarding the flow 
dynamics, venturi design, pumping systems, vacuum housings and the fundamental ion 
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chemistry of SIFT-MS led to the production of the profile 3 instrument, which was 
introduced in 2006 in the UK. In particular, the large pumps that were used in previous 
versions of SIFT-MS were replaced with rotary backing pumps, leading to reduced weight 
and size of the profile 3 instrument (weight ~ 120 Kg), resulting in a more easily moved 
instrument (Smith et al., 2009). 
The SIFT-MS instrument can be worked in two different modes. The first is the full-scan 
mode (FS); breath or liquid headspace gases are introduced into the carrier gas, and the 
downstream analytical mass spectrometer system is scanned over predetermined mass to 
charge ranges for a selected time period (Smith and Spanel., 2005). The count rates of the 
ions are then computed from the numbers of counts and the total sampling time for each 
ion. The count rates are kept, and then displayed on a linear or semi-logarithmic scale. The 
interpretation of the mass spectra relates the product ion peaks with the trace gases in the 
sample. The concentrations of the volatile compounds are computed from the count rates 
of the precursor ions and their distinct product ions and the proper k values (from 
standardized kinetics library) and the flow rates of the helium gas and of the breath or 
headspace sample. In the second, multi-ion monitoring mode (MIM), the downstream 
analytical mass spectrometer is quickly switched between selected mass to charge values to 
mark selected trace gas species (Smith and Spanel., 2005). The targeted volatile 
compounds are quantified in real-time from the obtained data and the rate coefficients of 
the reactions as included in the kinetic library. This real-time monitoring is possible 
because of the quick time response of SIFT-MS, which is approximately 20 ms; the quick 
response time is dictated by the fast flow rates of the helium gas along the flow tube and 
the sample gas along the inlet tube. In addition to the count rates of the selected product 
ions, the count rates for the precursor ions (e.g., H3O
+ and H3O
+(H2O)n) are also recorded 
simultaneously, because they frequently change with the humidity of the sample gas. This 
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is achieved by rapidly switching between several m/z values of the precursor and product 
ions in the downstream mass spectrometer (Smith and Spanel., 2005). 
1.10 Aims 
Metabolomics studies can yield powerful biochemical data at the cellular level, giving a 
snapshot view of the phenotype of cell population under any state.  
There are two main hypotheses to be explored in this thesis. Firstly, the physioxic 
condition can show changes in the metabolism of stem cells and subsequently differences 
in metabolite content of the cell culture media. Secondly, when stem cells differentiate, the 
metabolic profile of cells will shift from that characteristic of stem cells to that of the cell 
type into which the stem cells is differentiating.  
In this thesis, the aim is to investigate the ability of using volatile organic compounds 
(metabolites) released from or consumed by human stem cells as a profiling tool within 
metabolomics and to identify potential volatile organic compound biomarkers of stem cells 
differentiation. Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) has been employed 
in the analysis of volatile organic compounds to yield a broad set of data which will 
increase our understanding of the metabolism of self-renewal and differentiation of stem 
cells. 
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Chapter 2-Materials and 
Methods
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2.1 Pluripotent stem cells: 
2.1.1 Thawing: 
Early passage cryovials of human pluripotent stem cells (hPSCs), including SHEF1 and 
SHEF2 human embryonic stem cells (hESCs) (obtained under licence, from the UK Stem 
Cell Bank (UKSCB)) (Alfatoonian et. al., 2010) and human induced pluripotent stem cells 
(ZK2012L) (kindly supplied by Prof Sue Kimber) (Cheng et. al., 2014), were removed 
from liquid nitrogen and thawed in a 37 oC water bath with gentle agitation. Vials were 
then sterilized with 70% (v/v) IMS followed by transfer into the cell culture hood  and 
transfer of the thawed cells into a 15 ml conical tube followed by dilution with 10 ml of 
pre-warmed medium with medium added dropwise while gently shaking the tube back and 
forth to reduce osmotic shock. To remove the DMSO present in freezing medium, cells 
were pelleted by centrifugation (200 g for 4 min). Then the supernatant was removed and 
the cells re-suspended in 2 ml of medium and plated into one well of a vitronectin pre-
coated 6-well plate (see section 2.1.3). The next day of the thawing and plating the cells 
into a 6-well-coated culture plate, 95% of the medium was aspirated to avoid drying out 
the cells and added 2 ml of fresh medium/well by gently adding to the side of the well, 
after 4-5 days cells were about 85% confluent. 
2.1.2 Routine culture conditions: 
All cell harvesting and culture procedures were carried out in Class II microbiological 
safety cabinets using disposable sterile plastic consumables. All objects entering the 
cabinet were first sprayed with 70% (v/v) IMS to disinfect. Human pluripotent stem cells 
(hPSCs) were cultured in a xeno-free culture system using Essential 8 Medium (Gibco, 
Cat. No. A15169-01) and a truncated recombinant human vitronectin (rh VTN-N) (Gibco, 
Cat. No. A14701SA) substrate (see section 2.1.3) (Figure 2.1) with routine passaging by 
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ethylene diamine tetra acetic acid (EDTA) (Life Technologies, Cat. No. 15575-038) (see 
section 2.1.4). The morphology of the cells was observed daily under inverted light 
microscope (Nikon Eclipse TS100, Japan) to ensure the maintenance of an undifferentiated 
phenotype and evaluate the confluency level. 
Human ES cell lines SHEF1 and SHEF2, and iPSC from passage 35 to 65 were maintained 
under sterile conditions in a humidified incubator at 37 oC in the presence of 5% CO2 at 
either 2% (physioxia) or 21% O2 (air oxygen). 
 
Figure 2. 1. In vitro culture requirements of hPSCs. The figure showing the requirement 
for an extracellular matrix (vitronectin substrate) to support hPSCs self-renewal in culture 
medium. 
2.1.3 Substrate coating: 
To prepare the coated wells of a 6-well plate, a 0.5 mg/ml vitronectin solution was first 
removed from the -80 oC freezer, thawed at room temperature, and 60 µl added into a 15 
ml conical tube containing 6 ml of Dulbecco’s phosphate-buffer saline (DPBS) without 
calcium and magnesium (Gibco, Cat. No. 14190-094). The solution was then mixed gently 
by pipetting up and down to obtain a 5 µg/ml working vitronectin solution which was 
distributed equally across each well of 6-well plate (0.5 µg/cm2 as recommended by 
manufacturer) and incubated at room temperature for one hour prior to use. The plates 
were then used directly after the incubation or stored at 2-8 oC wrapped in parafilm for no 
more than one week. 
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2.1.4 Passaging: 
hPSCs were passaged upon reaching 85% confluency to avoid death and/or spontaneous 
differentiation roughly every 4-5 days at a 1:6 split ratio (3.3 x 105) using 0.5 mM EDTA 
(Life Technologies, Cat. No. 15575-038) in DPBS. To harvest hPSCs, they were washed 
twice with DPBS to remove the culture media and 1 ml of 0.5 mM EDTA solution added 
followed by incubation at room temperature for 5-8 minutes or until the cells started to 
separate and round up. After this time the EDTA was aspirated followed by the addition of 
1 ml pre-warmed E8M and the cells removed by gently pipetting media onto the plate 
surface. hPSCs media was changed 48 hrs after splitting and the spent medium replaced 
daily thereafter and maintained in a continuous culture during the whole experimental 
period.  
2.1.5 Haemocytometer cell counting: 
Cell count analysis was performed using Trypsin/EDTA (Lonza, Cat No. BE02-007E) to 
obtain a single cell suspension. The trypsinisation was carried out by diluting one volume 
of 5g/L trypsin and 2g/L EDTA stock solution in 10 volume of calcium and magnesium-
free DPBS. hPSCs were washed twice with DPBS and 1 ml/well of diluted trypsin/EDTA 
solution was added followed by incubation at 37 oC for 3-5 minutes. After the incubation 
period, a ten-fold excess of medium was added to halt the trypsin activity. The cells 
suspension was then transferred into a centrifuge tube and pelleted at 200 g. The 
supernatant was aspirated and the cells re-suspended in 1 ml medium. 
hPSC suspensions for counting were stained with Trypan blue (Sigma-Aldrich, Cat. No. 
T8154) by mixing 1 volume of cells suspension with 1 volume of Trypan blue. Cells were 
counted under a microscope in 4 of the large corner squares of the haemocytometer after 
introduce approximately 10 µl of the mixture (cell suspension and Trypan blue) very 
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gently between haemocytometer and coverslip by capillary action. The number of cells/ml 
in the original cell suspension was determined by the following equation: the mean number 
of cells of four square X 104 X 2 (dilution factor of Trypan blue added).  
2.1.6 Crypreservation of cells: 
A 70-80% confluent well of a 6-well culture plate of hPSC was harvested with EDTA as 
described in section 2.1.4; after aspirating the EDTA from the well, 1 ml of 10% (v/v) 
dimethyl sulfoxide (DMSO) (Fisher Scientific, Cat. No. D/4120/PB08) in Essential 8 
medium was added and the cryoprotectant solution gently washed over the well to dislodge 
the cells from the surface which were then transferred into a cryovial. Each well of 6-well 
culture plate of hPSCs was collected in one cryovial before quickly placing the cryovials 
into Mr Frosty container for storage at -80 oC overnight before transfer them into liquid 
nitrogen. 
2.2 Characterisation assays: 
2.2.1 MTT assay: 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell 
proliferation assay performed using MTT powder Thiazolyl Blue Tetrazolium Bromide 
(Sigma-Aldrich, Cat. No. M5655). The MTT powder was dissolved in dH2O at a 
concentration of 5 mg/ml and then filtered using a 0.2 um filter. Briefly, 104 hPSCs were 
seeded into each well of 6 X 96-well plates and cells were allowed to attach for 48 hours at 
either 2% O2 or 21% O2 at 37 
oC in a humidified incubator. Every day thereafter, MTT was 
performed on one plate in each condition. 150 µl of a 0.5 mg/ml MTT reagent-containing 
Essential 8 medium solution was added to each well followed by incubation at 37 oC for 4 
hours. After incubation 125 µl MTT solution was removed. The MTT-formazan product 
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was subsequently dissolved by addition of 100% DMSO (50 µl/well) in the dark, followed 
by further incubation for 45 minutes in the incubator at 37 oC. The absorption was then 
measured with a microplate reader (BioTek, synergy 2) at a 570 nm wavelength. Triplicate 
experiments were performed at both 2% and 21% oxygen conditions. 
2.2.2 Immunocytochemistry: 
Immunocytochemistry of hPSC markers of pluripotency was performed using live, unfixed 
cell staining (R&D system, GloLIVE Human Pluripotent Stem Cell Live Cell Imaging Kit, 
Cat. No. SC023). Briefly, 3.3 x105 hPSCs were seeded into each well of a 6-well plate and 
grown for 96 hours in E8M. The antibodies were diluted to 1X concentration (1:50) in 
E8M, media aspirated and 1 ml fresh media containing 1X of the desired antibody (SSEA-
4, TRA-1-60, SSEA-1) added to each well before returning to the incubator for 30 minutes 
incubation. Thereafter, the antibody-containing media were removed, hPSCs rinsed with 
fresh medium, and then re-fed with the medium. Labelled cells were imaged via 
fluorescence microscope (Nikon Eclipse Ti-S, Japan) with a Nikon DS-Qi1Mc camera. 
The NIS-elements BP software was used for image acquisition. 
2.2.3 Flow cytometry: 
Human PSCs were prepared for analysis by flow cytometry by dissociating to a single cell 
solution using trypsin-versene (EDTA) (Lonza, Cat No. BE02-007E). Approximately 
5x105 human PS cells were labelled with the antibodies (SSEA-4, TRA-1-60, SSEA-1) as 
described in section (2.2.2). When the antibody-containing medium was removed, cells 
were washed using PBS, trypsinised, and centrifuged at 300 g for 3 minutes. The 
supernatant was then aspirated and the pellet washed in flow cytometry buffer (PBS with 
0.5% (w/v) BSA (Fisher Scientific, Cat No. BP9703-100) and 2 mM EDTA (Fisher 
Scientific, Cat. No. BP2482-1) followed by centrifugation at 300 g. Samples were then re-
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suspended in PBS and analysed by flow cytometry utilizing a Cytomics FC 500 (Beckman 
Coulter). Data analysis was performed using Flowing Software (version 2.5.1). The 
pluripotent markers expression of SSEA-4 was determined in the FL1 channel, while 
TRA-1-60 and SSEA-1 were determined in the FL2 channel. 
2.2.4 Bioinformatics: 
A gene expression data set generated for hESCs (cell lines, H1, H9 and RH1) cultured on 
MatrigelTM in two conditions (2% and 21% O2) until 90% confluent was exploited via in 
silico analysis (Forsyth et al., 2008). Focussed analysis was performed based on 
observations made during hPSC SIFT-MS analysis (see Section 2.3.3).  
According to the KEGG `pathway database, the metabolic pathways for ethanol and 
acetaldehyde were recognised for further analysis. Since the complete pathway is separated 
into a several enzymatic reactions, NCBI web-based server was used to identify the genes 
to a specific enzymatic reaction. Based on the genes assignment, a list of genes was 
constructed by matching the identified genes for ethanol and acetaldehyde pathway to the 
(H1, H9 and RH1) gene expression data set. All expressed genes in ethanol and 
acetaldehyde metabolic pathway were then compared between 2% O2 and 21% O2 using t-
test to identify the significant genes. All of the genes that showed significant differences 
(P<0.05) were selected for further consideration. 
2.3 Spontaneous differentiation of human pluripotent stem cells: 
hPSCs were differentiated as previously described (Kumar et al., 2015). In brief, hPSCs 
(around 5x105) were cultured in 6-well vitronectin-coated culture plates in two different 
conditions (2% O2 and 21% O2) for 48 hours in Essential 8 medium to allow them to attach 
to the culture plates’ surface. Thereafter, the medium was switched to spontaneous 
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differentiated media consisting of Knockout DMEM (KO-DMEM) (GIBCO, Cat No. 
10829-018) supplemented with 10% (v/v) FBS, 2mM L-Glutamine (Lonza, Cat. No. 
BE17-605E), 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E) and 0.1 mM β-
mercaptoethanol (Gibco, Cat. No. 31350-010). 
2.3.1 Evaluation of pluripotent markers expression in human pluripotent 
stem cells and their progeny: 
hPSCs were cultured and expanded on vitronectin-coated 24-well plates in both 21% O2 
and 2% O2 in E8M for 0 day and in spontaneous differentiation media for a 21 day period. 
Pluripotent marker analysis was performed during the differentiation period at days 0, 5, 
10 and 20. For immunolabeling media was first removed, hPSC washed with PBS and 
fixed in 4% paraformaldehyde in PBS for 30 minutes at room temperature, and then 
washed 3 times with 1% BSA (Sigma-Aldrich, Cat. No. A1595) in PBS. The cells were 
then permeabilized and blocked with 10% normal donkey serum (Sigma-Aldrich, Cat. No. 
D9663), 0.3% triton X-100 (Sigma-Aldrich, Cat. No. T8787) and 1% BSA (Sigma-
Aldrich, Cat. No. A1595) in PBS for 45 minutes at room temperature. hPSCs and their 
progeny were then incubated with 1 µg/100 µl working solution of primary anti-human 
monoclonal antibodies; mouse anti-alkaline phosphatase, mouse anti-SSEA-4, goat anti-
Nanog and goat anti-Oct 3/4 (R&D system, Cat. No. SC008) overnight at 2-8 oC. hPSCs 
were washed 3 times with 1% BSA in PBS; antibodies Nanog and Oct 3/4 were treated 
using secondary antibody donkey anti-goat IgG (R&D system, Cat. No. NL003); alkaline 
phosphatase and SSEA-4 were treated with secondary antibody, donkey anti-mouse IgG 
(R&D system, Cat. No. NL557) at 5 µg/ml for 1 hour at room temperature. All immuno-
stained samples were further counterstained with DAPI (100ng/ml) (Sigma-Aldrich, Cat. 
No. D9542) in order to visualise nuclei of the cells and imaged using a fluorescence 
microscope (Nikon Eclips Ti-S, Japan). 
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2.3.2 RT-PCR: 
Gene expression analysis (RT-PCR) was performed at days 0, 5, 10 and 20 of 
differentiation; cell lysis at each time point was performed in situ for subsequent RNA 
extraction. Cell lysates were prepared and homogenised by following the manufacturer’s 
protocol (Qiagen, RNeasy Mini Kit, Cat. No. 74104). Briefly, prior to lysis cell 
monolayers were washed with PBS after which cells were lysed in 350 µl RLT buffer 
supplemented with 10 µl/ml of β-mercaptoethanol (Gibco, Cat. No. 31350010), a cell 
scraper was used to ensure cells were detached from the culture plate and the lysate was 
then transferred to a QIAshredder mini-spin column (Qiagen, Cat. No. 79656) for 
homogenisation and removal of insoluble material. This was centrifuged for 2 minutes at 
17000 g followed by removing and discarding the mini-spin column; the cell lysate was 
stored at -80 oC until RNA extraction was performed. 
2.3.2.1 RNA extraction: 
Undifferentiated and differentiated cell lysates were removed from the -80 oC freezer and 
thawed on ice. Total RNA extraction was carried out using the RNeasy mini kit (GIAQEN, 
Cat. No. 74104). One volume of 70% ethanol was added to the lysate and the mixed 
solution transferred to RNeasy mini-spin column. Samples were centrifuged for 15 seconds 
at 8000 g and the flow-through discarded with total RNA bound to the column membrane. 
To wash the membrane, 700 µl of RW1 buffer was added and the tube centrifuged for 15 
seconds at 8000 g after which the flow-through was discarded. This was repeated once 
before performing an RPE buffer (500 µl) wash at 8000 g for 15 seconds followed by a 
second 500 µl RPE wash of 2 minutes, the flow-through following each centrifugation was 
discarded. The residual fluid was then removed by centrifugation of the mini-spin column 
at 17000 g. The collection tube was discarded and replaced with a 1.5 ml lidded collection 
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tube. The RNA was eluted from the membrane by adding 25 µl of RNase-free water to the 
spin column membrane and standing for 5 minutes before being centrifuged for 1 min at 
17000 g. To increase the quantity of RNA, the eluent was re-pipetted on to the membrane 
and the column centrifuged for 1 minute at 17000 g. The concentration of the extracted 
RNA was measured using Nanodrop 2000 spectrometer (Thermo scientific) and transferred 
to store at -80 oC until required. 
2.3.2.2 One step reverse transcription polymerase chain reaction: 
RNA samples were diluted in ultrapure RNAse/DNAse-free dH2O to a concentration of 25 
ng/µl for gene expression analysis. Reverse transcription-polymerase chain reaction (RT-
PCR) was carried out with a one-step RT-PCR kit (Qiagen, Cat. No. 210210). Briefly, all 
primers were designed using the NCBI website, the primer sequences and the annealing 
temperature for each gene is listed in Table 2.1. All RT-PCR mixtures contained 2.5 µl of 
RT-PCR buffer, 0.5 µl dNTP, 2.5 µl of Q-solution, 1 µl (25ng/µl) of RNA sample, 1 µl of 
each forward and reverse relevant primer (10 µM), 0.5 µl of RT-PCR enzyme mix and 
final volume made up to 12.5 µl with RNAse/DNAse free water. All RT-PCR reactions 
consisted of one cycle of 50 oC for 30 minutes (reverse transcription step), one cycle of 95 
oC for 15 minutes, 39 cycles: 94 oC for one minute (DNA melting), primer specific 
annealing temperature (Table 2.1) for one minute, and 72 oC for one minute (DNA 
extension); one cycle of 72 oC for 10 minutes and finally 15 oC On hold. Following 
completion of amplification, samples (cDNA) were either fractionated directly on agarose 
gels or stored at 4 oC prior to fractionation. 
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Table 2. 1. Table of primer sequence, annealing temperatures and product size. 
Gene name  Sense sequence  
(5’ to 3’) 
Antisense sequence  
(5’ to 3’) 
Annealing 
temperat
ure (oC) 
Product 
size  
(bp) 
ACTB GCCACGGCTGCTTC
CAGC 
AGCCATGCCAATCT
CATCTT 
57 528 
POU5F1 
(Oct-4) 
GCAATTTGCCAAGC
TCCTGAAGCAG 
CATAGCCTGGGGTA
CCAAAATGGGG 
55 536 
NANOG GGTGGCAGAAAAA
CAACTGGC 
TGCAGGACTGCAG
AGATTC 
56 300 
SOX1 CCAGGAGAACCCC
AAGAGGC 
CGGCCAGCGAGTA
CTTGTCC 
56 206 
AFP AAGGATACCAGGA
GTTATTGG 
GTTGGCATATGAAG
AAGTGC 
56 398 
Brachyury GCATAAGTATGAG
CCTCGAA 
GTTGTCAGAATAGG
ATTGGGA 
56 256 
OTX2 CTCGCCACATCTAC
TTTGATA 
GGCGGTTGCTTAAG
ATAAGA 
57 226 
SOX17 GCAAGATGCTGGG
CAA 
GCCGGTACTTGTAG
TTGG 
56 120 
hTERT GCAGCTCCCATTTC
ATCAGC 
CAGGATGGTCTTGA
AGTCTG 
55 343 
ADH4 CGCATTCAGATCAT
TGCTAC 
ACTGGTTCCAAAGA
AATGGT 
56 339 
ADH5 CGAATCAAGATCAT
TGCCAC 
CTGGCATTAATCCT
TTCCCT 
56 268 
CYP2E1 CTGGCTCCAGCTTT
ACAATA 
AGAATCAGGAGCC
CATATCT 
56 306 
ALDH1A1 TCATTCCTTGGAAT
TTCCCG 
GCCCATAACCAGG
AACAATA 
57 183 
ALDH1A3 GAAGAAGGAGATA
AGCCCG 
CTGCAAAGTATCTG
AGGGTT 
56 247 
ALDH6A1 CTTGCTCCGCTATC
AACAA 
AGGAAGGTATTTCC
ACACAC 
57 309 
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2.3.2.3 Agarose gel electrophoresis: 
RT-PCR amplification products were confirmed by agarose gel electrophoresis. Agarose 
gels (Fisher Scientific, Cat. No. BP1356) were prepared at a 2% concentration in 1X tris-
acetate-EDTA (TAE) buffer (Thermo Fisher Scientific, Cat. No. B49) supplemented with 
0.3 µg/ml ethidium bromide (Sigma-Aldrich, Cat. No. E1510). Ethidium bromide which 
binds to a double strand DNA helix will increase its fluorescence 25-fold as compared to 
non-binding ethidium bromide (Severini and Morgan; 1991) following UV excitation 
allowing the visualisation of ethidium bromide binding DNA band within the gel. Agarose 
gels were poured into a gel tray with a gel comb and allowed to set for approximately 1 
hour prior to use, after which the set gel was transferred into the electrophoresis chamber 
containing 1X TAE buffer. Each sample was mixed with 2 µl aliquot of gel loading buffer 
(Sigma-Aldrich, Cat. No. G2526) and then pipetted into the gel wells. At the same time, 
DirectLoad wide range DNA marker (Sigma-Aldrich, Cat. No. D7058) was run to allow 
the determination of fragments size. All gels were run for 1 hour at 100 V in 1X TAE 
buffer. Following completion of electrophoresis, gels were transferred to UV 
transilluminator (Syngene) to visualise by fluorescence at 254 nm where images were 
captured using Syngene GenSnap software). 
2.3.3 Headspace analysis of pluripotent stem cells and their progeny by 
SIFT-MS: 
In order to prepare samples of each of the pluripotent stem cell types [hESCs (SHEF1 and 
SHEF2) and hiPSCs] in this study for headspace analysis, following expansion in 6-well 
tissue culture plate to around 70-80% confluence, the cells (around 12x106 cells) were 
incubated in 20 ml Essential 8 Medium in 2% and 21% O2 conditions for 24 hours before 
samples acquisition. In parallel 6-well tissue culture plates containing only 20 ml Essential 
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8 Medium without cells were incubated in 2% and 21% O2 for 24 hours as a control. After 
the incubation period, cell-free cell culture media and incubated cell culture media were 
transferred to clean, sterile 150 ml glass bottles, 20 ml fresh media were transferred to 
another bottle as a further control. The headspace of the bottles was then purged with dry 
and sterile air (20% oxygen and 80% nitrogen mixture; BOC, UK) for 1 minute and capped 
tightly with septum caps and parafilm and incubated for an additional 16 hours at 37 oC, 
this incubation period was chosen to allow accumulation of volatile organic compounds 
before a SIFT-MS measurement was taken. 
In order to prepare spontaneous differentiation samples of each human pluripotent stem 
cell, the differentiated progenitor cells in 6-well tissue culture plate at each time point (5, 
10 and 20 days) (Figure 2.2) were incubated in 20 ml differentiated medium for 24 hours 
in both conditions 2% and 21% O2 before sample acquisition. 6-well tissue culture plates 
containing 20 ml of the differentiated media without cells were incubated for 24 hours in 
relevant oxygen conditions in parallel. After the incubation period, the cell culture media 
were transferred into bottles as described above. 
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Figure 2. 2. The process flow of hPSCs and their progenitors’ VOCs extraction. The 
flow showing the time points of volatiles extracted from headspace (HS) of culture media 
throughout hPSCs differentiation period. 
Following the 16-hour incubation period for undifferentiated pluripotent stem cells and 
their differentiated progeny media samples, the headspace was measured using the Profile 
3 SIFT-MS instrument (Figure 2.3). The samples were placed in a water bath (37 oC) to 
maintain the temperature of the samples throughout the analysis.  
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Figure 2. 3. Photograph illustrating the SIFT-MS instrument set up. (A) SIFT-MS, (B) 
Helium cylinder and (C) laptop. 
The H3O
+ precursor (reagent) ion was applied to analyse the headspace gases using both 
Multi Ion Monitoring mode (MIM) and Full Scan mode (FS) operation of the instrument. 
Prior to analysis the samples, the water level of the operator’s exhaled breath (6% +/- 0.1) 
was achieved as a calibration procedure to check the flow rate of the sample into the 
instrument using flow rate adjustment incorporated into the software and post analysis the 
Excel was used to normalise the data to 6% exactly. In order to introduce the headspace 
gases of the samples into the flow tube of the instrument, the septa of the caps were 
punctured using a needle attached to the sampling arm of the SIFT-MS instrument. For 
each headspace measurement, the time for sampling was 1 minute. 
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2.4 Human pluripotent stem cells and application of both ADH and CYP2E1 
inhibitor: 
The routine culture of each human pluripotent stem cells types [hESCs (SHEF1 and 
SHEF2) and iPSC] in 6-well tissue culture plate was performed as described in section 
2.1.2 with Essential 8 Medium in two oxygen conditions (2% and 21% O2). Alcohol 
dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1) inhibitor 4-methyl pyrazole 
(4-MP) (Alfa Aesar, Cat. No. A18083) was dissolved in filtered dH2O prior to the 
experiments and stored as a 2.5 M stock inhibitor solution. Water solvent was selected to 
prevent any effect on the cells biochemistry and any interference with the SIFT-MS 
analysis and results. Fresh inhibitor (5 mM) / media solutions were prepared for each 
media replacement. 
2.4.1 Cell viability: 
The effect of the ADH and CYP2E1 inhibitor (4-MP) on the viability of each human 
pluripotent stem cell ((ESCs(SHEF1), ESCs(SHEF2), iPSCs) was assessed with the cells 
attached to 96-well plates and cultured in two oxygen conditions by determining the 
mitochondrial dehydrogenase activities in the living cells using the MTT assay. MTT 
(Sigma-Aldrich, Cat. No. M5655) solution was prepared as described in section 2.2.1. 
Equal numbers of cells (104 cells) were plated per well in 96-well plates and incubated for 
72 hours in two oxygen conditions. Three different concentrations of 4-MP inhibitor were 
used (0.5 mM, 5 mM and 50 mM). After this time, 150 µl/well of MTT reagent containing 
E8 medium solution was added with a final concentration 0.5 mg/ml of MTT and the cells 
were incubated at 37 oC for 4 hours. Thereafter, 125 µl of the MTT solution was removed. 
The MTT-formazan product was subsequently dissolved by addition of 100% DMSO (50 
µl/well) in the dark, followed by incubation for 45 minutes in the incubator at 37 oC. The 
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absorption was then measured with a microplate reader (BioTek, synergy 2) at a 570 nm 
wavelength. Triplicate experiments were performed at both oxygen conditions. 
2.4.2 Headspace analysis by SIFT-MS: 
Before commencing the ADH and CYP2E1 inhibition experiments, each human 
pluripotent stem cell was divided into two experimental groups: the first group was 
untreated cells serving as the control group and the second group was treated cells with 5 
mM 4-MP inhibitor; additional E8M containing 6-well tissue culture plates without cells 
were incubated in relevant oxygen condition with and without 5 mM 4-MP in parallel and 
processed as a control for the corresponding group. In this case, 70-80% confluence, the 
cells in one 6-well tissue culture plate were treated by applying the inhibitor (4-MP, 5 mM) 
containing E8 medium (20 ml) and the cells in the second 6-well tissue culture plate were 
treated with the E8 medium without inhibitor, while cell-free 6-well tissue culture plates 
were incubated with inhibitor (4-MP, 5 mM) containing E8 medium and E8M without 
inhibitor for 24 hours in relevant oxygen condition, prior to transferring the media to the 
150 ml glass bottles. The bottles were then purged with dry and sterile air (20% oxygen 
and 80% nitrogen mixture; BOC, UK) for 1 minute and capped tightly with septum caps 
and parafilm and incubated for an additional 16 hours at 37 oC, this incubation period was 
chosen to allow accumulation of volatile organic compounds before a SIFT-MS 
measurement was taken. Following the 16 hour incubation period for media samples, the 
headspace was measured using profile 3 SIFT-MS instrument as described in section 2.3.3. 
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2.5 Human mesenchymal stem cells: 
2.5.1 Isolation of mesenchymal stem cells from bone marrow aspirate and 
culture: 
Human mesenchymal stem cells (hMSCs) were isolated and cultured from whole bone 
marrow aspirates (BMA) by modification of the plastic adherent culture technique 
described by Kay et al, 2015. Commercially sourced (Lonza, USA) whole bone marrow 
aspirates aspirated from the bilateral iliac crest from 3 different healthy donors (Table 2.2) 
were and supplemented with 100 U heparin/ml to prevent coagulation.  
Table 2. 2. Donor details of human bone marrow aspirates. 
No BMA label Donor description Supplier 
1 BMA-15 Human Bone Marrow, Female, Age-36 years Lonza, MD, USA 
2 BMA-16 Human Bone Marrow, Male, Age-29 years Lonza, MD, USA 
3 BMA-17 Human Bone Marrow, Female, Age-50 years Lonza, MD, USA 
 
The aspirate was seeded within 48 hours of aspiration at a density of 105 total cells/cm2, 
according to the total cell count provided by the supplier with the aspirate, onto 
fibronectin-coated 75 cm2 tissue culture flasks. Fibronectin coating of flasks was 
performed with a 10 ng/ml solution of fibronectin in PBS for at least one hour at room 
temperature after which the fibronectin solution was aspirated and BMA added to a total 
volume of 20ml per T75. of Dulbecco’s Modified Eagle Medium (DMEM) (Lonza, Cat. 
No. BE12-709F) supplemented with 5% (v/v) Fetal Bovine Serum (FBS) (biosera, Cat. No. 
FB-1001/500), 2mM L-Glutamine (L-Glut) (Lonza, Cat. No. BE17-605E), 1% (v/v) non-
essential amino acid (NEAA) (Lonza, Cat. No. BE13-114E) and 1% (v/v) (PSA) 
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penicillin-streptomycin-amphotericin B (Lonza, Cat. No. 17-745E) (100 U/ml penicillin, 
100 µg/ml streptomycin, 0.25 µg/ml amphotericin B) at 37 oC in three different oxygen 
conditions (21% O2, 2% O2, 2% O2 Work Station (WS)) and 5% CO2. After one week of 
culture 50% media was removed and replaced with freshly prepared media as described 
above. Following this cells were incubated for a further week after time a whole media 
change was performed. hMSC isolation was complete at the end of the third week as 
evidenced by the appearance of colony forming units – fibroblastic (CFU-F) following the 
removal of all non-adherent cell populations. Once isolated hMSC media changes were 
carried out twice a week with freshly completed media as described above (Figure 2.4). 
 
Figure 2. 4. Experimental design showing MSCs isolation by adherent culture using 
plastic tissue culture. (A) MSCs isolation from heparinized human bone marrow aspirate 
by seeding all bone marrow cells on fibronectin-coated flask and (B) colony forming units-
fibroblast (CFU-F) appeared in flask after removing all non-adherent cells. 
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2.5.1.1 Mesenchymal stem cells sub-culture: 
As necessary, confluent T75 flasks of hMSCs were sub-cultured enzymatically using 
trypsin/EDTA (Lonza, Cat No. BE02-007E). Trypsinisation was carried out by diluting 
one volume of 5g/L trypsin and 2g/L EDTA stock solution in 10 volume of calcium and 
magnesium-free PBS; the cells were rinsed twice with PBS and 5 ml of diluted 
trypsin/EDTA solution was added to cover the cells before 3-5 minutes incubation at 37 oC 
for. After the incubation period, flasks were tapped to encourage cell detachment, and once 
microscopically confirmed, 10 ml of complete medium added to halt the trypsin activity. 
The cells suspension was then transferred into a centrifuge tube and pelleted at 200 g for 3 
minutes. The supernatant was aspirated and the cells re-suspended in medium for passage. 
2.5.1.2 Surface markers characterisation of mesenchymal stem cells: 
hMSCs surface marker expression was characterised on passage 1 cells. hMSCs were 
washed with PBS and then trypsinised using trypsin/EDTA as described in section 2.5.1.2. 
Thereafter, cells were counted and re-suspended in flow cytometry buffer (PBS with 0.5% 
(w/v) BSA (Fisher Scientific, Cat No. BP9703-100) and 2 mM EDTA (Fisher Scientific, 
Cat. No. BP2482-1) for 10 minutes and approximately 1x106 cells distributed equally 
across 10 x 1.5 ml eppendorf tubes for specific cell surface marker staining, centrifuged at 
300 g for 5 minutes and the supernatant discarded. 100 µl flow cytometry buffer and 10 µl 
of either CD73 (Miltenyi Biotech, Cat. No. 130-097-943), CD90 (Miltenyi Biotech, Cat. 
No. 130-097-932), CD105 (Miltenyi Biotech, Cat. No. 130-098-906), CD14 (Miltenyi 
Biotech, Cat. No. 130-098-067), CD19 (Miltenyi Biotech, Cat. No. 130-098-068), CD34 
(Miltenyi Biotech, Cat. No. 130-098-140), CD45 (Miltenyi Biotech, Cat. No. 130-098-
141), HLA-DR (Miltenyi Biotech, Cat. No. 130-098-177), IgG1 isotype control (Miltenyi 
Biotech, Cat. No. 130-098-845) or IgG2a isotype control (Miltenyi Biotech, Cat. No. 130-
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098-849) phycoerythrin-conjugated antibodies were added to the cells followed by 
incubation in the dark at (2-8 oC) for 10 minutes. Following incubation, flow cytometry 
buffer was added to a total volume of 1 ml and hMSC centrifuged at 300 g for 5 minutes, 
the supernatant removed and finally the cell re-suspended in 1 ml of flow cytometry buffer 
for analysis in the flow cytometer (Cytomics FC 500, Beckman Coulter), with at least 
50000 events count. The acquired data were analysed using Flowing Software (version 
2.5.1). IgG1 was the isotype control for CD19, CD73, CD90 and CD105, while IgG2a was 
the isotype control for CD14, CD34, CD45 and HLA-DR). FL2 channel was used for 
analysis. 
2.5.1.3 Tri-lineage differentiation: 
To determine the multipotency of hMSCs cells were seeded into a 24-well plate at a 
density of 2x104/cm2 in MSCs complete culture media and allowed to attach overnight. 
Following this the media was replaced with differentiation media and this marked as the 
first day of differentiation. hMSCs were then cultivated for 21 days in adipogenic 
differentiation medium, osteogenic differentiation medium and chondrogenic 
differentiation medium with medium changes twice a week whereas control culture, 
hMSCs were maintained in complete culture media for the same period with media 
changes twice a week. 
2.5.1.3.1 Adipogenic differentiation: 
Adipogenic differentiation media was made by supplementing Dulbecco’s Modified Eagle 
Medium (DMEM) (Lonza, Cat. No. BE12-709F) with 10% (v/v) FBS (biosera, Cat. No. 
FB-1001/500), 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E), 2mM L-Glut (Lonza, Cat. 
No. BE17-605E), 0.5 µM dexamethasone (Sigma-Aldrich, Cat. No. D2915), 0.5 mM 3-
isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich, Cat. No. I7018), 10 µg/ml insulin 
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(Sigma-Aldrich, Cat. No. I9278) and 0.1 mM indomethacin (Sigma-Aldrich, Cat. No. 
I7378). 
2.5.1.3.2 Osteogenic differentiation: 
Osteogenic differentiation media was made by supplementing Dulbecco’s Modified Eagle 
Medium (DMEM) (Lonza, Cat. No. BE12-709F) with 10% (v/v) FBS (biosera, Cat. No. 
FB-1001/500), 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E), 2mM L-Glut (Lonza, Cat. 
No. BE17-605E), 50 µM ascorbic acid phosphate (Sigma-Aldrich, Cat No. A8960), 10 
mM β-glycerophosphate (Sigma-Aldrich, Cat. No. G5422) and 0.1 µM dexamethasone 
(Sigma-Aldrich, Cat. No. D2915). 
2.5.1.3.3 Chondrogenic differentiation: 
Chondrogenic differentiation media was made by supplementing Dulbecco’s Modified 
Eagle Medium (DMEM) (Lonza, Cat. No. BE12-709F) with 1% (v/v) FBS (biosera, Cat. 
No. FB-1001/500), 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E), 2 mM L-Glut (Lonza, 
Cat. No. BE17-605E), 1% (v/v) Insulin, Transferrin, Sodium Selenite (ITS) (Sigma-
Aldrich, Cat. No. I3146), 1% (v/v) sodium pyruvate (Sigma-Aldrich, Cat. No. S8636), 0.1 
µM dexamethasone (Sigma-Aldrich, Cat. No. D2915), 50 µM ascorbic acid phosphate 
(Sigma-Aldrich, Cat. No. A8960), 40 µg/ml L-Proline (Sigma-Aldrich, Cat. No. P5607) 
and 10 ng/ml TGF-β3 (PeproTech, Cat. No. AF-100-36E). 
2.5.1.3.4 Histological staining of differentiated hMSCs: 
To confirm hMSCs differentiation after 21 days hMSC were washed twice with PBS and 
fixed with 4% paraformaldehyde in PBS for 20 minutes after which fixed cells were 
washed twice with PBS before being stored in PBS at 4 oC. Calcium deposition by 
differentiated osteoblasts, lipid accumulation in adipocytes and glycosaminoglycan-rich 
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matrix secreted by chondrocytes was detected by histological stains; Alizarin Red S, Oil 
Red O and Alcian Blue respectively. 
2.5.1.3.5 Alizarin Red: 
Fixed cells were stained with Alizarin Red S (Sigma-Aldrich, Cat. No. A5533) to detect 
calcium deposition. A 2% (w/v) of Alizarin Red S solution was prepared in distilled water 
(dH2O), filtered with 0.4 porous filter paper and the pH adjusted to 4.1 with the 10% 
ammonium hydroxide. For staining PBS was first removed from fixed cells followed by a 
dH2O wash and immersion in alizarin red s solution for 10 minutes. The cells were then 
washed five times with tap water to remove excess dye and covered with tap water before 
viewing the cells with an inverted microscope (OLYMPUS CKX41) with a colour camera 
attachment using Image-Pro Insight software. 
2.5.1.3.6 Oil Red O: 
A stock solution of Oil Red O was prepared by dissolving 175 mg Oil Red O (Sigma-
Aldrich, Cat. No. O0625) in 50 ml of 99% isopropanol (Fisher Scientific, Cat. No. 
P/7500/17) which was then left overnight to ensure saturation of the solution. The solution 
was then filtered with a 0.22 µm syringe filter. The working solution was prepared 
immediately prior to staining by mixing 6 ml of stock solution with 4 ml of dH2O. To stain 
fixed cells PBS was removed followed by two 60% isopropanol washes for 5 minutes 
each. Oil Red O working solution was then added for 10 minutes after which the stain was 
removed, cells washed 5 times with tap water before finally being immersed in tap water 
before being viewed with an inverted microscope (OLYMPUS CKX41) with a colour 
camera attachment using Image-Pro Insight software. 
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2.5.1.3.7 Alcian Blue: 
To detect glycosaminoglycan production by the differentiated chondrocytes a 1% Alcian 
blue stain solution (pH 1.5) was prepared by dissolving 500 mg of Alcian Blue 8GX 
(Sigma-Aldrich, Cat. No. A5268) in 3% acetic acid (Sigma-Aldrich, Cat. No. A6283). The 
solution was filtered using 0.2 µm porous paper filter. To stain PBS was removed from 
fixed cells which were then washed once with dH2O and then stained with 1% Alcian blue 
solution overnight at room temperature. The stain was then removed and cells washed 
gently with running tap water for 2 minutes. Images were captured via an inverted 
microscope (OLYMPUS CKX41) with a colour camera attachment using Image-Pro 
Insight software. 
2.5.2 Headspace analysis of human bone marrow aspirate and bone marrow-
derived mesenchymal stem cells by SIFT-MS: 
BMA were seeded in three conditions (21% O2, 2% O2 and 2% O2 WS) as described in 
section 2.5.1. After 24 hours incubation BMA in cell culture media (total volume 20 ml) 
was removed and placed into a 150 ml glass bottle and the volume raised to 50 ml with 
freshly prepared complete culture media. Media was again collected after 7 and 14 days 
incubation where either the collection was performed by transferring 50% (7 days’ time 
point) of the culture media (10 ml each flask) or 100% (14 days’ time point) of the culture 
media (20 ml each flask) into bottles and the volume raised to 50 ml with freshly prepared 
complete culture media. After 21 days, cell-free supernatant media (20 ml each flask) was 
collected and transferred into 150 ml glass bottles and completed to 50 ml with freshly 
complete culture media. For hMSCs, cells were detached from the flask with 
trypsin/EDTA as described in section 2.5.1.1, re-suspended in 50 ml freshly complete 
culture media and immediately transferred into 150 ml glass bottles. In parallel, incubated 
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cell culture media without cells and freshly prepared complete culture media were 
collected at each time point in the same fashion as described above (Figure 2.5). Once the 
media/cells were added to the bottles, the samples were purged with dry and sterile air 
(20% oxygen and 80% nitrogen mixture; BOC, UK) for 1 minute, sealed tightly with 
septum caps and parafilm, and incubated for 16 hour at 37 oC. This incubation period was 
to allow accumulation of volatile organic compounds before a SIFT-MS measurement was 
taken. Following the 16 hour incubation period the headspace was measured using profile 
3 SIFT-MS instrument as described in section 2.3.3. Each time point was evaluated in 
triplicate from three independent donors. 
 
Figure 2. 5. The process flow of VOCs extraction of bone marrow aspirate and BM-
MSCs. Volatile extraction using headspace (HS) was performed for culture media at bone 
marrow aspirate time point and days 7, 14 and 21 (adherent MSCs) of isolation and 
suspended MSCs.  
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2.6 Osteogenic differentiation of mesenchymal stem cells: 
For gene expression and volatile organic compound determination in response to 
osteogenic differentiation hMSC at P1 were harvested by trypsinisation using 
trypsin/EDTA (Lonza, Cat. No. BE02-007E) and subsequently seeded at densities of 2x104 
cells/cm2 into 24-well culture plates for histological characterisation (see section 2.5.1.3.5), 
6-well culture plates for RNA extraction (see section 2.3.2.1) and T75 culture flasks for 
volatile organic compound determination in the MSCs complete culture medium consisting 
of Dulbecco’s Modified Eagle’s Medium (DMEM) (Lonza, Cat. No. BE12-709F), 5% 
(v/v) FBS (biosera, Cat. No. FB-1001/500), 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E) 
and 2mM L-Glut (Lonza, Cat. No. BE17-605E), and incubated in a humidified atmosphere 
at 37 oC in three different oxygen conditions 21% O2, 2% O2 and 2% O2 WS, and 5% CO2 
for 24 hours. Osteogenic differentiation was induced by addition of osteogenic induction 
medium consisting of Dulbecco’s Modified Eagle Medium (DMEM) (Lonza, Cat. No. 
BE12-709F) supplemented with 10% (v/v) FBS (biosera, Cat. No. FB-1001/500), 1% (v/v) 
NEAA (Lonza, Cat. No. BE13-114E), 2mM L-Glut (Lonza, Cat. No. BE17-605E), 50 µM 
ascorbic acid phosphate (Sigma-Aldrich, Cat No. A8960), 10 mM β-glycerophosphate 
(Sigma-Aldrich, Cat. No. G5422) and 0.1 µM dexamethasone (Sigma-Aldrich, Cat. No. 
D2915). Uninduced control cultures were maintained in the MSCs complete culture media 
throughout and used as control samples. Osteogenic and maintenance media were changed 
twice a week over the culture period. 
2.6.1 Histological Characterisation of osteogenic differentiation: 
At each time point (7, 14 and 21 days), hMSCs were either expanded or induced to 
undergo osteogenic lineage commitment. The histological characterisation was performed 
as described in section 2.5.1.3. 
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2.6.2 RT-PCR: 
Semi-quantitative RT-PCR assay was performed to determine the expression levels of 
osteoblast-specific marker genes osteonectin (SPARC), collagen 1A1 (COL1A1), alkaline 
phosphatase liver/bone/kidney (ALPL), runt-related transcription factor 2 (RUNX2), and 
osteocalcin (BGLAP) at Days 0, 7, 14 and 21 of differentiation. The primers were designed 
using human gene sequences from NCBI Map Viewer. Customised primer sets were 
purchased from Invitrogen, USA. Primers are listed below (Table 2.2). 
Table 2. 3. Table of primers sequences, annealing temperatures and product size. 
Gene name Sense sequence  
(5’ to 3’) 
Antisense sequence  
(5’ to 3’) 
Annealing 
Temperat
ure (oC) 
Product 
size  
(bp) 
ACTB GCCACGGCTGCTTC
CAGC 
AGCCATGCCAATCT
CATCTT 
57 528 
ALPL TGCGCAGAGAAAG
AGAAAG 
CATTGGTGTTGTAC
GTCTTG 
56 259 
COL1A1 TGCTCGTGGAAATG
ATGG 
AATACCAGGAGCA
CCATTG 
56 256 
SPARC GGATGAGGACAAC
AACCTTC 
GATCCTTGTCGATA
TCTCTGC 
57 357 
RUNX2 TCCCAGTATGAGAG
TAGGTG 
GGCAGTGTCATCAT
CTGAAA 
56 274 
BGLAP CAAATAGCCCTGGC
AGATTC 
CTTGGACACAAAG
GCTGC 
57 278 
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2.6.2.1 RNA extraction: 
At each time point (0, 7, 14, 21 days) the RNA isolation was performed as described in 
section 2.3.2.1. 
2.6.2.2 One-step Reverse Transcription Polymerase Chain Reaction: 
At each time point of osteogenic differentiation 0, 7, 14 and 21 days, RT-PCR was 
performed as described in section 2.3.2.2.  
2.6.2.3 Gel electrophoresis: 
All the amplicons were confirmed by agarose gel electrophoresis as described in section 
2.3.2.3. 
2.6.3 Headspace analysis of mesenchymal stem cells and osteogenic cells by 
SIFT-MS: 
hMSC were seeded into 6X T75 cell culture flasks containing 20 ml MSCs complete 
culture media (DMEM, 2mM L-glutamine, 1% (v/v) NEAA and 5% (v/v) FBS) after 
trypsinisation as described in section 2.5.1.1 at a density of 2x104 cells/cm2. Cells were 
grown in an incubator for 24 hours at 37 oC in humidified, 5% CO2 and three different 
oxygen condition 21% O2, 2% O2 and 2% O2 Work Station (WS) atmosphere. After 24 
hours incubation, three cell culture flasks out of six in each condition were induced 
towards osteogenesis by addition of osteogenic differentiation media as described in 
section 2.5.1.3.2, for up to 21 days where the medium was changed every 2-3 days. hMSCs 
grown in MSCs medium were used as a control samples. At days 7, 14 and 21 (Figure 2.6), 
cells were incubated for 24 hours with 20 ml of MSCs culture media after which medium 
was removed from each flask (from hMSCs control and differentiation e) and transferred 
into 150 ml glass bottles. In parallel, incubated MSCs culture media without cells was 
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collected at each time point in the same fashion as described above. The volume of media 
in each bottle was raised to 50 ml and the samples were prepared for SIFT-MS as 
described in section 2.5.2. 
 
 
Figure 2. 6. The process flow showing key steps for VOCs extraction from MSCs 
culture media in standard and osteogenic treatment. MSCs were seeded in 6 X T75 
flasks, MSCs in three flasks induced into osteogenic while kept MSCs in the others in 
standard MSCs medium, volatile extraction using headspace (HS) was performed for cell 
culture media in standard and treated cells at days 7, 14, 21 of induction. 
 
55 
 
2.7 Headspace analysis of cell culture media: 
Dulbecco’s Modified Eagle Medium (DMEM) (Lonza, Cat. No. BE12-709F) 
supplemented with 1% (v/v) NEAA (Lonza, Cat. No. BE13-114E) and 2mM L-Glut 
(Lonza, Cat. No. BE17-605E); Essential 8 Medium (Gibco, Cat. No. A15169-01); 
Dulbecco’s Modified Eagle Medium/F12 (DMEM/F-12) (Gibco, Cat. No. 31330-038) and 
Knockout DMEM (KO-DMEM) (GIBCO, Cat No. 10829-018) supplemented with 2mM 
L-Glutamine (Lonza, Cat. No. BE17-605E), 1% (v/v) NEAA (Lonza, Cat. No. BE13-
114E) were used in this experiments. 20 ml of each media was incubated in 6-well tissue 
culture plates in 21% O2, 2% O2 and 2% O2 Work Station (WS) at 37 
oC and 5% CO2 for 
24 hours and then transferred into 150 ml glass bottles. Similarly, non-incubated media 
was added to 150 ml glass bottles. Once the media added to the bottles, the samples were 
purged with dry and sterile air (20% oxygen and 80% nitrogen mixture; BOC, UK) for 1 
minute and sealed tightly with septum caps and parafilm, and incubated for further 16 
hours at 37 oC, this incubation period was chosen to allow accumulation of volatile organic 
compounds before a SIFT-MS measurement was taken. Following the 16 hour incubation 
period for the samples, the headspace was measured using profile 3 SIFT-MS instrument 
as described in section 2.3.3. Each time point was made in triplicate. 
2.8 Data pre-treatment: 
Spectral datasets of full scan (FS) mode, obtained from analysis of the headspace vapour of 
samples, were analysed using multivariate statistical analysis using SIMCA 14.1 software 
(MKS Umetrics AB, Umeå, Sweden). Initially, principal component analysis (PCA) was 
applied as unsupervised clustering then orthogonal projection least squares discriminant 
analysis (OPLS-DA) as a supervised multivariate analyses. The data were transformed and 
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scaled before computing the PCA and OPLS-DA using log transformation and unit 
variance (UV) scaling.  
In addition to the multivariate analysis, ANOVA or t-test was also performed by 
investigating the spectra to identify significant variables (ions) in different cell culture 
media and conditions after removing m/z 19 precursor ion (H3O
+) and its isotopologues at 
m/z 20, m/z 21, plus water clusters (because of the aqueous nature of samples) and their 
isotopologues at m/z 37, m/z 38, m/z 39, m/z 55, m/z 56, m/z 57, m/z 73, m/z 74, m/z 75, 
m/z 91 (Spanel and Smith, 2000; Spooner et al., 2009; Shestivska et al., 2015) in addition 
to variables with zero values.
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Chapter 3-Cell 
functionality 
characterisation
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3.1 Introduction: 
Stem cells are functionally undifferentiated cells that have the ability to self-renew and to 
differentiate into specialised cell types. Stem cells may be isolated from embryo, bone 
marrow and several adult tissues, and the potential for differentiation of these stem cells 
into committed and more mature specialized cell varies depending on the source of stem 
cells (Ullah et al., 2015).  
Pluripotent stem cells have the potential to differentiate into three embryonic germ layers 
and give rise to all the cell types of the embryo proper. These cells include both embryonic 
stem cells, which derived from blastocyst stage embryo, and induced pluripotent stem 
cells, pluripotency has been induced via the reprogramming of somatic cell. (Avior et al., 
2016). The capability of hPSCs for application in cell replacement therapy and for 
treatment of disease has been discussed previously (Wu and Hochedlinger, 2011). Scale up 
and expansion of hPSC relies on in vitro culture and this includes a number of 
environmental limitations which place undue stresses onto the cells. Among these stresses 
is the routine use of non-physiological air oxygen concentrations (21% O2) (Stover et al., 
2016). 
In contrast, adult stem cells are multipotent stem cells, which are able to give rise to a 
subset of cell linages, and of these, the mesenchymal stem cells (MSCs) are an example of 
adult stem cells (Haasters et al., 2009). MSCs can be isolated from a wide range of adult 
tissues such as umbilical cord blood, adipose tissue, bone marrow and dental pulp (Erices 
et al., 2000; Lund et al., 2009; Shi and Gronthos, 2003). 
The two distinct stem cells populations that generally reside in bone marrow are 
haematopoietic and mesenchymal stem cells (Dawn and Bolli, 2005). Bone marrow-
derived MSCs are usually isolated via their physical adherence to the plastic tissue culture 
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plate (Meirelles and Nardi, 2003). An aspect of the utility of MSCs in cell-based therapies 
includes their differentiation capacity where, for instance, bone repair resides in their 
capacity to differentiate into osteoblasts (Im, 2015). It therefore becomes important to 
maintain multipotency in clinical mesenchymal stem cells prior to transplantation into the 
target tissue (Otte et al., 2013). 
The functional characterisation of cells in this first result chapter was essential before any 
further studies are carried out, to ensure the quality and the current status of the cells. 
3.2 Aims: 
1. To characterise hPSCs and assess their proliferation, metabolic activity and 
differentiation in two different oxygen conditions (21% O2 and 2% O2). 
2. To isolate mesenchymal stem cells (MSCs) from human bone marrow aspirate and 
culture them in three different oxygen conditions (21% O2, 2% O2 and 2% O2 WS). 
3. To characterise bone marrow derived mesenchymal stem cells (BM-MSCs) and 
assess their osteogenic differentiation in three different oxygen conditions (21% O2, 
2% O2 and 2% O2 WS). 
3.3 Materials and methods: 
hPSCs were cultured and expanded in xeno-free E8M under air (21% O2) and 
physiological normoxia (physioxia) (2% O2) (See chapter 2 for more details). hPSCs 
growth analysis was evaluated via cell counts and MTT while detailed characterisation of 
hPSCs was carried out to confirm pluripotency. Immunofluorescence- and FACS-based 
methods were applied to identify and quantify SSEA1, SSEA-4, TRA-1-60 expression. 
Pluripotency marker expression was also evaluated over 20 days of differentiation via both 
immunofluorescence and RT-PCR (Full methodology is detailed in chapter 2). 
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hMSCs isolation, characterisation and osteo-induction were carried out in three oxygen 
conditions (21% O2, 2% O2 and 2% O2 WS) (Full methodology in detailed in chapter 2). 
3.4 Results: 
3.4.1 Influence of physioxia (2% O2) on proliferation of hPSCs 
To determine the effect of oxygen on the proliferation of hPSC (ESCs and iPSCs) cells 
were seeded into multiple wells of a 6-well plate and cell counts performed daily over a 6-
day period.  From analysis of two hESC lines (SHEF1 and SHEF2) and a single hiPSC line 
(ZK2012L) it was apparent that no consistent pattern emerged (Figure 3.1). SHEF1 cell 
number increased significantly from day 3 onwards in physioxia vs. air oxygen (P<0.05). 
Conversely, SHEF2 and ZK2012L displayed increases from day 2 onwards in air oxygen 
vs. physioxia, with significant increases for ZK2021L cells at two, four and five days of 
counting(P<0.05).
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Figure 3. 1. hPSCs display cell line specific proliferation responses to physioxia. a) 
SHEF1 b) SHEF2 and c) ZK2012L in air oxygen (21% O2) and physioxia (2% O2). The x-
axis indicates time (days), y-axis indicates cells x 104/ml. Red and blue lines represent 
cells cultured under 21% O2 and 2% O2. Error bars represent +/- SD. Asterisk (*) indicates 
p<0.05 between conditions
62 
 
3.4.2. Influence of physioxia (2% O2) on hPSCs metabolic activity 
The impact of oxygen condition on mitochondrial metabolic activity was investigated via 
the MTT assay. Cells were seeded as described for the cell counting experiment (Section 
3.4.1) and MTT performed at each day post seeding in 2% O2 and 21% O2 conditions. 
Similar to influence of physioxia on proliferation of hPSCs (section 3.4.1) it was apparent 
that individual cell lines displayed distinct responses to a physioxia environment (Figure 
3.2). SHEF1 displayed a significant increase in MTT at Day 6 in physioxia only (Figure 
3.2a) whereas SHEF2 and ZK2012L (Figure 3.2b and c) both exhibited significant MTT 
decreases in physioxia across the bulk of the time points tested (only Day 5 for SHEF2 and 
Day 1 for ZK2012L were not significant).
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Figure 3. 2. hPSCs display cell line specific metabolic responses to physioxia. a) 
SHEF1, b) SHEF2, and c) ZK2012L in air oxygen (21% O2) and physioxia (2% O2). The 
x-axis indicates Time (days), y-axis indicates MTT absorbance (570 nm). Red and blue 
bars represent cells cultured under 21% O2 and 2% O2, respectively. Error bars represent 
+/- SD. Asterisk (*) indicates p<0.05 between conditions. 
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3.4.3. Characterisation of hPSCs by immunofluorescence staining and flow 
cytometry 
hPSCs expression of surface markers associated with retention of pluripotency was 
explored via immunostaining of live cells with SSEA-4, TRA-1-60, and the marker of 
differentiation, SSEA-1. The immunofluorescent staining of live, unfixed hPSCs showed 
positive expression of the pluripotent surface markers SSEA-4 and TRA-1-60 alongside 
negative expression of the SSEA-1 surface marker (figure 3.3a-c). These characteristics are 
typical of the surface antigen of hPSCs and distinct from the differentiated hPSCs. 
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Figure 3. 3. Analysis of SSEA-4, TRA-1-60 and SSEA-1 expression in live hPSCs 
cultured in 21% and 2% O2. a) SHEF1, b) SHEF2, and c) ZK2012L. For each 
pluripotent stem cell, the left panel shows cells cultured in 21% O2 and the right panel 
shows cells cultured in 2% O2. In each panel, the top row shows images stained with 
SSEA-4 antibody, the middle row shows images stained with TRA-1-60 antibody and the 
bottom row shows images stained with SSEA-1 antibody, whereas the left column shows 
phase-contrast images, the middle column shows fluorescent images and the right column 
shows merged images. Scale bars represent 100 µm. 
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Following on from marker expression by immunofluorescence, expression levels of each 
marker were quantified via flow cytometry analysis (Figure 3.4) and (Table 3.1). 
 
Table 3. 1. Mean ± SD percentage of hPSCs for each marker in 21% O2 and 2% O2 
conditions. 
Cell  Oxygen 
condition 
Marker 
SSEA-4 TRA-1-60 SSEA-1 
SHEF1 21% 97.86 ± 2.66 70.16 ± 14.4 2.55 ± 0.6 
2% 98.6 ± 1.17 76.2 ± 12.85 2.5 ± 0.3 
SHEF2 21% 83.43 ± 15.36 64.71 ± 12.87 4.54 ± 3.68 
2% 90.91 ± 6.89 68.76 ± 11.99 3.74 ± 1.5 
ZK2012L 21% 91.08 ± 2.61 52.25 ± 7.1 6.12 ± 4.46 
2% 92.07 ± 7.86 57.64 ± 5.13 5.82 ± 3.31 
 
No significant changes in expression levels of SSEA-4, TRA-1-60, or SSEA-1 were noted 
between cells cultured under physioxia and air oxygen. Previous reports have indicated 
that physioxia can reduce both size and complexity of hPSCs vs. air oxygen. The panel of 
cell lines was investigated using forward scatter (FS) and side scatter (SS) as surrogate 
markers for size and complexity, respectively. Overall reductions were noted in each 
instance but the associated variance made the bulk of these decreases non-significant. The 
only +exceptions to this were with ZK2012L (FS) and SHEF2 (SS). 
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Figure 3. 4. Analysis of SSEA-4, TRA-1-60 and SSEA-1 expression in hPSCs by flow 
cytometry analysis. Overlay histograms of pluripotent marker expression for SHEF1 (top 
panel), SHEF2 (middle panel) and ZK2012L (bottom panel) cultured in air oxygen (21% 
O2) (a) and physioxia (2% O2) (b). Percentage of positive cells identified from (a) and (b). 
(c). FS and SS graphs of SHEF1 (d), SHEF2 (e), and ZK2012L (f) where geometric mean 
of FS (size) and SS (complexity) for cells in 21% and 2% O2 (x-axis) are shown on y-axis. 
Error bar represent +/-SD. 
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3.4.4. Genes related to ethanol/acetaldehyde metabolism 
Acetaldehyde sits as a midpoint on the Ethanol to Acetate metabolic pathway controlled by 
expression of specific enzymes (Figure 3.5 and Table 3.2). In summary Ethanol is oxidised 
to acetaldehyde where the reaction is catalysed by ADH, CYP2E1 and CAT enzymes and 
the resultant acetaldehyde is further oxidised to acetate by the ALDH enzyme (Seitz and 
Stickel, 2007). The conversion involves 7 alcohol dehydrogenase (ADH) family members, 
a single cytochrome P4502E1 (CYP2E1), a single catalase (CAT), and 19 acetaldehyde 
dehydrogenase family members (ALDH).  
 
Figure 3. 5. Pathways of ethanol/acetaldehyde metabolism in human. The oxidation of 
ethanol by ADH and/or CYP2E1 and/or catalase produces acetaldehyde which is converted 
in turn into Acetate by ALDH. 
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Table 3. 2. Ethanol/acetaldehyde metabolism genes (NCBI). 
No. Metabolic reaction Enzyme Gene 
1 Ethanol                   Acetaldehyde Alcohol dehydrogenase ADH1B, 
ADH1C, 
ADH1A, 
ADH5, 
ADH4, 
ADH7, 
ADH6 
2 Ethanol                   Acetaldehyde Cytochrome P450 2E1 
(CYP2E1) 
CYP2E1 
3 Ethanol                  Acetaldehyde Catalase CAT 
4 Acetaldehyde                   Acetate Aldehyde dehydrogenase ALDH2, 
ALDH1A1, 
ALDH1B1, 
ALDH7A1, 
ALDH3A1, 
ALDH1L1, 
ALDH3A2, 
ALDH5A1, 
ALDH1A2, 
ALDH1A3, 
ALDH18A1, 
ALDH4A1, 
ALDH9A1, 
ALDH3B1, 
ALDH6A1, 
ALDH1L2, 
ALDH16A1, 
ALDH8A1, 
ALDH3B2 
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Our research group has previously noted that culture of hPSC in physioxia results in 
substantial modulation of the transcriptome vs. air oxygen cultured cells (Forsyth et al, 
2008). This microarray data was reanalysed via in silico analysis to determine if any 
significant changes in gene expression level were noted for the enzymes identified above. 
CAT, CYP2E1, ALDH1L2, ADH4, ADH5 and ALDH18A1 were all significantly 
upregulated in 2% O2, while ALDH9A1, ALDH4A1, ALDH7A1, ALDH16A1, 
ALDH1B1, ALDH1A2, ALDH3A2, ALDH5A1, ALDH6A1, ALDH1A3, ALDH1A1 
were all significantly downregulated in 2% O2 (Figure 3.6a). RT-PCR supported the 
upregulation of ADH4, ADH5 and CYP2E1 and downregulation of ALDH1A1, 
ALDH1A3 and ALDH6A1 in 2% O2 (Figure 3.6b). 
 
Figure 3. 6. Ethanol/acetaldehyde metabolic pathway linked gene expression. A) The 
fold change in microarray gene expression level in hESCs was plotted on scale 0 to 2 (>1 
for upregulation, while <1 for downregulation). Red bars represent the upregulated genes 
and blue bars represent downregulated genes in hESCs cultured in 2% O2 relative to 21% 
O2. B) RT-PCR of selected gene expression involved in ethanol/acetaldehyde metabolism 
of hPSCs. ACTB confirmed the presence of amplifiable RNA in all samples. 
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3.4.5. Assessment of cell viability in hPSCs cultures 
The effects of treating the cells with the 4-methyl pyrazole (4-MP), inhibitor of ADH and 
CYP2E1, on the viability of hPSCs were assessed under physioxia and air oxygen 
conditions, with the cells attached to 96-well plates, using MTT assay. MTT data indicated 
that 0.5 mM and 5 mM 4-MP inhibitor had no significant effect on the viability of hPSCs 
with the exception of ZK2012L cells treated with 0.5 mM 4-MP in 21% O2, which led to 
significant increase in the MTT reduction, while 50 mM was toxic (Figure 3.7). Therefore, 
the 4-MP concentration of 5 mM was selected in the subsequent SIFT-MS experiment. 
 
Figure 3. 7. Viability of hPSCs exposed to different concentration of 4-MP. X-axis 
represent each hPSCs in both 2% O2 and 21% O2 conditions. Y-axis represents MTT 
absorbance at 570 nm. Blue bars indicate control untreated cells, whereas red, green and 
purple bars indicate 0.5, 5 and 50 mM 4-MP concentrations, respectively. 
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3.4.6. RT-PCR analysis of undifferentiated and spontaneous differentiated 
hPSCs 
Having established the headspace profile of undifferentiated hPSCs alterations during the 
process of differentiation were established and characterised. To achieve this hPSCs were 
spontaneously differentiated by switching media and supplementing with serum. During 
differentiation RNA was extracted over a 20 day period and RT-PCR amplification of 
pluripotency associated and germ layer specific transcripts was performed. In addition to 
this retention of expression of pluripotency-linked proteins via immunofluorescence was 
determined. POU5F1, NANOG, and hTERT expression were detected over the entire 20 
day period in all hPSCs tested. Some evidence of down-regulation was apparent but this 
was not quantified further (Figure 3.8a, b, c). A pluripotent differentiation capacity 
requires evidence of expression of genes associated with the three germ layers. Expression 
of ectoderm (OTX2), endoderm (AFP) and mesoderm (Brachyury) in differentiating 
hPSCs was therefore evaluated. SHEF1 showed a notable gradual increase in AFP 
expression which though stronger in 21% was also apparent in 2% O2 throughout the 
differentiation period (Figure 3.8a). Brachyury gene expression shows upregulation in both 
21% O2 and 2% O2 which was subsequently down-regulated and virtually lost by day 20 
(Figure 3.8a). OTX2 expression was also noted at virtually all time points.  
 
Similar to SHEF1, SHEF2 displayed POU5F1 and NANOG expression at all points tested 
(Figure 3.8b). hTERT appeared to undergo some downregulation in 2% O2 culture only at 
Days 10 and 20. AFP and Brachyury displayed similar expression profiles in 21% O2 
SHEF2 ranging from being undetectable, or at very low levels, at Day 0 to upregulation at 
Day 5 and maintenance thereafter. Conversely in 2% O2 Brachyury was maintained at low 
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levels throughout the period while AFP, apart from a transient upregulation at Day 10, was 
absent. OTX2 was expressed in both undifferentiated and differentiated cells with some 
upregulation in the latter. 
 
ZK2012L was again similar to the above displaying continuous expression of POU5F1, 
NANOG, hTERT, and OTX2 in both 21% O2 and 2% O2 across the entire time-course 
(Figure 3.8c). AFP displayed a gradual increase in expression in 21% O2, while in 2% O2 
the expression of AFP increased through to Day 10 and decreased thereafter (Figure 3.8c). 
Brachyury expression was noted at Day 20 only in 21% O2 and at Days 10 and 20 only in 
2% O2. 
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Figure 3. 8. Expression of pluripotency and differentiation-linked genes in hPSCs 
from day 0 to day 20 of differentiation in 21% O2 and 2% O2. A) SHEF1. B) SHEF2. 
C)ZK2012L. ACTB confirms the presence of amplified RNA in all samples. POU5F1, 
NANOG, hTERT are markers of embryonic stem cell pluripotency. AFP is endoderm 
marker gene. Brachyury is mesoderm marker gene. OTX2 is ectoderm marker gene. 
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3.4.7. Pluripotency marker expression via immunofluorescence in 
undifferentiated and differentiated hPSCs 
Evaluation of transcript expression only indicates that the gene is being transcribed. 
Evidence was therefore next sought to identify that the translated proteins for both 
POU5F1 (OCT-4) and NANOG along with ALP and the SSEA-4 glycoprotein peptides 
were also downregulated during differentiation (Figure 3.9). It was clear that all 
undifferentiated hPSCs expressed high level of OCT-4, NANOG, ALP, and SSEA-4 in 
both 2% and 21% O2 conditions. During spontaneous differentiation, expression of 
pluripotent markers was decreased in a time-dependent manner from 0 to 20 days. SHEF1 
in 2% O2 showed notable reduction in OCT-4, NANOG, ALP and SSEA-4 expression 
after 10, 5, 10 and 20 days of differentiation (Figure 3.9a), respectively, while SHEF1 in 
21% O2 showed notable reduction in OCT-4 and NANOG after 5 days, and ALP and 
SSEA-4 after 10 days of differentiation (Figure 3.9b). SHEF2 in 2% O2 showed notable 
reduction in OCT-4 and NANOG after 5 days, and ALP and SSEA-4 after 10 days of 
differentiation (Figure 3.9c), while SHEF2 in 21% O2 showed notable reductions in OCT-
4, NANOG, ALP and SSEA-4 after 5 days of differentiation (Figure 3.9d). ZK2012L in 
2% and 21% O2 conditions showed notable reduction in OCT-4, NANOG and ALP after 5 
days, and SSEA-4 after 10 days of differentiation (Figure 3.9e and 3.9f). 
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Figure 3. 9. Pluripotency marker expression in undifferentiated and differentiating hPSCs. 
Oct-4, Nanog, ALP, and SSEA-4 expression was evaluated in hPSCs at selected time points of 
differentiation (0, 5, 10 and 20 days) in SHEF1 (21% O2) (A) and (2% O2) (B), SHEF2 (21% O2) 
(C) and (2% O2) (D), and ZK2012L (21% O2) (E) and2% O2 (F). Green fluorescence represents 
Oct-4 and Nanog expression, red fluorescence represents ALP and SSEA-4 expression whereas 
blue fluorescence represents DAPI staining for nuclei in all images. Each scale bar represents 100 
µm. 
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3.4.8. Influence of incubation condition on isolation of hMSCs 
At the culmination of the isolation procedure on day 28 cells were counted and quantified. 
In agreement with previous observations (Kay et al 2015) the highest number of cells were 
recovered under 2% O2 WS condition with a reduced, though not significantly so, number 
in 2% O2 and the least cells recovered under 21% O2 (Figure 3.10). 
 
Figure 3. 10. Oxygen conditions effects on human hMSCs recovery. Bars represent the 
number of cells recovered per T75 flask at first trypsinisation. X-axis indicates oxygen 
conditions and Y-axis indicates cell x 105 per T75 flask. Error bars represent +/- SD. 
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3.4.9. Immunophenotypic characterisation by flow cytometry 
To determine the immunophenotype of isolated cells flow cytometry was used to 
determine expression levels of a panel of cell surface markers, according to ISCT 
guidelines (Dominici et al., 2006) (Figure 3.11). Table 3.3. below indicates that the cells 
isolated displayed an immunophenotype characteristic of an hMSC and that there were no 
significant differences between isolation conditions. 
 
Table 3. 3. Mean ± SD percentage of hMSCs for each marker in three oxygen conditions 
(21% O2, 2% O2 and 2% O2 WS). 
Marker Oxygen condition 
21% 2% 2% WS 
Positive CD105 94.4 ± 4.2 96.5 ± 5.4 96.6 ± 4.2 
CD73 99.6 ± 0.3 99.8 ± 0.1 98.8 ± 1.1 
CD90 93.1 ± 10.7 95.9 ± 6.4 97.1 ± 3.8 
Negative CD19 3.9 ± 3.2 2.7 ± 2.4 0.8 ± 0.5 
CD45 1.2 ± 0.3 0.9 ± 0.8 0.4 ± 0.1 
CD34 1 ± 0.5 0.5 ± 0.4 0.3 ± 0.2 
CD14 5 ± 2.7 6.6 ± 4.5 5.3 ± 3.4 
HLA-DR 3.2 ± 1.2 2.1 ± 1.6 3.7 ± 3.1 
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Figure 3. 11. Immunophenotypic characterisation of BM-hMSCs. A) Flow cytometry 
analysis of cell surface antigens showed that the hMSCs in three oxygen conditions 
positively expressed CD105, CD73 and CD90, but were negative for CD34, CD45, CD14, 
and HLA-DR expression. Unfilled region is isotype control IgG1 or IgG2a, grey region is 
antibody marker. B) Percentage of positive events relative to relevant isotype control 
marker for each immunophenotype marker in each oxygen condition. Bar graph showing 
summary of flow cytometry result for hMSCs. X-axis indicates cell surface markers and y-
axis indicates the percentage of cells staining positive for each marker. Blue bars represent 
average cells in 21% O2, red bars represent average cells in intermittent 2% O2 and green 
bars represent average cells in 2% O2 WS. Error bars represent +/-SD, n=3 for each 
marker. 
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3.4.10. Differentiation of BM-hMSCs into mesenchymal lineage 
Bone marrow isolated cells displayed an hMSC guideline immunophenotype but it 
remained to be determined if they possessed a multipotent differentiation capacity. The 
cells were then exposed to either adipogenic, osteogenic, or chondrogenic differentiation 
cocktails. When cells were cultured in an adipogenic differentiation media, cells showed 
the formation of adipocytes, which were detected by staining the lipid droplet with Oil Red 
O stain; cells grown in control medium did not stain for Oil Red O. When cells were 
induced in osteogenic differentiation media, cells revealed mineralisation with calcium 
deposition confirmed by Alizarin red stain; there was no Alizarin red stain in the cells 
cultured in control media. When cells were differentiated into chondrocytes, cartilage 
matrix formation was demonstrated by Alcian blue staining of proteoglycans; cells grown 
in control media did not stain with Alcian blue (Figure 3.12). Taken together with the 
immunophenotype data the evidence of a tri-lineage differentiation potential allows us to 
refer to the cells as hMSC or BM-hMSC. 
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Figure 3. 12. Tri-lineage differentiation of bone marrow derived mesenchymal stem 
cells (BM-hMSCs). Adipogenic differentiation was characterised by the staining of lipid 
droplet with Oil Red O. Osteogenic differentiation was characterised by matrix 
mineralisation identification using the Alizarin Red stain. Chondrogenic differentiation 
was characterised by Alcian blue staining detection of proteoglycans. The first column in 
each condition stained cells following differentiation in induction media, while the second 
column shows control cells. The first row shows cells stained with Oil Red O; the second 
cells stained with Alizarin Red and the third cells stained with Alcian blue. The scale bar 
was 150 µm. 
 
3.4.11. Assessment of cell viability in hMSCs cultures 
The potential effects of the overnight incubation (16 hours) in the sealed bottles on the 
viability of hMSCs were assessed using the Trypan blue method. The result revealed that 
hMSCs showed little or no decline in viability following the incubation period of 16 hours. 
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Table 3. 4. Mean viable cell number prior and following 16 hours’ period of incubation in 
sealed glass bottles. 
 21% O2 2% O2 2% O2 WS 
Prior incubation 300000 300000 300000 
Following incubation 285000 287500 290000 
 
3.4.12. Assessment of osteogenic differentiation of hMSCs 
For detection of deposited mineralised matrix in the differentiated hMSCs, cells that were 
cultured in growth and osteogenic induction media were stained with Alizarin Red. The 
results of the staining directly indicated that osteogenic ability was enhanced in induced 
hMSCs as compared with controls on day 7, 14 and 21 in intermittent physioxia (2% O2), 
physioxia (2% O2 WS) and air oxygen (21% O2) (Figure 3.13a). 
RT-PCR results confirmed differentiation by showing that hMSC expression profiles 
matched osteogenic phenotype. RUNX2 was not upregulated but rather maintained and the 
expression over the time-period of differentiation was similar to its expression at day 0 in 
2% O2, 2% O2 WS and 21% O2. COL1A1 expression in 2% O2 increased on day 7 above 
the undifferentiated time-point and subsequently decreased and increased on day 14 and 
21, respectively. COL1A1 expression in 2% O2 WS and 21% O2 was maintained at the 
same level with the exception of day 21 in 21% O2 where expression of COL1A1 dropped 
below the previous time-points. ALPL expression in 2% O2 increased on day 7 post 
differentiation and decreased thereafter but was still higher than its expression in 
undifferentiated hMSCs, whereas ALPL expression in 2% O2 WS increased continuously 
over the period of differentiation. ALPL in 21% O2 expressed the same level at day 0 and 
day 7 of differentiation, whereas its level at day 14 dropped below the starting two points 
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and return increased at day 21. SPARC expression in 2% O2 decreased after 7 days of 
differentiation as compared with undifferentiated hMSCs and increased after 14 and 21 
days of differentiation, whereas its expression in 2% O2 WS was high in day 0 and day 7 of 
differentiation and dropped below the starting two points and then increased at time-point 
day 21 of differentiation. In 21% O2 SPARC expression was the same at day 0 and day 7 
of differentiation, and slightly decreased on day 14 and 21 of differentiation. BGLAP, a 
marker of an osteoblast, was expressed on day 21 of differentiation in all oxygen 
conditions with a maximum expression in physioxia (2% O2 WS) (Figure 3.13b). 
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Figure 3. 13. Osteogenic differentiation in hMSCs cultured in 2% O2, 2% O2 WS and 
21% O2 after 7, 14 and 21 days. (A) Alizarin red staining for osteo-induced hMSCs (top 
rows) and undifferentiated hMSCs (bottom rows) for 2% O2 (top panel), 2% O2 WS 
(middle panel) and 21% O2 (bottom panel). (B) RT-PCR of selected genes expression 
involved in osteogenic differentiation of hMSCs. ACTB confirmed the presence of 
amplifiable RNA in all samples.
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3.5 Discussion: 
The morphology of hESC and hiPSC colonies was expected, exhibiting characteristics of 
human pluripotent stem cells, for instance, high nucleus-to-cytoplasm ratio, flat, dense, 
colonies and well-defined colony borders. 
Several studies have reported on the valuable effects of culturing hPSCs under physioxic 
condition, including improved morphology, increased pluripotency markers and reduction 
in chromosomal abnormalities (Ezashi et al., 2005; Forristal et al., 2010; Forsyth et al., 
2006). Other studies showed that low oxygen tension (1-5%) allow cell proliferation via 
adapted mitochondrial respiration (Jiang et al., 1996; Guzy and Schumacker, 2006). In 
order to determine whether oxygen level affected proliferation and maintenance of 
undifferentiated state, the growth rate, MTT, and surface expression of SSEA-4, TRA-1-60 
and SSEA-1 was measured. 
Previous studies upon the effects of physioxic conditions on hPSCs were controversial in 
relation to proliferation and prevention of spontaneous differentiation. The MTT assay here 
revealed that SHEF1-hESCs during prolonged culture in physioxia stayed more or less the 
same in terms of proliferation curve when compared with those in air oxygen condition. 
This might be an indication of balance between proliferation and metabolic activity. The 
results are in agreement with previous papers in which hESCs were cultured at 21% O2 or 
5% O2 tension (Rajala et al., 2011; Forristal et al., 2010). In contrast, SHEF2-hESCs and 
ZK2012L-hiPSCs in air oxygen showed that the cell growth curve remained more or less 
the same as MTT results, again this might be an indication of balance between 
proliferation and metabolic activity. A similar result was also observed for mouse 
embryonic stem cells cultured under both 2% and 21% O2 (Fernandes et al., 2011). 
However, researchers observed that oxygen level as low as 1% leads to decreased 
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proliferation of hESCs, 3-5% O2 showing no difference in the proliferation of hESCs when 
compared with 21% O2 (Ezashi et al., 2005). The variability of these contrasting responses 
of hPS cell lines to oxygen may be due to the different cell line in addition to inadvertent 
re-oxygenation during the experiments. 
The characterisation of hPSCs is important for the stem cell community. Flow cytometry 
technique and fluorescence image-based analysis are useful to assess the undifferentiated 
state of hPSCs by cell surface and nuclear marker expression. Cell surface stemness 
markers SSEA4, SSEA3, TRA-1-60 and TRA-180 are routinely used in many laboratories. 
Recent studies have reported that hESCs did not show differences in expression of SSEA-
4, SSEA-1, TRA-1-60, TRA-1-81 when cultured in low oxygen tension (Chen et al., 2008; 
Forristal et al., 2010; Narva et al., 2013). Similarly, the study here was not able to observe 
any statistical difference for hPSCs between air oxygen (21% O2) and 2% O2 concentration 
in the expression of SSEA-4 and TRA-1-60, although there was a consistent trend for 
increasing SSEA-4 and TRA-1-60 indicators of the undifferentiated state.  Consistently, 
expression of the differentiation markers SSEA-1 was low. 
In vitro differentiation assays are useful and important for demonstrating the pluripotent 
nature of hPSCs by formation of progenitor cells from all three germ layers. 
The pluripotent phenotype of both hESC lines and hiPSCs during the differentiation was 
confirmed by the detection of stemness markers, by RT-PCR (Figure 3.8) and by 
immunocytochemistry (Figure 3.9). 
The observation of hPSCs differentiation was monitored in a timely manner by both RT-
PCR and immunocytochemistry analyses to determine the differentiated state of hPSCs 
cultured in two oxygen conditions. Observation of the expression of pluripotent gene 
markers including POU5F1 and Nanog, could not distinguish between undifferentiated 
87 
 
hPSCs and their progeny. The explanation for this observation may be that some 
undifferentiated hPSCs still remain in cultures. hTERT disappeared after 10 days of 
differentiation in SHEF1-hESCs and SHEF2-hESCs in 21% O2 and 2% O2 respectively, 
while ZK2012L-hiPSCs progeny still appeared. A previous study reported that different 
hPSC lines expressed similar genes in the undifferentiated state; however, the expression 
of these genes might become variable when the cells started to differentiated (Toivonen et 
al., 2013). In contrast to pluripotent gene markers, the variability in expression of gene 
markers for all three germ layers (ectoderm, endoderm and mesoderm) was noted in 
hPSCs. The difference in culture conditions appears to affect the differentiation capacity of 
the hPSCs that has been detected by RT-PCR. The effect of physioxia on embryonic stem 
cell differentiation is controversial (Millman et al., 2009). The study here reveals that 21% 
O2 condition improve endodermal lineage differentiation (AFP gene) which is in 
agreement with a previous study (Hakim et al., 2014) which reported that high oxygen was 
useful for efficient creation of insulin-producing cells. For mesodermal lineage 
differentiation, the results here show that physioxia improved expression of mesodermal 
gene (Brachyury) during the differentiation of ZK2012L-hiPSC, which is in agreement 
with previous studies (Niebruegge et al., 2009; Correia et al., 2014). In contrast, hESC 
lines showed that 21% O2 improved expression of mesodermal gene during the time-course 
of differentiation. Ectodermal differentiation (OTX2 gene) showed progenitor cells 
expressed the OTX2 gene. However, it was noticed that all undifferentiated hPSC lines 
visualised the OTX2 gene with some variation while undifferentiated SHFE1-hESCs in 
21% O2 visualised Brachyury. The variation between hPSC lines differentiation was not 
correlated with the method used for hPSCs induction. Both hESC and hiPSC lines were 
successfully differentiated into three germ layers regardless of the oxygen conditions. 
However, previous studies reported the differences between the differentiation propensities 
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within hESC and hiPSC lines (Bock et al., 2011; Kim et al., 2011; Boulting et al., 2011; 
Osafune et al., 2008; Lappalainen et al., 2010) and between hESC and hiPSCs lines (Hu et 
al., 2010). Results here are in agreement with these views. Furthermore, the expression of 
pluripotent markers Oct-4, Nanog, SSEA-4 as well as ALP were monitored for hPSCs 
cultured in two oxygen conditions by analysing the cellular expression of pluripotent 
markers (Oct-4, Nanog, ALP and SSEA-4) over the time-course of differentiation. 
Expression of theses markers gradually decreased over the time-course of differentiation 
which indicates that across all time points, cells gradually lost their pluripotency. 
This study investigated the effect of physioxia (intermittent and uninterrupted) on the 
isolation and metabolomics of human bone marrow-derived MSCs. Stem cells-based 
therapies require viable and high cell numbers for regenerative medicine. Evaluation of the 
cell number of the isolated MSCs, though not significant, showed that the number of 
isolated MSCs under continuous physioxia (2% O2) was higher than those isolated under 
intermitted physioxia (2% O2) and air oxygen (21% O2). Indeed the number of MSCs was 
higher in intermitted physioxia (2% O2) versus air oxygen (21% O2). These findings are in 
agreement with a recent study (Kay et al., 2015). In contrast, a previous study concluded 
that reduced oxygen tension (2% or 5% O2) decreased the number of bone marrow-isolated 
MSCs with a maximum at 20% O2 (Pattappa et al., 2012). The interpretation of this 
contrast may be due to different culture medium and its composition as well the exact 
oxygen tension. 
Human mesenchymal stem cells have gained wide interest in MSC-based tissue 
engineering of bone, due to their potential to differentiate into osteoblasts (Im, 2015). The 
results in figure 3.12 demonstrated that the cells confirmed the tri-lineage differentiation 
potential which is characteristic of mesenchymal stem cells.  
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Along with the positive results for differentiation into adipogenic, osteogenic and 
chondrogenic lineages, the surface protein profile was assessed according to the criteria 
established by the International Society for Cellular Therapy (ISCT) (Dominici et al., 
2006). hBM-MSCs were positive for CD105, CD 73 and CD 90 and negative for CD 45, 
CD34, CD14, CD19 and HLA-DR and no significant difference was detected between the 
three experimental oxygen conditions. Also under both conditions of intermittent physioxia 
and physioxia, the positive markers CD105, CD73 and CD90 were higher than 95%, 
whereas under normoxic condition only CD73 was higher than 95% but CD105 and CD 90 
were slightly lower than 95%. This lower CD105 and CD90 percentage of cells in 
normoxia may be related to prolonged enzymatic time exposure during cell detachment 
(Brown et al., 2007; Temtem et al., 2009). On the other hand, CD45 and CD34 markers 
showed lower than 2%, while CD14, CD19 and HLA-DR showed higher than 2% in three 
environmental conditions with the exception of CD19 in physioxia which showed lower 
than 2%. This may be due to impurity of MSCs with monocytes, which express CD14 
(Hubacek and Poledne, 1999). The increase of CD 19 may be due to adherence of B cells 
to MSCs in culture (Dominici et al., 2006). Although the surface expression of HLA-DR is 
negative on MSCs, they have been revealed to contain an intracellular HLA-DR that can 
be detected at the cell surface after stimuli by IFN-γ (Le Blanc et al., 2003). Other studies 
reported that HLA-DR surface marker was observed more on cells isolated from whole 
bone marrow when compared with those isolated from separated mononuclear cells (Tarte 
et al., 2010). Indeed, Immunogenicity of MSCs was poor in vitro regardless of the 
expression level of HLA-DR, and thus the expression of HLA-DR does not appear to be a 
critical criterion for MSCs (Tarte et al., 2010). 
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In terms of mineralisation, a higher amount of mineralised matrix was deposited at day 14 
and 21 compared with day 7 of the time-course of the osteogenic differentiation. The cells 
cultured in MSCs growth media revealed no mineralisation nodule formation. 
On the other hand, RUNX2 is the earliest marker of osteogenic differentiation and is 
described to be important for osteogenic lineage commitment of mesenchymal progenitors 
(Wang et al., 2015); the results here show expression before and during the osteogenic 
differentiation. A previous study reported that no major changes of RUNX2 level occurred 
during the time-course of human osteoblast differentiation (Shui et al., 2003). SPARC, also 
known as an osteogenic marker, whose expression appears from pre-osteoblastic to the 
osteoplastic phase, has an essential role in bone formation (Delany et al., 2000). SPARC 
shows expression during osteogenic differentiation, although undifferentiated MSCs also 
seem to express it. The expression of SPARC in undifferentiated MSCs is reported by a 
previous study (Silva et al., 2003). In the studies reported here RUNX2 is also expressed in 
undifferentiated MSCs. A recent study described the expression of RUNX2 in WRO and 
TCP-1 cells and showed that its expression is influenced by fetal bovine serum (FBS) (Niu 
et al., 2012). Hence, it is possible that the RUNX2 gene expression is directly related to 
fetal bovine serum. 
ALP and COL1A1 are known as early markers of osteogenic differentiation and BGLAP is 
described to be a later-stage marker (Jaiswal et al., 1997). The osteo-induction of MSCs in 
culture caused a constant high level of ALP expression from initiation. The increased 
expression of ALP is an indicator for osteogenic differentiation because ALP is responsible 
for mineralisation of extracellular matrix (Marom et al., 2005). Collagen I is important for 
mineralisation of bone matrix (Khosla et al., 2008) and its expression at a high level would 
be observed during the differentiation. Although there is no difference between day 0 and 
the whole process of differentiation, COL1A1 exhibits constant high expression levels 
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throughout. This result is also verified by previous study that showed COL1A1 was 
expressed before and during osteogenic differentiation (Friedman et al., 2006), indicating 
that MSCs are in the biosynthesis and maintenance of extracellular matrix.  
The BGLAP gene was described as a late osteogenic differentiation marker appearing with 
matrix mineralisation (Kulterer et al., 2007) and was expressed at late stage (day 21) of 
osteogenic differentiation of MSCs. 
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Chapter 4-Analysis of 
full scan spectra of VOCs in 
the headspace of cells
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4.1 Introduction 
In the context of regenerative medicine there is an emergent interest in the application of 
metabolomics to better understand the biology of hPSCs and their progeny, with respect to 
proteomics and transcriptomics. Incorporation of physiological normoxia into this process 
may help better elucidate a genuine vs. artefact-driven biology in the hPSC culture system. 
There is currently a limited knowledge of the extracellular metabolites released by human 
stem cells which have potential as biomarkers of stem cell activity. Metabolomics studies 
have been employed to investigate the culture media of bacteria (Villas-Boas et al., 2006) 
and yeast (Allen et al., 2003). Mammalian cell-based studies have included metabolic 
profiling of human hepatoma cell culture media in relation to cell growth (Miccheli et al., 
2006), and the identification of hESC-secreted molecules with the potential to serve as 
biomarkers of pharmacological efficacy (Cezar et al., 2007). NMR (Miccheli et al., 2006), 
GC-quadrupole MS (Villas-Boas et al., 2006) and LC-TOF MS (Allen et al., 2003; Cezar 
et al., 2007) instruments have been used in previous  metabolomics studies. For this study, 
SIFT-MS was selected for real time and on-line volatile organic compounds analysis.  
 
4.2 Aims: 
1. To compare the metabolic profile of hPSCs cultured in two different oxygen 
conditions (21% O2 and 2% O2). 
2. To compare the metabolic profile of hPSCs and their progenitor cells in two 
oxygen conditions (21% O2 and 2% O2). 
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3. To compare the metabolic profile of bone marrow-derived mesenchymal stem cells 
throughout the isolation process in three different oxygen conditions (21% O2, 2% 
O2 and 2% O2 WS). 
4. To compare the metabolic profile of MSCs during the time-course of osteogenic 
differentiation in three different oxygen conditions (21% O2, 2% O2 and 2% O2 
WS). 
 
4.3 Materials and methods 
In order to study volatile organic compounds headspace analysis experiments were 
performed using full scan (FS) mode of SIFT-MS (see Section 2.3.3). It is worth 
mentioning that about 8x106 hPSCs and their progeny were incubated for 24 hours with 
E8M and KO-DMEM respectively (more details in chapter 2). 
hMSCs isolation, characterisation and osteo-induction were carried out in three oxygen 
conditions (21% O2, 2% O2 and 2% O2 WS) (Full methodology in detailed in chapter 2). In 
order to study headspace trace gases of human bone marrow cells (BMCs) and MSCs (see 
section 2.3.3) it is important to note cell numbers. The numbers of BMCs collected at day 
0 were around 7.5x106, while for experimental reasons (using syringe and needle) cell 
numbers are unknown at days 7 and 14. One-half of the media was aspirated by syringe 
and needle from the flasks and dispensed straight into sealed glass bottles at day 7 and the 
second-half at day 14. For suspended hMSCs, cells were counted and 3x105 transferred 
into the glass bottles. 
The VOCs from plastic tissue culture plate containing media (appendix 1) were examined 
and the spectra of incubated media without cells were subtracted (normalised) from the 
spectra of cells exposed media. 
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4.4 Results 
4.4.1 Analysis of SIFT-MS mass spectra derived from the headspace of 
hPSCs cultures 
SIFT-MS has been used to successfully differentiate between a range of cell types as 
described elsewhere (Smith et al., 2003; Sule-Suso et al., 2009). However there are no 
studies described thus far which have sought to use SIFT-MS to identify metabolomics 
profiles in hPSCs in either air oxygen or physioxia conditions. Cell-free control media 
samples and media which had been incubated for 24 hours on adherent hPSC cultures in 
either air oxygen or physioxia conditions (See Section 2.3.3 for methodology) were 
therefore compared. PCA scores from the collected SIFT-MS hPSC datasets showed that 
all samples lay within the 95% confidence region (Hotelling T2 ellipse) (Figure 4.1). 
SHEF1 score plots showed that control media and cell-exposed media in both 21% O2 and 
2% O2 are separated. Control media samples clustered tightly whereas cell-exposed media 
in both 21% O2 and 2% O2 did not display well-defined clusters (Figure 4. 1a). SHEF2 
score plots again indicated an independent and distinct, tight, clustering of cell-free media 
but in contrast to above cell exposed media displayed substantial overlap in clustering 
between both 21% O2 and 2% O2 (Figure 4. 1b). Finally, and similar to SHEF1, ZK2012L 
score plots indicated that control cell-free media and cell-exposed medias all clustered in a 
distinct manner (Figure 4. 1c). Control media samples clustered together tightly while 21% 
O2 and 2% O2 cell exposed media displayed a loose, distinct, clustering pattern. 
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Figure 4. 1. PCA scores plot of hPSCs cultured in air oxygen (21% O2) and physioxia 
(2% O2). a) SHEF1. (t[1]= 26.3%, t[2]= 17.1%). b) SHEF2. (t[1]= 61.6%, t[2]= 29.2%). c) 
ZK2012L. (t[1]= 41%, t[2]= 20.3%). X and Y axes represent the second and first principal 
components, respectively. Ellipses represent the 95% confidence interval. Circles represent 
control media group (n=5), squares represent incubated media with cells in 21% O2 (n=5), 
triangles represent incubated media with cells in 2% O2 (n=5). 
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In the OPLS-DA models, all data lay inside the 95% confidence region (Hotelling T2 
ellipse) (Figure 4.2) SHEF1 displayed tight sample clustering within groups and clear 
separation across groups (Figure 4.2a). SHEF2 score plots showed distinct clustering for 
all groups. Clustering was tight for control cell-free media and 2% O2 cell-exposed media 
but in contrast was loose for 21% O2 cell-exposed samples (Figure 4.2b). ZK2012L 
displayed a similar clustering to SHEF1 with all groups occupying distinct regions of 
clustering though not as tightly as seen with SHEF1 samples (Figure 4.2c). 
 
Table 4. 1. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hPSCs media. 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
SHIF1 0.998 0.917 0.007 
SHEF2 0.876 0.76 0.004 
ZK2012L 0.946 0.8 0.04 
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Figure 4. 2. Scores plot from the OPLS-DA discrimination of SIFT-MS spectra of 
hPSCs cultured in 21% and 2% O2. a) SHEF1. b) SHEF2. c) ZK2012L. X-axis, t[2] and 
Y-axis, t[1], indicate the second and first principal components, respectively. Ellipses 
represent the 95% confidence intervals. Circles represent control media group (n=5), 
squares represent incubated media with cells in 21% O2 (n=5), triangles represent 
incubated media with cells in 2% O2 (n=5).
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The variables relevant for discrimination in OPLS-DA models were identified from their 
variable importance in the projection (VIP) values for each of the hPSCs lines explored. 
Large VIP values (≥1) are the most relevant for predicted variables. 
The number of VIP variables (≥1) shared and unique across the hPSC lines examined are 
indicated (Figure 4.3, Table 4.2). SHEF1, SHEF2 and ZK2012L shared by 2 unique 
variables. Variables shared across two lines were; SHEF1 and SHEF2 shared 11 unique 
variables, ZK2012L shared 4 unique variables with both SHEF1 andSHEF2, whereas 
SHEF1, SHEF2 and ZK2012L had 12, 36 and 5 unique variables, respectively. 
 
Figure 4. 3. Venn diagram showing statistically-selected discriminating variables 
(ions) in hPSCs. Overlap between SHEF1, SHEF2, and ZK2012L OPLS-DA models are 
indicated. As indicated in the diagram, there are unique and shared (ions) variables from 
the three hPSCs models. Blue circle represent the number of variables (m/z) in SHEF1, red 
circle represent the number of variables (m/z) in SHEF2 and green circle represent the 
number of variables (m/z) in ZK2012L. 
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Table 4. 2. Significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of hPSCs by OPLS-DA (with VIP score ≥1). 
 
 
 
 
 
 
hPSCs No. of 
m/z 
ions 
Variable (ions) m/z 
SHEF1, SHEF2, ZK2012L 2 m/z 54,  m/z 18 
SHEF1, SHEF2 11 m/z 45,  m/z 125,  m/z 113,  m/z 34,  
m/z 32,  m/z 90,  m/z 97,  m/z 30,  
m/z 58,  m/z 115,  m/z 49 
SHEF1, ZK2012L 4 m/z 101,  m/z 81,  m/z 69,  m/z 63 
SHEF2, ZK20212L 4 m/z 111,  m/z 43,  m/z 84,  m/z 33 
SHEF1 12 m/z 44,  m/z 123,  m/z 176,  m/z 72,  
m/z 60,  m/z 128,  m/z 161,  m/z 119,  
m/z 71,  m/z 52,  m/z 141,  m/z 88 
SHEF2 36 m/z 95,  m/z 134,  m/z 41,  m/z 86,  
m/z 92,  m/z 142,  m/z 155,  m/z 110,  
m/z 136,  m/z 169,  m/z 145,  m/z 
129,  m/z 147,  m/z 132,  m/z 124,  
m/z 79,  m/z 94,  m/z 61,  m/z 40,  
m/z 106,  m/z 109,  m/z 68,  m/z 146,  
m/z 78,  m/z 70,  m/z 135,  m/z 117,  
m/z 107,  m/z 153,  m/z 31,  m/z 139,  
m/z 103,  m/z 50,  m/z 67,  m/z 126,  
m/z 157 
ZK2012L 6 m/z 47,  m/z 83,  m/z 51,  m/z 65,  
m/z 99,  m/z 82 
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Metabolite profiling associated with hPSCs culture in physioxia and air oxygen was 
derived from VIP plots where metabolites (ions) that fulfilled the criteria (VIP≥1) were 
subjected to univariate analysis (t-test). Significant variables (P<0.05) which presented 
increases in either 21% O2 and 2% O2 are illustrated in Figure 4.4 and listed in Table 4.3. 
 
 
Figure 4. 4. Increased variables in hPSC-conditioned media. Venn diagram showing 
the number of variables (ions) that increased significantly (P<0.05) in 21% O2 and 2% O2 
conditions within the analysed variables. a) SHEF1. b) SHEF2. c) ZK2012L. Blue circle 
represent the number of variables (m/z) in21% O2 condition, red circle represent the 
number of variables (m/z) in 2% O2 condition. 
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Table 4. 3. Expected compounds at each protonated mass (m/z) where significant 
differences in the headspace gases of media of hPSCs were noted between 21% O2 and 2% 
O2 conditions over the m/z ranges 10 to 180. 
hPSCs Conditions Statistics m/z Proposed compounds 
SHEF1 21% O2 Significantly 
increased 
m/z 18 (Ammonia, 2-methylbutylamine 
(50%), 2-methyl-2-butylamine 
(90%), 3-methylbutylamine (5%), 
3-methyl-2-butylamine (65%), 2-
pentylamine (60%), 3-pentylamine 
(70%)) 
m/z 54 (2-propenenitrile, ammonia with 
hydrates) 
m/a 123 (4-ethylphenol, 1-phenylethanol, 2-
phenylethanol) 
2% O2 Significantly 
increased 
m/z 72 (2-methyl-2-propen-1-amine, N-
ethyl-azitidine, Pyrrolidine, N-
thylidene-ethanamine, ethyl azide, 
acrylamide, methoxyacetonitrile, 2-
azetidinone) 
SHEF2 21% O2 Significantly 
increased 
NI  
2% O2 Significantly 
increased 
m/z 18 (Ammonia, 2-methylbutylamine 
(50%), 2-methyl-2-butylamine 
(90%), 3-methylbutylamine (5%), 
3-methyl-2-butylamine (65%), 2-
pentylamine (60%), 3-pentylamine 
(70%)) 
m/z 94 (aniline) 
ZK2012L 21% O2 Significantly 
increased 
NI  
2% O2 Significantly 
increased 
m/z 63 (Carbon dioxide, ethanediol (35%), 
ethanethiol, dimethyl sulphide) 
m/z 81 (1,1-dichloroethane (50%), 1,2-
dichloroethane (35%), cis-3-
hexenal (65%), camphene (14%), 
2-carene (18%), 3-carene (24%), s-
limonene (30%), myrcene (30%), 
ocimene (25%), α-pinene (39%), β-
pinene (40%), α-terpinene (10%), 
Y-terpinene (16%)) 
NI: no ions (m/z) increased significantly were found. 
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4.4.2. Analysis of SIFT-MS mass spectra derived from the headspace of hPSCs 
and their progenitors cultures 
PCA scores were produced for collected datasets of hPSCs in air oxygen (21% O2) and 
physioxia (2% O2) (Figure 4.5). The score plot of SHEF1 in 21% O2 indicated considerable 
overlap between control undifferentiation and differentiation media samples (Figure 4.5a). 
Cell exposed media revealed relatively distinct and tight clustering for media from 
differentiating cells at Days 5, 10, and 20 while undifferentiated Day 0 cell exposed media 
did not fall into well-defined clusters but remained distinct. Control media for SHEF1 in 
2% O2 again showed a considerable evidence of overlap and associated clustering (Figure 
4.5b). Similar to 21% O2 undifferentiated cell exposed media clustered distinct to that of 
the differentiated cell exposed media which clustered together tightly with a minimum of 
overlap. SHEF2 score plots in 21% O2 indicated that control media samples were clearly 
separated from differentiated cell media and from all cell exposed media (Figure 4.5c). 
Undifferentiated 21% O2 SHEF2 exposed media displayed a loose and disperse clustering 
profile while all differentiated cell media (Day 5, 10, and 20) clustered tightly together but 
remained distinct with little or no overlap. The score plot of SHEF2 in 2% O2 indicated 
that control media samples clustered together with little or no overlap and were distinct 
from cell exposed samples (Figure 4.5d). Clear separation between undifferentiated cells 
and differentiated cells media was again noted where the differentiated cell samples 
clustered tightly together with no overlap noted. Finally, the score plots of ZK2012L in 
21% O2 indicated a previously noted overlap between control undifferentiation and 
differentiation media which was distinct to all cell exposed media samples (Figure 4.5e). 
Unlike the previous cell lines; SHEF1 and SHEF2, ZK2012L cell exposed media samples 
did not cluster together but were instead loosely dispersed across the plot. This pattern was 
repeated for ZK2012L samples cultured in physioxia (Figure 4.5f).
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Figure 4. 5. PCA score plots of hPSCs exposed culture media headspace. a) SHEF1 in 
21% O2 (t[1]=33.9%, t[2]=14.3%). b) SHEF1 in 2% O2 (t[1]=33.3%, t[2]=14.5%). c) 
SHEF2 in 21% O2 (t[1]=24.6%, t[2]=14.7%). d) SHEF2 in 2% O2 (t[1]=21.5%, 
t[2]=16.1%). e) ZK2012L in 21% O2 (t[1]=9.4%, t[2]=47.4%). f) ZK2012L in 2% O2 
(t[1]=11.7%, t[2]=45.8%). For each score plot X and Y axes represent the second and first 
principal components, respectively. Ellipses represent the 95% confidence intervals for 
each PCA score plot. The control undifferentiated media (n=5), differentiation media (n=9) 
are shown as circles and squares, respectively whereas undifferentiated cells media (day 0), 
differentiated cell media (day 5), differentiated cell media (day 10) and differentiated cell 
media (day 20) are shown as triangles inverted triangles, diamonds and pentagons, 
respectively. 
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In the OPLS-DA models, all samples lay within the 95% confidence region (Hotelling T2 
ellipse) (Figure 4.6). SHEF1 score plots for both in 21% O2 and 2% O2 indicated that 
undifferentiated and differentiated control media were distinct from undifferentiated and 
differentiated cell exposed media and that they overlapped with each other.(Figure 4.6a, b). 
Similarly, in both settings undifferentiated cell exposed media clustered distinctly from 
differentiated cell exposed media. In 21% O2 differentiated cell exposed media clustered 
distinctly while in 2% O2 tight clustering with some overlap was noted. SHEF2 21% O2 
and 2% O2 OPLS-DA score plots indicated clear separation between all groups, distinct 
clustering and no overlap (Figure 4.6c, d). The score plots of ZK2012L in 21% O2 and 2% 
O2 again showed that undifferentiated and differentiated control media were clearly 
separated, and overlapping with each other, from undifferentiated and differentiated cell 
exposed media (Figure 4.6e, f). Undifferentiated cell exposed media displayed distinct 
clustering in both conditions and while this was also true of differentiated cell exposed 
media in air oxygen some overlap was noted in physioxia. 
 
Table 4. 4. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hPSCs media. 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
SHEF1/ air oxygen 0.778 0.612 0.001 
SHEF1/ physioxia 0.774 0.584 0.001 
SHEF1/ air oxygen 0.827 0.0.605 0.03 
SHEF1/ physioxia 0.836 0.677 0.0005 
ZK2012L/ air oxygen 0.803 0.603 0.008 
ZK2012L/ physioxia 0.795 0.647 0.002 
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Figure 4. 6. Scores plot from the OPLS-DA discrimination of SIFT-MS spectra of 
hPSCs cultured in 21% and 2% O2. a) SHEF1 in 21% O2 score plot. b) SHEF1 in 2% O2 
score plot. c) SHEF2 in 21% O2 score plot. d) SHEF2 in 2% O2 score plot. e) ZK2012L in 
21% O2 score plot. f) ZK2012L in 2% O2 score plot. For each score plot X-axis, t[2] and 
Y-axis, t[1], represent the second and first principal components, respectively. Ellipses 
represent the 95% confidence intervals for each OPLS-DA score plot. The control 
undifferentiated media (n=5), differentiation media (n=9) are shown as circles and squares, 
respectively, whereas undifferentiated cells media (day 0), differentiated cells media (day 
5), differentiated cells media (day 10) and differentiated cells media (day 20) are shown as 
triangles, inverted triangles, diamonds and pentagon, respectively. 
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The number of shared and unique VIP≥1 variables for each hPSC and between each 
oxygen condition across the entire differentiation course were determined (Figure 4.7 and 
Table 4.5). 
 
   
Figure 4. 7. Discriminating variables (ions) from OPLS-DA models for hPSCs 
cultured in 21% O2 and 2% O2. a) SHEF1. b) SHEF2. c) ZK2012L. As indicated in the 
diagrams, there are unique and shared variables (ions) for each hPSCs cultured in both 
oxygen conditions. Blue circle represent the number of variables (m/z) in 21% O2 and red 
circle represent the number of variables (m/z) in 2% O2 
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Table 4. 5. The significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of hPSCs cultured in 21% O2 and 2% O2 by OPLS-DA (with VIP score ≥1). 
PSCs Conditions m/z 
No. 
Variables 
SHEF1 21% O2, 
2% O2 
45 m/z 167, m/z 95, m/z 122, m/z 44, m/z 112, m/z 123, m/z 142, 
m/z 162, m/z 155, m/z 45, m/z 105, m/z 76, m/z 169, m/z 72, 
m/z 29, m/z 124, m/z 113, m/z 94, m/z 114, m/z 40, m/z 104, 
m/z 128, m/z 106, m/z 161, m/z 143, m/z 53, m/z 68, m/z 131, 
m/z 78, m/z 119, m/z 107, m/z 43, m/z 118, m/z 54, m/z 120, 
m/z 31, m/z 63, m/z 103, m/z 90, m/z 141, m/z 30, m/z 42, m/z 
18, m/z 115, m/z 163 
21% O2 19 m/z 86, m/z 77, m/z 176, m/z 133, m/z 145, m/z 138, m/z 60, 
m/z 61, m/z 93, m/z 71, m/z 52, m/z 28, m/z 177, m/z 80, m/z 
139, m/z 67, m/z 148, m/z 49, m/z 82 
2% O2 25 m/z 164, m/z 100, m/z 111, m/z 41, m/z 171, m/z 101, m/z 87, 
m/z 110, m/z 125, m/z 83, m/z 137, m/z 32, m/z 81, m/z 70, m/z 
35, m/z 99, m/z 98, m/z 151, m/z 85, m/z 48, m/z 50, m/z 97, 
m/z 165, m/z 116, m/z 88 
SHEF2 21% O2, 
2% O2 
38 m/z 159, m/z 167, m/z 111, m/z 87, m/z 105, m/z 77, m/z 136, 
m/z 169, m/z 145, m/z 129, m/z 108, m/z 113, m/z 79, m/z 94, 
m/z 114, m/z 61, m/z 109, m/z 34, m/z 143, m/z 81, m/z 68, m/z 
135, m/z 35, m/z 71, m/z 107, m/z 43, m/z 31, m/z 177, m/z 85, 
m/z 48, m/z 139, m/z 59, m/z 62, m/z 97, m/z 141, m/z 67, m/z 
82, m/z 126 
21% O2 26 m/z 123, m/z 86, m/z 142, m/z 162, m/z 125, m/z 124, m/z 173, 
m/z 60, m/z 40, m/z 121, m/z 106, m/z 149, m/z 53, m/z 146, 
m/z 69, m/z 119, m/z 52, m/z 154, m/z 120, m/z 84, m/z 80, m/z 
90, m/z 50, m/z 115, m/z 49, m/z 157 
2% O2 22 m/z 164, m/z 100, m/z 64, m/z 101, m/z 110, m/z 76, m/z 175, 
m/z 137, m/z 131, m/z 28, m/z 54, m/z 63, m/z 96, m/z 165, m/z 
30, m/z 58, m/z 148, m/z 116, m/z 18, m/z 163, m/z 88, m/z 117 
ZK2012L 21% O2, 
2% O2 
37 m/z 95, m/z 47, m/z 123, m/z 111, m/z 64, m/z 46, m/z 142, m/z 
45, m/z 77, m/z 129, m/z 83, m/z 113, m/z 102, m/z 40, m/z 89, 
m/z 109, m/z 34, m/z 137, m/z 143, m/z 81, m/z 32, m/z 78, m/z 
135, m/z 178, m/z 117, m/z 52, m/z 43, m/z 153, m/z 65, m/z 
99, m/z 84, m/z 63, m/z 85, m/z 59, m/z 96, m/z 141, m/z 18 
21% O2 27 m/z 122, m/z 112, m/z 100, m/z 86, m/z 168, m/z 150 m/z 155, 
m/z 110, m/z 108,  m/z 132, m/z 173, m/z 94, m/z 106, m/z 93, 
m/z 68, m/z 119, m/z 70, m/z 51, m/z 107, m/z 80, m/z 33, m/z 
48, m/z 139, m/z 103, m/z 97, m/z 30, m/z 49 
2% O2 21 m/z 167, m/z 134, m/z 170, m/z 101, m/z 171, m/z 87, m/z 145, 
m/z 138, m/z 127, m/z 128, m/z 130, m/z 146, m/z 69, m/z 120, 
m/z 158, m/z 151, m/z 177, m/z 50, m/z 67, m/z 163, m/z 82 
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The number of VIP≥1 variables that were both shared and unique among hPSCs across 
each oxygen condition (Figure 4.8, Table 4.6) were then identified. 
 
  
Figure 4. 8. hPSC line specific statistically-selected discriminating variables (ions) 
from OPLS-DA models. a) 21% O2. b) 2% O2 condition. As represented in the diagrams, 
there are shared and unique variables (ions) among hPSCs cultured in air oxygen (21% O2) 
and physioxia (2% O2). Blue circle represent the number of variables (m/z) in SHEF1, red 
circle represent the number of variables (m/z) in SHEF2 and green circle represent the 
number of variables (m/z) in ZK2012L 
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Table 4. 6. The significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of hPSCs cultured in 21% O2 and 2% O2 by OPLS-DA (with VIP score ≥1). 
Condition hPSCs m/z
No. 
Variables 
21% O2 SHEF1, SHEF2, 
ZK2012L 
18 m/z 123, m/z 86, m/z 142, m/z 77, m/z 113, m/z 94, m/z 
40, m/z 106, m/z 143, m/z 68, m/z 119, m/z 52, m/z 107, 
m/z 43, m/z 80, m/z 139, m/z 141, m/z 49 
SHEF1, SHEF2 18 m/z 167, m/z 162, m/z 105, m/z 169, m/z 145, m/z 124, 
m/z 60, m/z 114, m/z 61, m/z 53, m/z 71, m/z 120, m/z 31, 
m/z 177, m/z 90, m/z 67, m/z 115, m/z 82 
SHEF1, 11 m/z 95, m/z 122, m/z 112, m/z 155, m/z 45, m/z 93, m/z 
78, m/z 63, m/z 103, m/z 30, m/z 18 
SHEF2), 
ZK2012L 
14 m/z 111, m/z 129, m/z 108, m/z 173, m/z 109, m/z 34, m/z 
81, m/z 135, m/z 117, m/z 84, m/z 48, m/z 85, m/z 59, m/z 
97 
SHEF1 17 m/z 44, m/z 176, m/z 76, m/z 133, m/z 72, m/z 29, m/z 
138, m/z 104, m/z 128, m/z 161, m/z 131, m/z 28, m/z 118, 
m/z 54, m/z 42, m/z 148, m/z 163 
SHEF2 15 m/z 159, m/z 87, m/z 125, m/z 136, m/z 79, m/z 121, m/z 
149, m/z 146, m/z 69, m/z 35, m/z 154, m/z 62, m/z 50, 
m/z 126, m/z 157 
ZK2012L 21 m/z 47, m/z 100, m/z 168, m/z 64, m/z 46, m/z 150, m/z 
110, m/z 132, m/z 83, m/z 102, m/z 89, m/z 137, m/z 32, 
m/z 70, m/z 178, m/z 51, m/z 153, m/z 65, m/z 99, m/z 33, 
m/z 96 
2% O2 SHEF1, SHEF2, 
ZK2012L 
14 m/z 167, m/z 111, m/z 101, m/z 87, m/z 113, m/z 137, m/z 
143, m/z 81, m/z 43, m/z 63, m/z 85, m/z 141, m/z 18, m/z 
163 
SHEF1, SHEF2 20 m/z 164, m/z 100, m/z 105, m/z 110, m/z 76, m/z 169, m/z 
94, m/z 114, m/z 68, m/z 131, m/z 35, m/z 107, m/z 54, 
m/z 31, m/z 48, m/z 97, m/z 165, m/z 30, m/z 116, m/z 88 
SHEF1), 
ZK2012L 
14 m/z 95, m/z 123, m/z 171, m/z 142, m/z 45, m/z 83, m/z 
40, m/z 128, m/z 32, m/z 78, m/z 99, m/z 120, m/z 151, 
m/z 50 
SHEF2, 
ZK2012L 
13 m/z 64, m/z 77, m/z 145, m/z 129, m/z 109, m/z 34, m/z 
135, m/z 117, m/z 177, m/z 59, m/z 96, m/z 67, m/z 82 
SHEF1 22 m/z 122, m/z 44, m/z 112, m/z 41, m/z 162, m/z 155, m/z 
125, m/z 72, m/z 29, m/z 124, m/z 104, m/z 106, m/z 161, 
m/z 53, m/z 70, m/z 119, m/z 118, m/z 98, m/z 103, m/z 
90, m/z 42, m/z 115 
SHEF2 13 m/z 159, m/z 136, m/z 175, m/z 108, m/z 79, m/z 61, m/z 
71, m/z 28, m/z 139, m/z 62, m/z 58, m/z 148, m/z 126 
ZK2012L 17 m/z 47, m/z 134, m/z 170, m/z 46, m/z 138, m/z 127, m/z 
102, m/z 89, m/z 130, m/z 146, m/z 69, m/z 178, m/z 52, 
m/z 153, m/z 65, m/z 158, m/z 84 
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Metabolite profiling associated with hPSCs and their progenitors cultured in two different 
oxygen conditions (air oxygen and physioxia) was obtained based on VIP scores. These 
metabolites (ions) that fulfilled the criteria (VIP≥1) were subjected to one-way ANOVA 
with post-hoc Tukey. The proposed compounds for each variable (ion) (from m/z10 to 
180) that significantly (P< 0.05 or 0.01) decreased or increased in the headspace of each 
hPSC during the differentiation in 21% O2 and 2% O2 are listed in Table 4.7. 
 
Table 4. 7. Expected compounds at each protonated mass (m/z) shows a significant 
difference by one-way ANOVA with post-hoc Tukey test, in headspace gases between 
undifferentiated hPSCs and their progenitors throughout the differentiation over the m/z 
ranges 10 to 180. 
hPSCs and their 
progenitors 
Condition m/z ANOVA
(p-value) 
Post Hoc Tukey (p-value) 
(significant) 
Proposed Compounds 
SHEF1 and 
their 
progenitors 
21% O2 m/z 44 0.001 Undiff Vs. 5 days (0.001) ↓ isocyanic acid, n-
methyl methanimine, 
acetaldimine, 
ethenamine, 
ethylenimine) 
Undiff Vs. 10 days (0.005) ↓ 
Undiff Vs. 20 days (0.001) ↓ 
m/z 45 0.001 Undiff Vs. 5 days (0.005) ↓ (Acetaldehyde, 
ethanediol (65%), lactic 
acid (75%), 1,1-
dichloroethane (50%)) 
Undiff Vs. 10 days (0.005) ↓ 
Undiff Vs. 20 days (0.005) ↓ 
m/z 61 0.021 Undiff Vs. 5 days (0.047) ↓ (acetic acid, methyl 
formate (95%), 1-
propanol (10%), 2-
propanol (2-%)) 
Undiff Vs. 10 days (0.03) ↓ 
m/z 67 0.033 Undiff Vs. 10 days (0.047) ↑ (water cluster of 
methanethiol) 
m/z 123 0.031 Undiff Vs. 10 days (0.029) ↑ (4-ethyl phenol, 1-
phenyl ethanol, 2-
phenyl ethanol) 
2% O2 m/z 44 0.024 Undiff Vs. 20 days (0.03) ↓ (1-propanol (isotope of 
main fragment), 2-
propanol (isotope of 
main fragment), 
isocyanic acid, n-
methyl methanimine, 
acetaldimine, 
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ethenamine, 
ethylenimine) 
m/z 45 0.009 Undiff Vs. 5 days (0.028) ↓ (Acetaldehyde, 
ethanediol (65%), lactic 
acid (75%), 1,1-
dichloroethane (50%)) 
Undiff Vs. 10 days (0.022) ↓ 
Undiff Vs. 20 days (0.028) ↓ 
m/z 48 0.045 Undiff Vs. 20 days (0.044) ↓ o-
methylhydroxylamine 
m/z 54 0.022 Undiff Vs. 20 days (0.022) ↑ (2-propenenitrile, 
NH4+.2H2O) 
m/z 63 0.004 Undiff Vs. 5 days (0.016) ↓ (Carbon dioxide, 
Ethanediol (35%), 
ethanethiol, dimethyl 
sulphide) 
Undiff Vs. 10 days (0.011) ↓ 
Undiff Vs. 20 days (0.013) ↓ 
m/z 71 0.045 ND (2-butenal, 2-methyl-2-
butene, 1-pentene, 
trans-2-pentene, iso-
butyric acid (10%), n-
butyric acid (5%), 2-
methyl-2-butanol, 3-
methyl-1-butanol, 1-
pentanol, 3-pentanol, 
methyl butyrate (10%), 
tert-pentyl (amyl) 
methyl ether (95%), 1-
octene (35%), trans-2-
octene (35%), 1-nonene 
(30%), trans-2-nonene 
(25%), 3-methyl-1-
butyl acetate (40%), 1-
octanol (35%), 2-
octanol (15%), 1-
decene (20%)) 
m/z 81 0.025 ND (1,1-dichloroethane 
(50%), 1,2-
dichloroethane (35%), 
cis-3-hexenal (65%), 
camphene (14%), 2-
carene (18%), 3-carene 
(24%), s-limonene 
(30%), myrcene (30%), 
ocimene (25%), α-
pinene (39%), β-pinene 
(40%), α-terpinene 
(10%), Y-terpinene 
(16%)) 
m/z 89 0.02 Undiff Vs. 20 days (0.027) ↓ (Pyruvic acid (80%), 
iso-butyric acid (90%), 
n-butyric acid (95%), 
1,4-dioxane, ethyl 
acetate, 3-
hydroxybutanone, 
methyl propionate 
(95%), butyl methyl 
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ether (40%)) 
m/z 97 0.048 ND (fluorobenzene, 2-
furancarboxaldehyde, 
1,1,1-trichloroethane) 
m/z 113 0.032 ND (Chlorobenzene, trans-
2-heptenal, 1-octene 
(30%), trans-2-octene 
(35%), 1-octanol 
(40%), 2-octanol 
(75%)) 
m/z 123 0.01 Undiff Vs. 5 days (0.009) ↑ (4-ethylphenol, 1-
phenylethanol, 2-
phenylethanol) 
SHEF2 and 
their 
progenitors 
21% O2 m/z 45 0.001 Undiff Vs. 5 days (0.001) ↓ (Acetaldehyde, 
ethanediol (65%), lactic 
acid (75%), 1,1-
dichloroethane (50%)) 
Undiff Vs. 10 days (0.001) ↓ 
Undiff Vs. 20 days (0.001) ↓ 
m/z 63 0.001 Undiff Vs. 5 days (0.002) ↓ (Carbon dioxide, 
ethanediol (35%), 
ethanethiol, dimethyl 
sulphide) 
Undiff Vs. 10 days (0.001) ↓ 
Undiff Vs. 20 days (0.002) ↓ 
m/z 67 0.006 Undiff Vs. 20 days (0.014) ↓ (Water cluster of 
methanethiol) 
m/z 81 0.001 Undiff Vs. 5 days (0.001) ↓ (1,1-dichloroethane 
(50%), 1,2-
dichloroethane (35%), 
cis-3-hexenal (65%), 
camphene (14%), 2-
carene (18%), 3-carene 
(24%), s-limonene 
(30%), myrcene (30%), 
ocimene (25%), α-
pinene (39%), β-pinene 
(40%), α-terpinene 
(10%), Y-terpinene 
(16%)) 
Undiff Vs. 10 days (0.001) ↓ 
Undiff Vs. 20 days (0.001) ↓ 
2% O2 m/z 45 0.015 Undiff Vs. 5 days (0.04) ↓ (Acetaldehyde, 
ethanediol (65%), lactic 
acid (75%), 1,1-
dichloroethane (50%)) 
Undiff Vs. 10 days (0.038) ↓ 
Undiff Vs. 20 days (0.047) ↓ 
m/z 63 0.011 Undiff Vs. 5 days (0.029) ↓ (Carbon dioxide, 
ethanediol (35%), 
ethanethiol, dimethyl 
sulphide) 
Undiff Vs. 10 days (0.03) ↓ 
Undiff Vs. 20 days (0.039) ↓ 
m/z 81 0.002 Undiff Vs. 5 days (0.005) ↓ (1,1-dichloroethane 
(50%), 1,2-
dichloroethane (35%), 
cis-3-hexenal (65%), 
camphene (14%), 2-
carene (18%), 3-carene 
(24%), s-limonene 
(30%), myrcene (30%), 
ocimene (25%), α-
pinene (39%), β-pinene 
Undiff Vs. 10 days (0.005) ↓ 
Undiff Vs. 20 days (0.013) ↓ 
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(40%), α-terpinene 
(10%), Y-terpinene 
(16%)) 
ZK2012L and 
their 
progenitors 
21% O2 m/z 18 0.029 Undiff Vs. 5 days (0.026) ↓ (Ammonia, 2-
methylbutylamine 
(50%), 2-methyl-2-
butylamine (90%), 3-
methylbutylamine 
(5%), 3-methyl-2-
butylamine (65%), 2-
pentylamine (60%), 3-
pentylamine (70%)) 
m/z 45 0.006 Undiff Vs. 10 days (0.011) ↓ (Acetaldehyde, 
ethanediol (65%), lactic 
acid (75%), 1,1-
dichloroethane (50%)) 
Undiff Vs. 20 days (0.013) ↓ 
m/z 48 0.008 Undiff Vs. 20 days (0.035) ↑ o-
methylhydroxylamine 
m/z 63 0.001 Undiff Vs. 5 days (0.003) ↓ (Carbon dioxide, 
ethanediol (35%), 
ethanethiol, dimethyl 
sulphide) 
Undiff Vs. 10 days (0.007) ↓ 
Undiff Vs. 20 days (0.001) ↓ 
m/z 81 0.004 Undiff Vs. 20 days (0.002) ↓ (1,1-dichloroethane 
(50%), 1,2-
dichloroethane (35%), 
cis-3-hexenal (65%), 
camphene (14%), 2-
carene (18%), 3-carene 
(24%), s-limonene 
(30%), myrcene (30%), 
ocimene (25%), α-
pinene (39%), β-pinene 
(40%), α-terpinene 
(10%), Y-terpinene 
(16%)) 
m/z 84 0.009 Undiff Vs. 5 days (0.027) ↓ (1-methylpyrrolidine 
(25%), piperidine 
(10%)) 
m/z 99 0.005 Undiff Vs. 5 days (0.012) ↓ (1,2-dichloroethane 
(10%), cyclohexanone, 
trans-2-hexenal, cis-3-
hexenal (35%), 1-
heptene (25%), trans-2-
heptene (35%), 
methylcyclohexane 
(5%), 1-decene (10%), 
trichloronitromethane 
(2%), iso-flurane 
(10%)) 
Undiff Vs. 10 days (0.011) ↓ 
Undiff Vs. 20 days (0.037) ↓ 
2% O2 m/z 59 0.008 Undiff Vs. 20 days (0.005) ↓ (Acetone, propanal, 
allyl ethyl ether (15%), 
1-nitropropane (5%), 2-
nitropropane (60%)) 
m/z 72 0.032 Undiff Vs 5 days (0.02) ↑ (pyrrolidine, 
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diethylamine (5%))  
m/z 77 0.011 Undiff Vs. 20 days (0.02) ↓ (carbon disulphide, 
thioacetic acid (77%), 
1,2-propanediol (5%), 
1,3-propanediol (30%)) 
m/z 82 0.033 Undiff Vs. 5 days (0.031) ↑ (2,2-difluoro-
ethylamine) 
m/z 83 0.031 Undiff Vs. 20 days (0.035 ↑ (4-methyl-1,3-
pentadiene, 1,5-
pentanedial 
(glutyraldehyde)(30%), 
hexanal (50%), 
cyclohexane (50%)) 
m/z 101 0.006 Undiff Vs. 5 days (0.018) ↑ (1,5-pentanedial 
(glutyraldehyde) 
(50%), Y-
valerolactone, 2-
hexanone, 3-hexanone, 
hexanal (50%)) 
Undiff Vs. 10 days (0.024) ↑ 
Undiff Vs. 20 days (0.016) ↑ 
m/z 111 0.02 Undiff Vs. 5 days (0.039) ↑ (2-fluorotoluene, 4-
fluorotoluene, 2-
hydroxyphynol, 5-
methyl-1,2-
furancarboxaldehyde, 
n-octanal (15%)) 
ND: no significant difference were found 
 
4.4.3. Analysis of SIFT-MS mass spectra derived from the headspace of bone 
marrow cells and bone marrow-derived mesenchymal stem cells 
The hMSCs were successfully isolated from bone marrow aspirates. Isolated hMSCs were 
able to attach to surfaces of culture flask and expand in air oxygen (21% O2), intermittent 
physioxia (2% O2) and physioxia (2% O2) work station (WS). The impact of oxygen 
tension on hMSCs isolation throughout the isolation from bone marrow aspirate was 
assessed with SIFT-MS analysis of the headspace of human bone marrow cells and MSCs. 
PCA scores from the collected SIFT-MS human bone marrow cells (BMCs) and MSCs 
datasets during different time points of isolation showed that all samples lay within the 
95% confidence region (Hotelling T2 ellipse) (Figure 4.9). Score plot of day 0 time point 
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indicated distinct clustering of control media from incubated BMCs; samples of incubated 
BMCs in 21% O2 clustered more tightly than incubated cells in 2% O2, whereas incubated 
cells in 2% O2 WS showed that all samples do not cluster well (Figure 4.9a). Day 7 score 
plot again showed clear separation between control media and incubated BMCs clusters. 
Incubated cells in 2% O2 WS showed that all samples do not cluster well, whereas samples 
of incubated cells in either 21% O2 group or 2% O2 group displayed clustering. In addition, 
incubated cells groups displayed substantial overlap (Figure 4.9b). The Day 14 score plot 
showed that control media samples were clustered tightly and separated from incubated 
cells groups. Incubated cells samples in either 21% O2 group or 2% O2 group displayed 
little evidence of tight clustering with broad dispersal while 2% O2 WS displayed tight and 
distinct clustering (Figure 4.9c). Adherent hMSCs score plot revealed control media 
samples clustered and separated from incubated cells groups but little beyond that where 
all cell groups displayed substantial overlap and loose distribution (Figure 4.9d). 
Suspended hMSCs score plot indicated distinct clustering over groups with substantial 
overlap between groups of incubated cells in 21% O2 and 2% O2 (Figure 4.9e). 
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Figure 4. 9. PCA scores plot of hBMCs and hMSCs cultured in air oxygen (21% O2), 
intermittent physioxia (2% O2) and physioxia (2% O2) work station (WS). a) Day 0 
(t[1]= 40%, t[2]= 19.3%). b) Day 7 (t[1]= 36.4%, t[2]= 24.9%). c) Day 14 (t[1]= 27.2%, 
t[2]= 23.1%). d) Adherent hMSCs (t[1]= 26.6%, t[2]= 19.5%). e) suspended hMSCs (t[1]= 
30.2%, t[2]= 19%). X and Y axes represent the second and first principal components, 
respectively. Ellipses represent the 95% confidence intervals. Circles represent control 
media group (n=3), squares represent incubated media with cells in 21% O2 (n=3), 
triangles represent incubated media with cells in 2% O2 (n=3), inverted triangles represent 
incubated media with cells in 2% O2 WS (n=3). 
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In the OPLS-DA models, all data lay inside the 95% confidence region (Hotelling T2 
ellipse) (Figure 4.10). Day 0 (Figure 4.10a) and day 7 (Figure 4.10b) scores plot displayed 
tight samples clustering within groups and clear separation over groups; 21% O2 and 2% 
O2 groups appeared close to each other. Day 14 score plots again showed clear group 
separation between groups with tight sample clustering for media control, incubated cells 
in 21% O2 and 2% O2 groups (Figure 4.10c). Adherent hMSCs (Figure 5.5d) and 
suspended hMSCs (Figure 4.10e) again showed clear cluster separation between groups 
with close sample clustering for media control group and cells cultured in 2% O2 WS 
group. 
 
Table 4. 8. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hBMCs and hMSCs media. 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
Day 0 0.941 0.798 0.0288 
Day 7 0.921 0.682 0.0381 
Day 14 0.966 0.784 0.028 
Adherent MSCs 0.913 0.652 0.0427 
Suspended MSCs 0.927 0.729 0.0261 
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Figure 4. 10. Scores plot from OPLS-DA discrimination of SIFT-MS spectra of 
hBMCs and hMSCs cultured in 21% O2, 2% O2 and 2% O2 WS. a) Day 0. b) Day 7. c) 
Day 14. d) Adherent hMSCs. e) suspended hMSCs. X-axis, t[2] and Y-axis, t[1], indicate 
the second and first principal components, respectively. Ellipses represent the 95% 
confidence intervals. Circles represent control media group (n=3), squares represent 
incubated media with cells in 21% O2 (n=3), triangles represent incubated media with cells 
in 2% O2 (n=3). Inverted triangles represent incubated media with cells in 2% O2 WS 
(n=3). 
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The variables relevant for discrimination in OPLS-DA models were identified from their 
VIP values for each time point during hMSCs isolation and isolated hMSCs. Large VIP 
values (≥1) are the most relevant for predicted variables. 
The number of VIP variables (≥1) shared and unique across the time points examined 
throughout hMSCs isolation are indicated (Figure 4.11, Table 4.9). 
 
 
Figure 4. 11. Venn diagram showing statistically-selected discriminating variables 
(ions) in human BMCs and MSCs. Overlap of time points of hMSCs isolation and 
isolated hMSCs OPLS-DA models are indicated. As indicated in the diagram, there are 
unique and shared (ions) variables from the five cells models. Blue shape represent the 
number of variables (m/z) in BMCs (Day 0), red shape represent the number of variables 
(m/z) in BMCs (Day 7), brown shape represent the number of variables (m/z) in BMCs 
(Day 14), yellow shape represent the number of variables (m/z) in adherent MSCs and 
green shape represent the number of variables (m/z) in suspended MSCs. 
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Table 4. 9. Significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of BMCs over time-course of hMSCs isolation and isolated hMSCs by 
OPLS-DA (with VIP score ≥1). 
Cells No. of 
m/z 
ions 
Variables (ions) m/z 
BMCs (day 0), BMCs (day 7), BMCs (day 
14), Adherent hMSCs, suspended hMSCs 
6 m/z 146, m/z 169, m/z 140, m/z 44, 
m/z 105, m/z 40 
BMCs (day 0), BMCs (day 7), BMCs (day 
14), Adherent hMSCs 
2 m/z 124, m/z 113 
BMCs (day 0), BMCs (day 7), BMCs (day 
14), suspended hMSCs 
3 m/z 138, m/z 31, m/z 147 
BMCs (day 0), BMCs (day 7), Adherent 
hMSCs, suspended hMSCs 
4 m/z 32, m/z 61, m/z 123, m/z 78 
BMCs (day 0), BMCs (day 14), Adherent 
hMSCs, suspended hMSCs 
2 m/z 114, m/z 34 
BMCs (day 7), BMCs (day 14), Adherent 
hMSCs, suspended hMSCs 
6 m/z 41, m/z 155, m/z 93, m/z 82, m/z 
98, m/z 84 
BMCs (day 0), BMCs (day 7), BMCs (day 
14) 
2 m/z 104, m/z 117 
BMCs (day 0), BMCs (day 7), Adherent 
hMSCs  
5 m/z 134, m/z 170, m/z 132, m/z 177, 
m/z 115 
BMCs (day 0), BMCs (day 7), suspended 
hMSCs 
6 m/z 77, m/z 59, m/z 151, m/z 142, m/z 
63, m/z 87 
BMCs (day 0), BMCs (day 14), Adherent 
hMSCs 
6 m/z 88, m/z 103, m/z 119, m/z 167, 
m/z 165, m/z 76 
BMCs (day 0), BMCs (day 14), suspended 
hMSCs 
3 m/z 86, m/z 45, m/z 99 
BMCs (day 0), Adherent MSCs, 
suspended hMSCs 
4 m/z 171, m/z 96, m/z 90, m/z 148 
BMCs (day 7), BMCs (day 14), Adherent 
hMSCs 
3 m/z 111, m/z 159, m/z 139 
BMCs (day 7), BMCs (day 14), suspended 
hMSCs 
2 m/z 47, m/z 101 
BMCs (day 7), Adherent hMSCs, 
suspended hMSCs 
1 m/z 58 
BMCs (day 14), Adherent hMSCs, 
suspended hMSCs 
4 m/z 18, m/z 175, m/z 89, m/z 50 
BMCs (day 0), BMCs (day 7) 3 m/z 160, m/z 127, m/z 178 
BMCs (day 0), BMCs (day 14) 4 m/z 158, m/z 136, m/z 68, m/z 130 
BMCs (day 0), Adherent hMSCs 8 m/z 60, m/z 153, m/z 97, m/z 125, m/z 
156, m/z 168, m/z 30, m/z 43 
BMCs (day 0), suspended hMSCs 3 m/z 179, m/z 137, m/z 143 
BMCs (day 7), BMCs (day 14) 6 m/z 94, m/z 80, m/z 69, m/z 42, m/z 
35, m/z 129 
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BMCs (day 7), Adherent hMSCs 8 m/z 106, m/z 53, m/z 133, m/z 173, 
m/z 161, m/z 154, m/z 62, m/z 131 
BMCs (day 7), suspended hMSCs 5 m/z 46, m/z 71, m/z 128, m/z 174, m/z 
79 
BMCs (day 14), Adherent hMSCs 3 m/z 141, m/z 85, m/z 112 
BMCs (day 14), suspended hMSCs 5 m/z 65, m/z 92, m/z 48, m/z 28, m/z 
66 
Adherent hMSCs, suspended hMSCs 2 m/z 33, m/z 145 
BMCs (day 0) 6 m/z 180, m/z 164, m/z 72, m/z 107, 
m/z 162, m/z 176 
BMCs (day 7) 7 m/z 157, m/z 126, m/z 81, m/z 135, 
m/z 120, m/z 52, m/z 109 
BMCs (day 14) 6 m/z 149, m/z 150, m/z 121, m/z 110, 
m/z 100, m/z 49 
Adherent hMSCs 5 m/z 163, m/z 116, m/z 95, m/z 122, 
m/z 118 
suspended hMSCs 2 m/z 70, m/z 102 
 
Metabolite profiling associated with BMCs and hMSCs culture in 21% O2, 2% O2 and 2% 
O2 WS was derived from VIP scores where metabolites (ions) that fulfilled the criteria 
(VIP≥1) were subjected to ANOVA analysis. 
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Table 4. 10. Expected compounds at each protonated mass (m/z) where significant 
differences in the headspace gases of media of BMCs or hMSCs were noted over 21% O2, 
2% O2 and 2% O2 WS conditions over the m/z ranges 10 to 180. 
Samples m/z ANOVA 
(p-value) 
Post Hoc Tukey (p-value) 
(significant) 
Proposed Compounds 
BMCs (day 0) m/z 125 0.033 21% O2 Vs. 2% O2 (0.028) (4-fluorobenzaldehyde, 5,5-
dimethyl-2-cyclohexenone, 
(methylthio)-benzene, 2,3,4,5-
tetramethylfuran) 
m/z 127 0.041 21% O2 Vs. 2% O2 WS 
(0.034) 
(2-chlorotoluene, 4-chlorotoluene, 
dimethyl trisulphide, trans-2-octenal, 
1-nonene (30%), trans-2-nonene 
(40%)) 
BMCs (day 7) m/z 31 0.028 21% O2 Vs. 2% O2 (0.049) (Formaldehyde, ethylene glycol 
dimethyl (5%)) 2% O2 Vs. 2% O2 WS 
(0.037) 
m/z 71 0.029 21% O2 Vs. 2% O2 (0.025) (2-butenal, 2-methyl butane, 1-
pentene, trans-2-pentene, isobutyric 
acid (10%), butyric acid (5%), 2-
methyl-2-butanol, 3-methyl-1-
butanol, 1-pentanol, 3-pentanol, tert-
pentyl methylether (95%), 1-octene 
(35%), trans-2-octene (35%), 1-
nonene (30%), trans-2-nonene 
(25%), 3-methyl-1-butyl acetate 
(40%), 1-octanol (35%), 2-octanol 
(15%), 1-decene (20%)) 
m/z 80 0.016 21% O2 Vs. 2% O2 (0.019) (pyridine) 
21% O2 Vs. 2% O2 WS 
(0.037) 
m/z 127 0.038 21% O2 Vs. 2% O2 (0.037) (2-chlorotoluene, 4-chlorotoluene, 
dimethyl trisulphide, trans-2-octenal, 
1-nonene (30%), trans-2-nonene 
(40%)) 
BMCs (day 
14) 
m/z 44 0.047 ND (Isocyanic acid, n-methyl 
methanimine, acetaldimine, 
ethenamine, ethylenimine) 
Adherent 
hMSCs 
m/z 97 0.013 21% O2 Vs. 2% O2 WS 
(0.012) 
(Fluorobenzene, 2-
furancarboxaldehyde, 
methylcyclohexane (95%), 1,1,1-
trichloroethane) 
2% O2 Vs. 2% O2 WS 
(0.048) 
suspended 
hMSCs 
m/z 79 0.021 21% O2 Vs. 2% O2 (0.02) (Benzene, dimethyl sulphoxide, 2-
thioethanol (5%)) 
m/z 93 0.045 21% O2 Vs. 2% O2 (0.048) (Toluene) 
ND: No significant difference were found 
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4.4.4. Analysis of SIFT-MS mass spectra derived from the headspace of hMSCs 
and osteogenic differentiation of hMSCs 
To investigate the metabolic changes occurring in the BM-hMSCs during osteogenesis and 
to compare with undifferentiated hMSCs SIFT-MS analysis of the media headspace was 
performed. PCA score plot from the collected SIFT-MS hMSCs and hMSCs after 
osteoinduction showed that all samples lay within the 95% confidence region (Hotelling T2 
ellipse) (Figure 4.12, 4.13 and 4.14). The score plot of undifferentiated and differentiated 
hMSCs in 21% O2 showed a clear cluster separation of control media samples. 
Undifferentiated and differentiated hMSCs media at Day 7 showed broad overlaps between 
groups, day 14 cell-exposed media showed some separation between undifferentiated and 
differentiated clusters, while day 21 cell-exposed media again showed a high degree of 
overlap (Figure 4.12a). The score plot of 21% O2 undifferentiated hMSCs over the time 
course revealed clear cluster separation of control media samples. hMSCs exposed media 
revealed distinct separation for day 7 but some overlap for days 14 and 21 (Figure 4.12b). 
In contrast to 21% O2 undifferentiated hMSCs, 21% O2 differentiated hMSCs exposed 
media showed clustered distinct groups over the time course of differentiation and separate 
from control media which clustered together tightly (Figure 4.12c). 
The score plot of undifferentiated and differentiated hMSCs in 2% O2 showed a clear 
cluster separation of control media samples. Undifferentiated and differentiated hMSCs 
Day 7 exposed media showed overlap and associated clustering, whereas undifferentiated 
and differentiated hMSCs Days 14 and 21 showed strong overlap between samples and 
were distinct from Day 7 cells (Figure 4.13a). The score plot of 2% O2 Undifferentiated 
hMSCs over the time course revealed clear cluster separation of control media samples. 
Undifferentiated hMSCs exposed media showed strong evidence of overlap at Days 14 and 
21 while undifferentiated Day 7 hMSCs exposed media revealed distinct clustering (Figure 
125 
 
4.13b). Similar to 2% O2 undifferentiated hMSCs, 2% O2 differentiated hMSCs exposed 
media showed overlap at Days 14 and 21 while differentiated Day 7 hMSCs exposed 
media revealed a distinct cluster (Figure 4.13c). 
The score plot of undifferentiated and differentiated hMSCs in 2% O2 WS showed a clear 
cluster separation of control media samples. Undifferentiated and differentiated hMSCs 
Day 7 exposed media revealed clustering with strong overlap between them, whereas 
undifferentiated and differentiated hMSCs Days 14 and 21 showed distinct clustering 
(Figure 4.14a). The score plot of 2% O2 WS undifferentiated hMSCs over the time course 
revealed clear cluster separation of control media samples. Undifferentiated hMSCs 
exposed media showed distinct cluster separation at Days 7 and 21 while undifferentiated 
Day 14 hMSCs exposed media displayed a looser organisation (Figure 4.14b). Similar to 
2% O2 WS undifferentiated hMSCs, 2% O2 WS differentiated hMSCs exposed media 
showed clear cluster separation at Days 7 and 21 while differentiated Day 14 hMSCs 
exposed media displayed a looser organisation (Figure 4.14c). 
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Figure 4. 12. PCA scores plot of hMSCs and osteo-induced hMSCs media over the 
time-course of differentiation in air oxygen (21% O2). a) undifferentiated and 
differentiated hMSCs (t[1]= 20.3%, t[2]= 15.7%). b) undifferentiated hMSCs (t[1]= 
30.2%, t[2]= 21.5%). c) differentiated hMSCs (t[1]= 33.1%, t[2]= 25.2%). X and Y axes 
represent the second and first principal components, respectively. Ellipses represent the 
95% confidence intervals. Circles represent control media group (n=3), squares represent 
incubated media with undifferentiated hMSCs (day 7) (n=3), triangles represent 
undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent undifferentiated 
hMSCs media (day 21) (n=3) whereas differentiated hMSCs media at day 7 (n=3), 14 
(n=3) and 21 (n=3) represent as diamonds, pentagons and hexagons, respectively. 
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Figure 4. 13. PCA scores plot of hMSCs and osteo-induced hMSCs media over the 
time-course of differentiation in intermittent physioxia (2% O2). a) undifferentiated 
and differentiated hMSCs (t[1]= 24.4%, t[2]= 18.1%). b) undifferentiated hMSCs (t[1]= 
29.3%, t[2]= 26%). c) differentiated hMSCs (t[1]= 28.5%, t[2]= 26.6%). X and Y axes 
represent the second and first principal components, respectively. Ellipses represent the 
95% confidence intervals. Circles represent control media group (n=3), squares represent 
incubated media with undifferentiated hMSCs (day 7) (n=3), triangles represent 
undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent undifferentiated 
hMSCs media (day 21) (n=3) whereas differentiated hMSCs media at day 7 (n=3), 14 
(n=3) and 21 (n=3) represent as diamonds, pentagons and hexagons, respectively. 
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Figure 4. 14. PCA scores plot of hMSCs and osteo-induced hMSCs media over the 
time-course of differentiation in physioxia (2% O2 WS). a) undifferentiated and 
differentiated hMSCs (t[1]= 26.8%, t[2]= 22.6%). b) undifferentiated hMSCs (t[1]= 28%, 
t[2]= 24.7%). c) differentiated hMSCs (t[1]= 31.3%, t[2]= 24.9%). X and Y axes represent 
the second and first principal components, respectively. Ellipses represent the 95% 
confidence intervals. Circles represent control media group (n=3), squares represent 
incubated media with undifferentiated hMSCs (day 7) (n=3), triangles represent 
undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent undifferentiated 
hMSCs media (day 21) (n=3) whereas differentiated hMSCs media at day 7 (n=3), 14 
(n=3) and 21 (n=3) represent as diamonds, pentagons and hexagons, respectively. 
 
 
 
 
129 
 
In the OPLS-DA models for cells cultured in 21% O2, all samples lay within the 95% 
confidence region (Hotelling T2 ellipse) (Figure 4.15). The two-dimensional (2D) and 
three-dimensional (3D) score plot for 21% O2 control media was distinct from 
undifferentiated and differentiated cell exposed media. The 2D (Figure 4.15ai) and 3D 
(Figure 4.15aii) scores plot showed clustering but not good separation between 
undifferentiated and differentiated hMSCs at Day 7. Differentiated hMSCs at Days 14 
overlapped with differentiated and undifferentiated hMSCs at Day 21 but revealed 
separation from undifferentiated hMSCs at Day 14 based on the 2D score plot. 
Differentiated and undifferentiated hMSCs at Day 21 could not be distinguished by the 2D 
score but an obvious cluster separation of undifferentiated hMSCs from differentiated 
hMSCs was revealed based on the 3D score plot. The 2D and 3D score plots of 
undifferentiated hMSCs revealed clear cluster separation of control media and cells 
exposed media at Days 7, 14 and 21 (Figure 4.15bi, bii). 2D and 3D scores plot of 
differentiated hMSCs indicated distinct control media from differentiated cell exposed 
media. Exposed cell media at Day 7 revealed distinct from cell exposed media at Days 14 
and 21 by 2D and 3D scores. Exposed cell media at Day 14 and 21 revealed some overlap 
by 2D score plot but an obvious cluster separation was revealed by 3D score plot (Figure 
4.15ci, cii). 
Table 4. 11. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hMSCs and osteo-induced hMSCs media in air oxygen (21% O2). 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
Undifferentiated and differentiated hMSCs 0.883 0.621 0.0389 
Undifferentiated hMSCs 0.916 0.755 0.0074 
Differentiated hMSCs 0.89 0.68 0.0265 
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Figure 4. 15. OPLS-DA discrimination score plots of SIFT-MS spectra of hMSCs and 
osteo-induced hMSCs media over the time-course of differentiation in air oxygen 
(21% O2). Undifferentiated and differentiated hMSCs (2D score plot) (ai) and (3D score 
plot) (aii). Undifferentiated hMSCs (2D score plot) (bi) and (3D score plot) (bii). 
Differentiated hMSCs (2D score plot) (ci) and (3D score plot) (cii). X-axis, t[2] and Y-
axis, t[1], indicate the second and first principal components, respectively. Ellipses 
represent the 95% confidence intervals. Circles represent control media group (n=3), 
squares represent incubated media with undifferentiated hMSCs (day 7) (n=3), triangles 
represent undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent 
undifferentiated hMSCs media (day 21) (n=21) whereas diamonds, pentagons and 
hexagons represent differentiated hMSCs media at day 7 (n=3), 14 (n=3) and 21 (n=3), 
respectively. 
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In the OPLS-DA models for cells cultured in 2% O2, all samples lay within the 95% 
confidence region (Hotelling T2 ellipse) (Figure 4.16). The two-dimensional (2D) and 
three-dimensional (3D) score plot for control media was distinct from undifferentiated and 
differentiated cell exposed media. The 2D and 3D scores plot indicated undifferentiated 
hMSCs exposed media distinct with little or no overlap from differentiated hMSCs 
exposed media at Day 7. Both undifferentiated and differentiated hMSCs at Day7 were 
located farther away from undifferentiated and differentiated hMSCs at Days 14 and 21 
that revealed strong overlap by 2D score plot (Figure 4.16ai), whereas the 3D score plot 
revealed cluster separation between undifferentiated and differentiated hMSCs exposed 
media for both Days 14 and 21 with strong evidence of overlap and associated clustering 
between differentiated hMSCs exposed media at Day 14 and Day 21 (Figure 4.16aii). The 
2D and 3D score plot of undifferentiated hMSCs revealed cluster separation among groups 
with little or no overlap between Day 14 and Day 21 by 2D score plot (4.16bi, bii). The 2D 
and 3D score plot of differentiated hMSCs revealed cluster separation among groups with 
partial overlap between Day 14 and Day 21 by 2D score plot (Figure 4.16ci, cii). 
 
Table 4. 12. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hMSCs and osteo-induced hMSCs media intermittent physioxia (2% O2). 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
Undifferentiated and differentiated hMSCs 0.862 0.655 0.0079 
Undifferentiated hMSCs 0.923 0.722 0.00749 
Differentiated hMSCs 0.886 0.709 0.0102 
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Figure 4. 16. OPLS-DA discrimination score plots of SIFT-MS spectra of hMSCs and 
osteo-induced hMSCs media over the time-course of differentiation in intermittent 
physioxia (2% O2). Undifferentiated and differentiated hMSCs (2D score plot) (ai) and 
(3D score plot) (aii). Undifferentiated hMSCs (2D score plot) (bi) and (3D score plot) (bii). 
Differentiated hMSCs (2D score plot) (ci) and (3D score plot) (cii). X-axis, t[2] and Y-
axis, t[1], indicate the second and first principal components, respectively. Ellipses 
represent the 95% confidence intervals. Circles represent control media group (n=3), 
squares represent incubated media with undifferentiated hMSCs (day 7) (n=3), triangles 
represent undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent 
undifferentiated hMSCs media (day 21) (n=21) whereas diamonds, pentagons and 
hexagons represent differentiated hMSCs media at day 7 (n=3), 14 (n=3) and 21 (n=3), 
respectively. 
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In the OPLS-DA models for cells cultured in 2% O2 WS, all samples lay within the 95% 
confidence region (Hotelling T2 ellipse) (Figure 4.17). The two-dimensional (2D) and 
three-dimensional (3D) score plot for control media was distinct from undifferentiated and 
differentiated cell exposed media. The 2D and 3D scores plot of undifferentiated and 
differentiated hMSCs indicated undifferentiated hMSCs and differentiated hMSCs exposed 
media distinct with strong overlap between them at Day 7. Both undifferentiated and 
differentiated hMSCs at Day 7 were located farther away from undifferentiated hMSCs 
and differentiated hMSCs at Days 14 and 21 which revealed distinct cluster from each 
other by 2D and 3D score plot (Figure 4.17ai) and (Figure 4.17aii). The 2D score plot of 
undifferentiated hMSCs showed cluster separation for control media and cells exposed 
media at Day 14, whereas strong overlapping between cells exposed media at day 7 and 
day 21 (Figure 4.17bi); 3D score plot displayed distinct cluster separation among groups 
(Figure 4.17bii). The 2D and 3D score plot of differentiated hMSCs revealed cluster 
separation among groups with no overlap (Figure 4.17ci, cii). 
 
Table 4. 13. Results of the cross validation and CV-ANOVA for OPLS-DA models of 
hMSCs and osteo-induced hMSCs media physioxia (2% O2 WS). 
OPLS-DA model R2Y (cum) Q2 (cum) P-value 
(CV-ANOVA) 
Undifferentiated and differentiated hMSCs 0.889 0.737 0.002 
Undifferentiated hMSCs 0.924 0.823 0.00012 
Differentiated hMSCs 0.928 0.822 0.0005 
 
 
134 
 
Figure 4. 17. OPLS-DA score plot discrimination of SIFT-MS spectra of hMSCs and 
osteo-induced hMSCs media over the time-course of differentiation in physioxia (2% 
O2 WS). Undifferentiated and differentiated hMSCs (2D score plot) (ai) and (3D score 
plot) (aii). Undifferentiated hMSCs (2D score plot) (bi) and (3D score plot) (bii). 
Differentiated hMSCs (2D score plot) (ci) and (3D score plot) (cii). X-axis, t[2] and Y-
axis, t[1], indicate the second and first principal components, respectively. Ellipses 
represent the 95% confidence intervals. Circles represent control media group (n=3), 
squares represent incubated media with undifferentiated hMSCs (day 7) (n=3), triangles 
represent undifferentiated hMSCs media (day 14) (n=3), inverted triangles represent 
undifferentiated hMSCs media (day 21) (n=21) whereas diamonds, pentagons and 
hexagons represent differentiated hMSCs media at day 7 (n=3), 14 (n=3) and 21 (n=3) as, 
respectively. 
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The variables relevant for discrimination in OPLS-DA models were identified from their 
VIP values for either both undifferentiated and differentiated hMSCs, or undifferentiated 
hMSCs alone and differentiated hMSCs alone over time-course in each oxygen condition. 
Large VIP values (≥1) are the most relevant for predicted variables. 
The number of shared and unique VIP≥1 variables for undifferentiated and differentiated 
hMSCs among oxygen conditions were determined (Figure 4.18, Table 4.14). 
 
Figure 4. 18. Discriminating variables (ions) from OPLS-DA models for 
undifferentiated and differentiated hMSCs cultured in 21% O2, 2% O2 and 2% O2 
WS. As indicated in the diagram, there are unique and shared variables (ions) for cells 
cultured in each oxygen conditions. Blue circle represent the number of variables (m/z) in 
21% O2, red circle represent the number of variables (m/z) in 2% O2 and green circle 
represent the number of variables (m/z) in 2% O2 WS.  
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Table 4. 14. Significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of undifferentiated and differentiated hMSCs over time-course of 
differentiation by OPLS-DA (with VIP score ≥1). 
Conditions No. of 
m/z 
ions 
Variables (ions) m/z 
21% O2, 2% O2, 2% O2 WS 12 m/z 114, m/z 167, m/z 85, m/z 87, m/z 168, m/z 
88, m/z 147, m/z 45, m/z 59, m/z 115, m/z 165, 
m/z 63 
21% O2, 2% O2 16 m/z 18, m/z 93, m/z 171, m/z 107, m/z 95, m/z 
51, m/z 173, m/z 135, m/z 61, m/z 77, m/z 36, 
m/z 81, m/z 30, m/z 78, m/z 76, m/z 49 
21% O2, 2% O2 WS 16 m/z 106, m/z 157, m/z 154, m/z 141, m/z 94, 
m/z 159, m/z 169, m/z 137, m/z 113, m/z 70, 
m/z 82, m/z 111, m/z 68, m/z 121, m/z 48, m/z 
84 
2% O2, 2% O2 WS 16 m/z 102, m/z 86, m/z 90, m/z 120, m/z 42, m/z 
123, m/z 52, m/z 89, m/z 92, m/z 35, m/z 170, 
m/z 153, m/z 129, m/z 177, m/z 67, m/z 44 
21% O2 20 m/z 172, m/z 112, m/z 46, m/z 178, m/z 148, 
m/z 62, m/z 136, m/z 126, m/z 71, m/z 162, m/z 
143, m/z 151, m/z 99, m/z 176, m/z 69, m/z 161, 
m/z 97, m/z 101, m/z 175, m/z 64 
2% O2 19 m/z 163, m/z 33, m/z 158, m/z 72, m/z 138, m/z 
127, m/z 32, m/z 152, m/z 41, m/z 28, m/z 65, 
m/z 119, m/z 80, m/z 54, m/z 104, m/z 50, m/z 
132, m/z 131, m/z 117 
2% O2 WS 17 m/z 130, m/z 125, m/z 145, m/z 146, m/z 105, 
m/z 155, m/z 40, m/z 96, m/z 22, m/z 109, m/z 
34, m/z 79, m/z 58, m/z 164, m/z 108, m/z 144, 
m/z 43 
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The number of VIP≥1 variables that were both shared and unique between undifferentiated 
hMSCs and differentiated hMSCs across the time-course of differentiation in each oxygen 
condition were identified (Figure 4.19, Table 4.15). 
 
 
 
Figure 4. 19. Discriminating variables (ions) from OPLS-DA models for 
undifferentiated hMSCs and differentiated hMSCs. 21% O2 (a), 2% O2 (b) and 2% O2 
WS (c). As indicated in the diagrams, there are unique and shared variables (ions) for cells 
cultured in each oxygen condition. Blue circle represent the number of variables (m/z) in 
differentiation media and  red circle represent the number of variables (m/z) in 
undifferentiation media.
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Table 4. 15. Significant variables (ions) mass to charge ratio (m/z) accountable for class 
discrimination of undifferentiated hMSCs and differentiated hMSCs in 21% O2, 2% O2 and 
2% O2 WS over time-course of differentiation by OPLS-DA (with VIP score ≥1). 
Conditions 21% O2 2% O2 2% O2 WS 
No. 
of 
m/z 
ions 
Variables (ions) m/z No. 
of 
m/z 
ions 
Variables (ions) m/z No. 
of 
m/z 
ions 
Variables (ions) m/z 
Unifferentiated, 
differentiated 
44 m/z 172, m/z 18, m/z 
106, m/z 93, m/z 114, 
m/z 171, m/z 157, 
m/z 141, m/z 107, 
m/z 94, m/z 95, m/z 
46, m/z 32, m/z 159, 
m/z 169, m/z 105, 
m/z 51, m/z 85, m/z 
113, m/z 87, m/z 135, 
m/z 168, m/z 82, m/z 
147, m/z 178, m/z 65, 
m/z 126, m/z 136, 
m/z 143, m/z 45, m/z 
77, m/z 59, m/z 36, 
m/z 151, m/z 79, m/z 
99, m/z 69, m/z 97, 
m/z 175, m/z 63, m/z 
76, m/z 83, m/z 49, 
m/z 64 
45 m/z 18, m/z 33, m/z 
114, m/z 93, m/z 72, 
m/z 125, m/z 107, 
m/z 102, m/z 86, m/z 
90, m/z 32, m/z 159, 
m/z 60, m/z 41, m/z 
105, m/z 51, m/z 87, 
m/z 173, m/z 168, 
m/z 88, m/z 96, m/z 
147, m/z 65, m/z 126, 
m/z 68, m/z 45, m/z 
77, m/z 59, m/z 36, 
m/z 179,  m/z 81,  
m/z 54,  m/z 92,  m/z 
78, m/z 35,  m/z 104, 
m/z 153, m/z 69, m/z 
129, m/z 177, m/z 
101, m/z 67,  m/z 63,    
m/z 76, m/z 43 
51 m/z 18, m/z 106, m/z 
33, m/z 93, m/z 72, 
m/z 171, m/z 116, 
m/z 107, m/z 95, m/z 
32, m/z 60, m/z 169, 
m/z 51, m/z 149, m/z 
87, m/z 173, m/z 82, 
m/z 47, m/z 147, m/z 
65, m/z 62, m/z 22, 
m/z 61, m/z 150, m/z 
68, m/z 52, m/z 45, 
m/z 119, m/z 77, m/z 
34, m/z 59, m/z 81, 
m/z 89, m/z 98, m/z 
100, m/z 48, m/z 78, 
m/z 142, m/z 84, m/z 
99, m/z 69, m/z 129, 
m/z 161, m/z 165, 
m/z 175, m/z 44, m/z 
144, m/z 63, m/z 83, 
m/z 43, m/z 64 
Undifferentiated 14 m/z 167, m/z 154, 
m/z 173, m/z 47, m/z 
162, m/z 68, m/z 81, 
m/z 30, m/z 78, m/z 
84, m/z 58, m/z 176, 
m/z 177, m/z 101 
13 m/z 158, m/z 171, 
m/z 95, m/z 152, m/z 
82, m/z 42, m/z 52, 
m/z 89, m/z 30, m/z 
132, m/z 131, m/z 49, 
m/z 117 
19 m/z 141, m/z 145, 
m/z 102, m/z 159, 
m/z 137, m/z 85, m/z 
75, m/z 113, m/z 135, 
m/z 168, m/z 70, m/z 
40, m/z 88, m/z 96, 
m/z 123, m/z 92, m/z 
170, m/z 153, m/z 
108 
Differentiated 21 m/z 33, m/z 133, m/z 
102, m/z 112, m/z 41, 
m/z 88, m/z 111, m/z 
62, m/z 71, m/z 61, 
m/z 123, m/z 52, m/z 
119, m/z 121, m/z 89, 
m/z 48, m/z 100, m/z 
153, m/z 165, m/z 67, 
m/z 31 
28 m/z 160, m/z 138, 
m/z 167, m/z 141, 
m/z 127, m/z 134, 
m/z 169, m/z 85, m/z 
28, m/z 120, m/z 178, 
m/z 111, m/z 61, m/z 
123, m/z 109, m/z 
119, m/z 34, m/z 80, 
m/z 98, m/z 48, m/z 
79, m/z 115, m/z 58, 
m/z 84, m/z 170, m/z 
165, m/z 83, m/z 64 
24 m/z 172, m/z 167, 
m/z 154, m/z 125, 
m/z 86, m/z 46, m/z 
90, m/z 41, m/z 111, 
m/z 126, m/z 42, m/z 
118, m/z 36, m/z 80, 
m/z 121, m/z 30, m/z 
54, m/z 79, m/z 58, 
m/z 177, m/z 97, m/z 
101, m/z 67, m/z 76 
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The proposed compounds for each variable (ion) (from m/z10 to 180) that showed 
significant (P< 0.05 or 0.01) difference among groups by ANOVA and decreased or 
increased in the headspace of undifferentiated and osteo-induced hMSCs during the 
differentiation in 21% O2 and 2% O2 and 2% O2 WS are listed in Table 4.16.  
 
Table 4. 16. Expected compounds at each protonated mass (m/z) where significant 
differences in the headspace gases of undifferentiated and differentiated hMSCs media 
were noted in 21% O2, 2% O2 and 2% O2 WS conditions over the m/z ranges 10 to 180. 
Conditions m/z ANOVA 
(p-value) 
Diff Vs. Undiff Proposed compounds 
7 
days 
14 
days 
21 
days 
21% O2 m/z 36 0.004 ↑ ↑ ↓ (NH3.H3O+) 
m/z 45 0.001 ↓ ↓ ↓ (Acetaldehyde, ethanediol (65%), lactic acid 
(75%), 1,1-dichloroethane (50%)) 
m/z 61 0.003 ↑ ↓ ↓ (Propanol, acetic acid) 
m/z 63 0.017 ↓ ↓ ↓ (Carbon dioxide, Ethanediol (35%), ethanethiol, 
dimethyl sulphide) 
m/z 65 0.001 ↓ ↑ ↑ (ethanol) 
m/z 77 0.044 ↓ ↑ ↑ (Carbon disulphide, thioacetic acid (80%), 1,2-
propanediol (5%), 1,3-propanediol (30%) 
m/z 82 0.009 ↓ ↓ ↓ (2,2-difluoro-ethylamine) 
m/z 83 0.001 ↑ ↑ ↓ (4-methyl-1,3-pentadiene, 1,5-pentandial 
(glutyraldehyde) (30%), hexanal (50%), 
cyclohexane (50%), water cluster of ethanol) 
m/z 85 0.002 ↑ ↑ ↓ (Trans-2-methyl-2-butenal, trans-2-pentenal, 
cyclohexane (50%), 1-hexene, trans-2-hexene, 
Pentanoic acid (10%), trimethylacetic acid 
(10%), 1-hexanol, 1,2-cyclo-propylether (94%), 
1-nonene (20%), trans-2-nonene (15%), 1-
decene (15%), hexyl acetate (7%)) 
m/z 97 0.001 ↓ ↓ ↑ (fluorobenzene, 2-furancarboxaldehyde, 1,1,1-
trichloroethane) 
m/z 99 0.022 ↓ ↑ ↓ (1,2-dichloroethane (10%), cyclohexanone, 
trans-2-hexenal, cis-3-hexenal (35%), 1-heptene 
(25%), trans-2-heptene (35%), 
methylcyclohexane (5%), 1-decene (10%), 
trichloronitromethane (2%), iso-flurane (10%)) 
m/z 
101 
0.001 ↑ ↑ ↑ (1,5-pentanedial (glutyraldehyde) (50%), Y-
valerolactone, 2-hexanone, 3-hexanone, hexanal 
(50%)) 
m/z 0.005 ↑ ↑ ↓ (2-hydroxy butyric acid (95%), 3-hydroxy 
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105 butyric acid (95%), 2-isohydroxy butyric acid 
(>5%), 1,5-pentanediol (10%)) 
m/z 
111 
0.047 ↑ ↑ ↑ (2-fluorotoluene, 4-fluorotoluene, 2-
hydroxyphynol, 5-methyl-1,2-
furancarboxaldehyde, n-octanal (15%)) 
m/z 
113 
0.015 ↓ ↓ ↑ (Chlorobenzene, trans-2-heptenal, 1-octene 
(30%), trans-2-octene (35%), 1-octanol (40%), 
2-octanol (75%)) 
 2% O2 m/z 18 0.001 ↓ ↑ ↓ (Ammonia, 2-methylbutylamine (50%), 2-
methyl-2-butylamine (90%), 3-
methylbutylamine (5%), 3-methyl-2-butylamine 
(65%), 2-pentylamine (60%), 3-pentylamine 
(70%)) 
m/z 54 0.024 ↑ ↓ ↑ (2-propenenitrile, NH4+.2H2O) 
m/z 63 0.006 ↓ ↑ ↓ (Carbon dioxide, Ethanediol (35%), ethanethiol, 
dimethyl sulphide) 
m/z 65 0.032 ↓ ↑ ↑ (ethanol) 
m/z 69 0.012 ↓ ↓ ↑ (Chloromethane, furan, isoprene (2-methyl 
butadiene), cluster of methanol, 
cyclopropanecarboxylic acid (10%), 3-
methylbutanal (30%), 1-pentanal (25%), 
myrcene (2%), ocimene (3%)) 
m/z 72 0.001 ↑ ↓ ↑ (2-methyl-2-propen-1-amine, N-ethyl-azitidine, 
Pyrrolidine, N-thylidene-ethanamine, ethyl 
azide, acrylamide, methoxyacetonitrile, 2-
azetidinone) 
m/z 77 0.025 ↓ ↓ ↑ (Carbon disulphide, thioacetic acid (80%), 1,2-
propanediol (5%), 1,3-propanediol (30%) 
m/z 81 0.029 ↓ ↑ ↓ (1,1-dichloroethane (50%), 1,2-dichloroethane 
(35%), cis-3-hexenal (65%), camphene (14%), 
2-carene (18%), 3-carene (24%), s-limonene 
(30%), myrcene (30%), ocimene (25%), α-
pinene (39%), β-pinene (40%), α-terpinene 
(10%), Y-terpinene (16%)) 
m/z 82 0.048 ↑ ↓ ↑ (2,2-difluoro-ethylamine) 
m/z 83 0.016 ↑ ↑ ↑ (4-methyl-1,3-pentadiene, 1,5-pentandial 
(glutyraldehyde) (30%), hexanal (50%), 
cyclohexane (50%), water cluster of ethanol) 
m/z 
101 
0.001 ↓ ↑ ↑ (1,5-pentanedial (glutyraldehyde) (50%), Y-
valerolactone, 2-hexanone, 3- hexanone, hexanal 
(50%)) 
m/z 
105 
0.003 ↓ ↓ ↓ (2-hydroxy butyric acid (95%), 3-hydroxy 
butyric acid (95%), 2-isohydroxy butyric acid 
(>5%), 1,5-pentanediol (10%)) 
2% O2 WS m/z 33 0.002 ↓ ↑ ↓ (methanol, butyl methyl ether (10%)) 
m/z 36 0.0001 ↑ ↑ ↑ (NH3.H3O+) 
m/z 43 0.0001 ↓ ↓ ↓ (Cyclopropane, pyruvic acid (20%), 1,5-
pentanedial (glutyraldehyde) (20%), propyl ether 
(5%)) 
m/z 45 0.028 ↑ ↓ ↑ (Acetaldehyde, ethanediol (65%), lactic acid 
(75%), 1,1-dichloroethane (50%)) 
m/z 48 0.019 ↑ ↓ ↓ (o-methylhydroxylamine) 
m/z 51 0.028 ↑ ↓ ↓ (Water cluster of methanol) 
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m/z 54 0.023 ↑ ↑ ↑ (2-propenenitrile, NH4+.2H2O) 
m/z 61 0.001 ↑ ↓ ↓ (acetic acid, methyl formate (95%), 1-propanol 
(10%), 2-propanol (2-%)) 
m/z 69 0.0001 ↑ ↓ ↓ (Chloromethane, furan, isoprene (2-methyl 
butadiene), cluster of methanol, 
cyclopropanecarboxylic acid (10%), 3-
methylbutanal (30%), 1-pentanal (25%), 
myrcene (2%), ocimene (3%)) 
m/z 77 0.004 ↑ ↑ ↓ (Carbon disulphide, thioacetic acid (80%), 1,2-
propanediol (5%), 1,3-propanediol (30%) 
m/z 81 0.03 ↑ ↓ ↑ (1,1-dichloroethane (50%), 1,2-dichloroethane 
(35%), cis-3-hexenal (65%), camphene (14%), 
2-carene (18%), 3-carene (24%), s-limonene 
(30%), myrcene (30%), ocimene (25%), α-
pinene (39%), β-pinene (40%), α-terpinene 
(10%), Y-terpinene (16%)) 
m/z 83 0.04 ↑ ↓ ↑ (4-methyl-1,3-pentadiene, 1,5-pentandial 
(glutyraldehyde) (30%), hexanal (50%), 
cyclohexane (50%), water cluster of ethanol) 
m/z 84 0.0001 ↑ ↓ ↑ (2,2-dimethyl-propanenitrile, ter-butyl 
isocyanide, 4-NH2-pyrazole, 3(5)- 
aminopyrazole, N,N-dimethyl-2-propyne-1-
amine) 
m/z 97 0.015 ↑ ↑ ↓ (fluorobenzene, 2-furancarboxaldehyde, 1,1,1-
trichloroethane) 
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The proposed compounds for each variable (ion) (from m/z10 to 180) that shows 
significant (P< 0.05 or 0.01) difference among groups by ANOVA and decreased or 
increased in the headspace of osteo-induced hMSCs (Table 4.17) and undifferentiated 
hMSCs (Table 4.18) during time-course in 21% O2 and 2% O2 and 2% O2 WS were 
identified. 
 
Table 4. 17. Expected compounds at each protonated mass (m/z) where significant 
differences in the headspace gases of osteo-induced hMSCs media were noted in 21% O2, 
2% O2 and 2% O2 WS conditions over the m/z ranges 10 to 180. 
Conditions m/z ANOVA 
(p-value) 
Time-course 
of 
differentiation 
Proposed compounds 
21% O2 m/z 45 0.004 Increased (Acetaldehyde, ethanediol (65%), lactic acid (75%), 
1,1-dichloroethane (50%)) 
m/z 46 0.007 Decreased (dimethylamine) 
m/z 61 0.001 Decreased (Propanol, acetic acid) 
m/z 65 0.016 Decreased (ethanol) 
2% O2 m/z 18 0.002 Decreased (Ammonia, 2-methylbutylamine (50%), 2-methyl-2-
butylamine (90%), 3-methylbutylamine (5%), 3-
methyl-2-butylamine (65%), 2-pentylamine (60%), 3-
pentylamine (70%)) 
m/z 72 0.007 Increased (2-methyl-2-propen-1-amine, N-ethyl-azitidine, 
Pyrrolidine, N-thylidene-ethanamine, ethyl azide, 
acrylamide, methoxyacetonitrile, 2-azetidinone) 
m/z 77 0.033 Increased (Carbon disulphide, thioacetic acid (80%), 1,2-
propanediol (5%), 1,3-propanediol (30%) 
m/z 83 0.012 Increased (4-methyl-1,3-pentadiene, 1,5-pentandial 
(glutyraldehyde) (30%), hexanal (50%), cyclohexane 
(50%), water cluster of ethanol) 
m/z 93 0.019 Decreased (Toluene) 
2% O2 WS m/z 36 0.023 Decreased (NH3.H3O+) 
m/z 72 0.007 Increased (2-methyl-2-propen-1-amine, N-ethyl-azitidine, 
Pyrrolidine, N-thylidene-ethanamine, ethyl azide, 
acrylamide, methoxyacetonitrile, 2-azetidinone) 
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Table 4. 18. Expected compounds at each protonated mass (m/z) where significant 
differences in the headspace gases of undifferentiated hMSCs media were noted in 21% 
O2, 2% O2 and 2% O2 WS conditions over the m/z ranges 10 to 180. 
Conditions m/z ANOVA 
(p-value) 
Time-course 
of 
differentiation 
Proposed compounds 
21% O2 m/z 45 0.004 Increased (Acetaldehyde, ethanediol (65%), lactic acid (75%), 
1,1-dichloroethane (50%)) 
m/z 81 0.041 Increased Cluster of acetaldehyde  
m/z105 0.028 Increased (2-hydroxy butyric acid (95%), 3-hydroxy butyric 
acid (95%), 2-isohydroxy butyric acid (>5%), 1,5-
pentanediol (10%)) 
2% O2 m/z 72 0.007 Increased (2-methyl-2-propen-1-amine, N-ethyl-azitidine, 
Pyrrolidine, N-thylidene-ethanamine, ethyl azide, 
acrylamide, methoxyacetonitrile, 2-azetidinone) 
2% O2 WS m/z 36 0.0001 Decreased (NH3.H3O+) 
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4.5 Discussion 
In this chapter the analysis of volatile organic compounds using full scan (FS) mode of the 
SIFT-MS technique has been used to compare and differentiate metabolic profiles of 
classes of stem cells.  
In the regulation of cellular metabolism, oxygen plays a role, and it has been studied over 
long time (Henderson, 1969; Hu et al, 2016). Metabolomic analysis was conducted to 
characterise the metabolic profile in air oxygen (21% O2) and physioxic (2% O2) 
pluripotent stem cells. The distinctive metabolic profile of air oxygen (21% O2) and 
physioxic (2% O2) hPSCs was successfully demonstrated using OPLS-DA. This study is in 
agreement with a previous study on MEL2 hES cell that showed the effect of oxygen 
environment (5% O2 and 20% O2) on metabolic profiles and mitochondria using NMR 
spectroscopy (Less et al., 2015). Furthermore, the alteration of metabolic profile between 
physioxic and air oxygen HCT 116 cancer cell line have been documented by Frezza et al. 
who showed the metabolic profile of physioxic cells by using LC-MS (Frezza et al., 2011). 
The metabolic profile of hPSCs and their progenitor cells over the time-course of 
differentiation was also investigated. Several studies reported large metabolic differences 
between pluripotent stem cells and somatic cells using 1H NMR and LC-MS (Folmes et al., 
2011; Panopoulos et al., 2012). A recent study has shown discriminated metabolic profile 
of human induced pluripotent stem cells from early neural progenitor cells and embryoid 
bodies during differentiation using GC-MS to investigate VOCs (Capuano et al., 2017). In 
accordance with these studies, the results presented here show large differences in 
metabolic profiles between hPSCs and their progenitor cells in air oxygen and physioxic 
conditions using SIFT-MS. 
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In conclusion, analysis of volatile organic compounds seems promising in comparing the 
metabolic profile of hPSCs in normoxic versus physioxic conditions in vitro. Furthermore, 
it seems that VOCs can be used as a distinguishing characteristic profile in the 
characterisation of hPSCs and their progenitor cells. 
 
MSCs separation techniques generally depend on the pattern expression specific membrane 
protein markers. As a result, isolation of MSCs requires confirming by the presence or 
absence of the combination of several antibodies (Zhao et al., 2016). Although several 
studies have indicated the effect of low oxygen tension on MSCs behaviour and function 
(Das et al., 2010; Holzwarth et al., 2010; Efimenko et al., 2011; Rosova et al., 2008), this 
effect has not been exploited for identification of a unique metabolic profile of MSCs. On 
the basis of MSCs isolation protocol, a mass spectrometry approach was adopted to 
compare the three oxygen conditions of MSCs derivation here which may affect their 
isolation. The OPLS-DA score plot from metabolic profile of bone marrow cells and 
isolated MSCs at each time point suggest that the metabolic profile of 2% O2 WS cells 
differs from those in 2% O2 and 21% O2 over the time-course of isolation. The spectra 
differences between 2% O2 and 21% O2 cells has been noted from day 14 time point 
toward suspended MSCs. 
A comprehensive analysis of BM-MSCs metabolism during osteogenesis was studied 
employing three oxygen environments (21% O2, 2% O2 and 2% O2 WS). 21% O2 was 
shown to be less effective than 2% O2 and 2% O2 WS in inducing hMSCs osteogenesis. 
Importantly, metabolic profiling revealed differences in the osteogenic effect of three 
oxygen conditions and proved that cells undergo metabolic alterations before reaching a 
terminal metabolic state which revealed their degree of differentiation. 
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Metabolomics comparison of MSCs and in vitro osteogenic differentiation of MSCs over 
time course (OPLS-DA score plot 3D) demonstrated that metabolism has the potential to 
capture the degree of osteogenic differentiation. Although the variability of osteogenic 
differentiation depends upon oxygen tension, metabolomics described the overall process 
of differentiation and showed the stage of cells differentiation. This picture is suggesting 
that metabolic profiling can be used as a tool for the monitoring of MSCs maintenance and 
differentiation. Similar studies have been carried out to investigate the effects of different 
environmental oxygen culture on MSCs during the differentiation. Particularly, Munoz et 
al. revealed that the osteo-induction of MSCs was successfully carried out in 20% oxygen 
concentration for 21 days and subsequently cultured under either 21% O2 or 2% O2 for 
further 3 days (Munoz et al., 2014). Jang et al. suggested the metabolomic profiles as 
biomarkers of MSCs differentiation to monitor chondrogenesis by using nuclear magnetic 
resonance spectroscopy (Jang et al., 2013). Surrati et al. performed metabolomics of the 
culture media to monitor osteogenesis of mouse MSCs (Surrati et al., 2016). 
In conclusion, the metabolic phenotype of isolated hMSCs outlined here is supportive of 
the discrimination of isolated MSCs in different oxygen conditions. Moreover, the 
metabolic profile changes upon osteogenic differentiation at three different oxygen 
tensions provide a picture for how hMSCs and osteo-induced hMSCs reveal a related 
metabolic profile, and the individual OPLS-DA score plots revealed clear discrimination 
between media headspace samples from undifferentiated and osteo-induced hMSCs and a 
gradual shift of metabolic profile during the differentiation. 
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Chapter 5-MIM analysis 
of selected VOCs in the 
headspace of cells
148 
 
5.1 Introduction 
In the previous chapter, the full scan (FS) mode of SIFT-MS technique was used and the 
acquired data were analysed using multivariate analysis. The results highlighted the 
differential metabolic profile associated with cell status. 
In this chapter, the multiple ion monitoring (MIM) mode of selected Ion Flow Tube-Mass 
Spectrometry (SIFT-MS) technique is employed to quantify the metabolites in the 
headspace of stem cell culture and their progenitor in normoxic and physioxic conditions. 
Recently, SIFT-MS-based approaches have been employed for the quantification of 
volatile metabolites of cells above the growth medium (Sule-Suso et al., 2009; Rutter et al., 
2013), it is therefore acceptable to use this technique, in which volatile compounds can be 
analysed using non-invasive measurement. 
 
5.2 Aims: 
1. To compare the volatile organic compounds (VOCs) of hPSCs cultured in two 
different oxygen conditions (21% O2 and 2% O2). 
2. To investigate the activity of intracellular enzymes (ADH and CYP2E1) within 
hPSCs. 
3. To compare the volatile organic compounds (VOCs) of hPSCs and their progenitor 
cells in two oxygen conditions (21% O2 and 2% O2). 
4. To compare the volatile organic compounds (VOCs) of bone marrow-derived 
mesenchymal stem cells throughout the isolation process in three different oxygen 
conditions (21% O2, 2% O2 and 2% O2 WS). 
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5. To compare the volatile organic compounds (VOCs) of MSCs during the time-
course of osteogenic differentiation in three different oxygen conditions (21% O2, 
2% O2 and 2% O2 WS). 
5.3 Materials and Methods: 
In order to study volatile organic compounds headspace analysis experiments were 
performed using multiple ion monitoring (MIM) mode of SIFT-MS (see Section 2.3.3). It 
is worth mentioning that about 8x106 hPSCs and their progeny were incubated for 24 hours 
with E8M and KO-DMEM respectively; and the same number of hPSCs was used for 
quantification of ethanol/acetaldehyde in the presence of the ADH & CYP2E1 enzymes 
inhibitor (more details in chapter 2). 
hMSCs isolation, characterisation and osteo-induction were carried out in three oxygen 
conditions (21% O2, 2% O2 and 2% O2 WS) (Full methodology in detailed in chapter 2). In 
order to quantify headspace trace gases of human bone marrow cells (BMCs) and MSCs 
(see section 2.3.3) it is important to note cell numbers. The numbers of BMCs collected at 
day 0 were around 7.5x106, while for experimental reasons (using syringe and needle) cell 
numbers are unknown at days 7 and 14. One-half of the media was aspirated by syringe 
and needle from the flasks and dispensed straight into sealed glass bottles at day 7 and the 
second-half at day 14. For suspended hMSCs, cells were counted and 3x105 transferred 
into the glass bottles. 
As the VOCs from plastic tissue culture plate containing media (appendix 2) were 
examined the concentration of VOCs of incubated media without cells were subtracted 
(normalised) from the concentration of VOCs of cells exposed media. 
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5.4 Results: 
5.4.1. Quantification of VOCs present in the headspace of hPSCs 
A total of 10 volatile compounds (acetone, acetaldehyde, ethanol, butanol, pentanol, 
DMS/ethanethiol, hexanal, butyric acid, pentene, putresceine) in the headspace of media of 
three hPSCs cultured in 21% O2 and 2% O2 were analysed using MIM mode of the SIFT-
MS (Figure 5.1) and (Table 5.1). Following normalisation of incubated media with cells to 
incubated media without cells a t-test was performed for all volatile organic compounds of 
two conditions to assess for any differences in the concentration of volatile compounds 
between 21% O2 and 2% O2 conditions. 
Figure 5. 1. Physioxia effects on the levels of volatile organic compounds in the 
headspace of SHEF1, SHEF2 and ZK2012L media. Bars represent normalised mean 
values of compounds for each hPSCs in both air oxygen (21% O2) (blue bars) and 
physioxia (2% O2) (red bars). Error bars represent +/-SD, asterisks represent significance at 
(P<0.05) between 21% O2 and 2% O2 conditions. X-axis indicates of hPSCs, and Y-axis 
indicates of concentration (ppbv) of volatile compounds (a=acetaldehyde, 
b=DMS/ethanethiol). 
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Table 5. 1. Summary of mean ± SD for VOCs detected in the headspace of SHEF1, 
SHEF2 and ZK2012L media in air oxygen (21% O2) and physioxia (2% O2). The 
concentrations are measured in parts per billion by volume (ppbv). The P-values were 
calculated by t-test. 
VOC 
 
Oxygen 
condition 
 
SHEF1 SHEF2 ZK2012L 
Mean ± SD P-
value 
Mean ± SD P-
value 
Mean ± SD P-
value 
Acetone 21% 162.5 ± 688.4 0.73 18.1 ± 8.4 0.84 6.5 ± 13 0.86 
2% 55.9 ± 205.2 16.1 ± 16.3 5.2 ± 20.6 
Acetaldehyde 21% 2021.9 ± 
715.4 
0.85 1093.6 ± 
253.7 
0.001 1372.7 ± 
329.9 
0.001 
2% 1955.5 ± 
279.6 
2140.5 ± 
560.2 
2988.4 ± 
902.1 
Ethanol 21% 22220.3 ± 
13208.1 
0.03 7848.6 ± 
16707.9 
0.75 3076.1 ± 
3354.8 
0.059 
2% 1479.3 ± 
1594.8 
4277.4 ± 
15393.3 
-436.1 ± 
5795.9 
Butanol 21% 261.3 ± 338.8 0.11 84.1 ± 371.6 0.47 110.5 ± 71.6 0.051 
2% 52.3 ± 184.5 -67 ± 156.4 -10.3 ± 63.2 
Pentanol 21% 13.6 ± 9.5 0.51 7.1 ± 16 0.54 1.8 ± 16.8 0.14 
2% 12.7 ± 7.6 0.7 ± 13.2 11.9 ± 10 
DMS/Ethanethiol 21% 1383.6 ± 
497.3 
0.91 632.6 ± 138.1 0.03 967.8 ± 178.2 0.01 
2% 1356.7 ± 
248.7 
1301.3 
±559.5 
1960.6 ± 636 
Hexanal 21% 240.6 ± 203.7 0.06 98.7 ± 219.3 0.57 -5.4 ± 67.8 0.50 
2% 0.6 ± 39.3 21.5 ± 160.9 23.4 ± 65.3 
Butyric acid 21% 1.4 ± 10.5 0.97 5.1 ± 14.2 0.98 2.1 ± 15.8 0.23 
2% 1.3 ± 4.9 5.3 ± 13.6 9 ± 8.8 
Pentene 21% 13.7 ± 7.5 0.82 2 ± 2.9 0.06 -0.3 ± 2.7 0.09 
2% 12.8 ± 3.4 -5.3 ± 6.9 3.1 ± 4 
Putresceine 21% 2.8 ± 13.5 0.49 6.1 ± 22.4 0.94 4.1 ± 19.5 0.29 
2% 7.2 ± 9.2 5.1 ± 15.3 13.8 ± 23.4 
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5.4.2. Quantification of ethanol and acetaldehyde in the headspace of hPSCs 
treated with ADH and CYP2E1 inhibitor 
From interpretation of the analysis above (section 5.4.1) significant increases in 
Acetaldehyde and DMS/Ethanthiol release were noted in physioxia in two of the three 
hPSC lines under investigation and comparable levels in the third. Acetaldehyde was then 
selected as a metabolite to explore further and to determine if its environmental modulation 
were reflected in altered transcriptional activity. 
Having established the non-toxic dosage of 4-MP (section 3.4.5) alteration of headspace 
concentrations of Ethanol and/or acetaldehyde (Figure 5.2) were investigated to establish 
the effects of the inhibition of ADH and CYP2E1). The results of the SIFT-MS headspace 
analysis were again normalised to incubated media. Supplementation of SHEF1, SHEF2 
and ZK2012L cultures with 4-MP resulted in increased ethanol headspace concentrations 
in both 2% and 21% O2 as compared with untreated cells (Figure 5.2a). Conversely, an 
overall reduction was observed in acetaldehyde release from treated hPSCs in comparison 
to untreated cells in both 2% and 21% O2 conditions (Figure 5.2b). The single exception to 
this was noted with SHEF2 where acetaldehyde levels in the media of treated SHEF2 was 
higher than that of untreated in 21% O2. Furthermore, a significant difference (p<0.01) has 
been noticed between treated and non-treated ZK2012L in 21% O2 condition. 
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Figure 5. 2. 4-MP induced ethanol and acetaldehyde concentration changes in hPSC 
headspace. Concentrations of ethanol (A) and acetaldehyde (B), represented in part-per-
billion by volume (ppbv) (Y-axis), measured in the headspace of samples of non-treated 
cells (blue bars) and cells treated with 5 mM 4-MP inhibitor (red bars). In this case the 
cells were SHEF1, SHEF2 and ZK2012L in both Physioxia (2% O2) and air oxygen (21% 
O2) conditions (X-axis). Error bars indicate +/-SD. Asterisk indicates significant difference 
between non-treated and 4-MP treated samples at (P<0.01). 
 
5.4.3. Quantification of VOCs present in the headspace of hPSCs and their 
progenitors 
A total of 10 volatile compounds (Acetone, acetaldehyde, ethanol, butanol, pentanol, 
DMS/Ethanethiol, hexanal, butyric acid, pentene, putresceine) in the headspace of hPSCs 
and their progenitors for each oxygen condition were analysed using MIM mode of the 
SIFT-MS (Table 5.2, 5.3, 5.4) and (Figure 5.3, 5.4, 5.5). Following normalisation of 
incubated media with cells to incubated media without cells One-way ANOVA and post-
hoc Tukey were performed for all volatile compounds to assess for any difference in 
concentration over time-course of differentiation and between undifferentiated cells and 
each time point of differentiation for 21% O2 and 2% O2 conditions. 
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Table 5. 2. Summary of mean ± SD for VOCs detected in the headspace of SHEF1 and 
their progenitors media in air oxygen (21% O2) and physioxia (2% O2). The concentrations 
are measured in parts per billion by volume (ppbv). The P-values were calculated by 
ANOVA. 
VOCs Oxygen 
condition 
(0 Day) 
Mean±SD 
(5 Days) 
Mean±SD 
(10 Days) 
Mean±SD 
(20 Days) 
Mean±SD 
ANOVA 
(P-value) 
Acetone 21% 162.5 ± 
600.8 
-186.1 ± 
657.6 
486.6 ± 
667.9 
-372.7 ± 
625.1 
0.436 
2% 59 ± 177.9 -213. ± 
49492.1 
-6.9 ± 
1053.8 
617.6 ± 
561.5 
0.539 
Acetaldehyde 21% 2021.9 ± 
662.9 
140 ± 188.1 27 ± 168.2 31.5 ± 140.7 0.001 
2% 1955.5 ± 
378.7 
168 ±185.7 44.6 ± 165.3 30.4 ± 95.4 0.001 
Ethanol 21% 22220.2 ± 
20639.4 
9354.9 ± 
14566.4 
21562.6 ± 
4915.2 
6811.2 ± 
2226.4 
0.203 
2% 617 ± 
2371.8 
1584.7 ± 
3004.5 
1935 ± 4001 1622.8 ± 
4984.5 
0.998 
Butanol 21% 261.3 ± 
318.5 
-1.5 ± 317.8 449.2 ± 95.4 -163.2 ± 
274.3 
0.097 
2% 67.7 ± 163.4 -41.7 ± 
309.2 
1.7 ± 396.4 -379.5 ± 
226.8 
0.271 
Pentanol 21% 13.6 ± 11.9 1.7 ± 22 31.8 ± 27.3 -3.6 ± 30.4 0.29 
2% 13.7 ± 7 4.2 ± 21.7 9.7 ± 16.2 -21.3 ± 15.7 0.077 
DMS/Ethanethiol 21% 1383.6 ± 
473.9 
33.8 ± 157.8 21.8 ± 118.2 16.3 ± 98.9 0.001 
2% 1254.3 ± 
314.3 
40.4 ± 161.4 17.4 ± 133.1 18.4 ± 90.3 0.001 
Hexanal 21% 240.6 ± 
284.8 
-69 ± 224.2 344.3 ± 
263.8 
-5.6 ± 190.5 0.128 
2% -2.9 ± 35 -63.4 ± 72.1 -28 ± 57.8 -40.9 ± 12.5 0.43 
Butyric acid 21% 1.4 ± 9.1 -1.8 ± 10.4 20 ± 8 -8.5 ± 10.1 0.033 
2% 4.4 ± 8.2 -0.3 ± 10.4 2.2 ± 7.6 -15.5 ± 4.8  0.039 
Pentene 21% 13.7 ± 12.8 3.9 ± 13.4 12.8 ± 22.5 5.5 ± 23.5 0.841 
2% 10.4 ± 6.1 5.2 ± 13.6 8.5 ± 10.2 -6.2 ± 16.2 0.234 
Putresceine 21% 2.8 ± 12.1 -4.5 ± 13.1 24.8 ± 14.7 -2.6 ± 14.9 0.104 
2% 9.9 ± 10 -0.7 ± 19.7 9.6 ± 13 -16.6 ± 14.9 0.16 
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Figure 5. 3. Mean values of volatile organic compounds detected in the headspace of 
SHEF1 and their progenitors media over time-course of differentiation in air oxygen 
(21% O2) and physioxia (2% O2). Red and blue lines represent mean values of 
compounds in air oxygen (21% O2) and physioxia (2% O2), respectively, over time-course 
of differentiation. Error bars represent +/-SD. Hatched lines indicate of trendlines for 21% 
O2 (red lines) and 2% O2 (blue lines). Red R-squared and blue R-squared values indicate 
the correlation coefficient for 21% O2 and 2% O2, respectively. X-axis indicates time 
points (days) of differentiation, and Y-axis indicates concentration (ppbv) of volatile 
compounds (a=acetaldehyde, b=DMS/ethanethiol). 
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Table 5. 3. Summary of mean ± SD for VOCs detected in the headspace of SHEF2 and 
their progenitors media in air oxygen (21% O2) and physioxia (2% O2). The concentrations 
are measured in parts per billion by volume (ppbv). The P-values were calculated by 
ANOVA. 
VOCs Oxygen 
condition 
(0 Day) 
Mean±SD 
(5 Days) 
Mean±SD 
(10 Days) 
Mean±SD 
(20 Days) 
Mean±SD 
ANOVA 
(P-
value) 
Acetone 21% 18.1 ± 8.4 56 ± 41.1 13.7 ± 17.3 16 ± 101.9 0.727 
2% 16.1 ± 16.3 66.5 ± 61.8 -0.08 ± 19.1 40.6 ± 54.1 0.318 
Acetaldehyde 21% 1093.6 ± 
253.7 
-142.6 ± 
95.2 
-153 ± 161.3 -103 ± 53.8 0.001 
2% 2140.5 ± 
560.2 
-48.2 ± 40.3 -203.9 ± 
215.2 
-128 ± 91.5 0.001 
Ethanol 21% 7848.6 ± 
16707.9 
-269 ± 
3644.3 
9423 ± 
9158.4 
344.4 ± 
2158.4 
0.615 
2% 4277.4 ± 
15393.2 
779.4 ± 
2972.3 
4707.4 ± 
9821.8 
407.8 ± 
2107.5 
0.922 
Butanol 21% 84.1 ± 371.6 -35.2 ± 43.1 137.8 ± 
109.9 
-49 ± 72.1 0.725 
2% -67 ± 156.4 -45.9 ± 73.8 67.2 ± 119.4 -27.8 ± 45.6 0.493 
Pentanol 21% 7.1 ± 16 -11.2 ± 11 -16.9 ± 18.6 7 ± 5.8 0.111 
2% 0.7 ± 13.2 -6.4 ± 8.3 -0.6 ± 14.8 -6.2 ± 12.7 0.833 
DMS/Ethanethiol 21% 632.6 ± 
138.1 
-100.9 ± 
61.5 
-87.2 ± 
149.1 
-80.1 ± 24.1 0.001 
2% 1301.3 ± 
559.5 
-87.9 ± 70.8 -89.8 ± 87.1 -78.5 ± 26.9 0.001 
Hexanal 21% 98.7 ± 219.3 31.4 ± 126.1 64.8 ± 93.6 26.1 ± 61.9 0.908 
2% 21.5 ± 160.9 21.3 ± 6.5 39.1 ± 89.4 -12 ± 27.5 0.94 
Butyric acid 21% 5.1 ± 14.2 -0.7 ± 9.4 -7.4 ± 15.2 6.8 ± 3 0.466 
2% 5.3 ± 13.6 -5.7 ± 7.7 -2.2 ± 7 -4.2 ± 8.4 0.495 
Pentene 21% 2 ± 2.9 -11.7 ± 18.8 -10.5 ± 3.8 0.08 ± 3.4 0.142 
2% -5.3 ± 6.9 -0.6 ± 12.7 1.8 ± 9.6 -2.1 ± 5.8 0.764 
Putresceine 21% 6.1 ± 22.4 9.1 ± 7 -10.8 ± 23.4 -0.1 ± 12.4 0.572 
2% 5.1 ±15.3 -1.6 ± 3.2 6.6 ± 14.8 -0.03 ± 0.4 0.766 
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Figure 5. 4. Mean values of volatile organic compounds detected in the headspace of 
SHEF2 and their progenitors media over time-course of differentiation in air oxygen 
(21% O2) and physioxia (2% O2). Red and blue lines represent mean values of 
compounds in air oxygen (21% O2) and physioxia (2% O2), respectively, over time-course 
of differentiation. Error bars represent +/-SD. Hatched lines indicate trendlines for 21% O2 
(red lines) and 2% O2 (blue lines). Red R-squared and blue R-squared values indicate the 
correlation coefficient for 21% O2 and 2% O2, respectively. X-axis indicates time points 
(days) of differentiation, and Y-axis indicates concentration (ppbv) of volatile compounds 
(a=acetaldehyde, b=DMS/ethanethiol). 
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Table 5. 4. Summary of mean ± SD for VOCs detected in the headspace of ZK2012L and 
their progenitors media in air oxygen (21% O2) and physioxia (2% O2). The concentrations 
are measured in parts per billion by volume (ppbv). The P-values were calculated by 
ANOVA. 
VOCs Oxygen 
condition 
(0 Day) 
Mean±SD 
(5 Days) 
Mean±SD 
(10 Days) 
Mean±SD 
(20 Days) 
Mean±SD 
ANOVA 
(P-value) 
Acetone 21% 6.5 ± 13 -52.6 ± 76.6 33.1 ± 22 25.3 ± 25 0.077 
2% 5.2 ± 20.6 -164.3 ± 
106.4 
-116.4 ± 18 -251.5 ± 
22.2 
0.001 
Acetaldehyde 21% 1372.7 ± 
329.9 
698.4 ± 
108.7 
570.1 ± 
104.6 
173.2 ± 89.3 0.001 
2% 2988.4 ± 
902.1 
391.9 ± 
303.2 
-3188.5 ± 
6277.4 
497.1 ± 
168.5 
0.088 
Ethanol 21% 3076.1 ± 
3354.8 
-15579.6 ± 
31142.2 
3479.1 ± 
3893.1 
4717.7 ± 
3668.1 
0.292 
2% -436.1 ± 
5795.9 
6280.5 ± 
6731.3 
9335 ± 
1232.3 
16042.8 ± 
8970 
0.028 
Butanol 21% 110.5 ± 71.6 -201.5 ± 
410.4 
44.6 ± 80.3 -5 ± 60.4 0.237 
2% -10.3 ± 63.2 -41.4 ± 
116.3 
-2.5 ± 39.3 -14.2 ± 83.4 0.929 
Pentanol 21% 1.8 ± 16.8 5.1 ± 16.2 10 ± 18 15 ± 12.7 0.714 
2% 11.9 ± 10 -8.5 ± 15.1 -16.3 ± 20.2 -7 ± 12.3 0.081 
DMS/Ethanethiol 21% 967.8 ± 
178.2 
463.2 ± 51.2 388.4 ± 57.1 62.6 ± 84 0.001 
2% 1960.6 ± 636 252.4 ± 
229.5 
-1827.3 ± 
3695.9 
255.7 ± 74.5 0.075 
Hexanal 21% -5.4 ± 67.8 -247.1 ± 
302.7 
-60.4 ± 80.6 61.1 ± 151 0.165 
2% 23.4 ± 65.3 67.1 ± 49.6 109.5 ± 40 143 ± 60.5 0.073 
Butyric acid 21% 2.1 ± 15.8 8.7 ± 9.9 10.4 ± 17.8 13.3 ± 9.2 0.716 
2% 9 ± 8.8 -3.3 ± 10.8 -14.3 ± 20 -6 ± 12.9 0.148 
Pentene 21% -0.3 ± 2.7 -4.1 ± 7.5 -0.6 ± 2.5 1.7 ± 3.7 0.445 
2% 3.1 ± 4 -5.8 ± 4.8 -2 ± 1.5 -1 ± 1.6 0.036 
Putresceine 21% 4.1 ± 19.5 1 ± 7.5 1.4 ± 8.5 6.7 ± 7.3 0.95 
2% 13.8 ± 23.4 2.8 ± 12.4 -33.7 ± 43.8 -6.5 ± 8.6 0.144 
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Figure 5. 5. Mean values of volatile organic compounds detected in the headspace of 
ZK2012L and their progenitors media over time-course of differentiation in air 
oxygen (21% O2) and physioxia (2% O2). Red and blue lines represent mean values of 
compounds in air oxygen (21% O2) and physioxia (2% O2), respectively, over time-course 
of differentiation. Error bars represent +/-SD. Hatched lines indicate trendlines for 21% O2 
(red lines) and 2% O2 (blue lines). Red R-squared and blue R-squared values indicate the 
correlation coefficient for 21% O2 and 2% O2, respectively. X-axis indicates time points 
(days) of differentiation, and Y-axis indicates concentration (ppbv) of volatile compounds 
(a=acetaldehyde, b=DMS/ethanethiol). 
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5.4.4. Quantification of VOCs present in the headspace of BMCs and hMSCs 
across the time-course of isolation 
A total of 9 volatile compounds (acetone, acetaldehyde, ethanol, pentanol, 
DMS/Ethanethiol, hexanal, butyric acid, pentene, putresceine) in the headspace of BMCs 
and MSCs cultured in 21% O2 and 2% O2 were analysed using MIM mode of the SIFT-MS 
(Table 5.5) (Figure 5.6, 5.7). Following normalisation of incubated media with cells to 
incubated media without cells in the relevant oxygen condition ANOVA and Post Hoc 
Tukey were performed for all volatile organic compounds of three conditions to assess for 
any differences in the concentration of volatile compounds among and between any 
oxygen conditions. 
 
Table 5. 5. Summary of mean ± SD for VOCs detected in the headspace of BMCs and 
MSCs media in air oxygen (21% O2), intermittent physioxia (2% O2) and physioxia (2% 
O2 WS). The concentrations are measured in parts per billion by volume (ppbv). The P-
values were calculated by ANOVA. 
VOCs Cells 21% O2 
(Mean ± SD) 
2% O2 
(Mean ± SD) 
21% O2 WS 
(Mean ± SD) 
P-value 
Acetone BMCs (0 Day) 232.9 ± 476 252.7 ± 442.6 -150.9 ± 129.8 0.32 
BMCs (7 Days) -447.5 ± 594.2 -46.6 ± 248.8 -77.1 ± 529 0.46 
BMCs (14 Days) -694 ± 963.5 -898.9 ± 1418.2 -991.8 ± 1546.6 0.96 
Adherent MSCs 527 ± 551.7 540.6 ± 699.6 -341 ± 466.4 0.18 
Suspended 
MSCs 
32.6 ± 75.8 1.9 ± 23.1 -20.3± 18.5 0.40 
Acetaldehyde BMCs (0 Day) -37.1 ± 79 -153.5 ± 58.2 -2286.6± 1969.5 0.09 
BMCs (7 Days) 164.9 ± 161.3 -35.4 ± 83.5 -2071.5± 1894.5 0.03 
BMCs (14 Days) 628.2 ± 238.2 167 ± 777 -36.4 ± 388.6 0.42 
Adherent MSCs 47.6 ± 79.4 24.3 ± 76.5 -1026.4± 2220.6 0.53 
Suspended 
MSCs 
-175.9 ± 220.3 -241.5 ± 212.4 33.7 ± 269.4 0.32 
Ethanol BMCs (0 Day) 523.6 ± 2059.5 572.9 ± 1677.7 40069 ± 57924.7 0.32 
BMCs (7 Days) 8473 ± 13931.7 -1840.1 ± 2013 32262.3 ± 28729 0.07 
BMCs (14 Days) 1674.3 ± 7307.4 2011.3 ± 5599.3 64283.6±90487.9 0.26 
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Adherent MSCs 7950.6± 13563.4 1052 ± 2488.7 8371.7 ± 8028.5 0.52 
Suspended 
MSCs 
229.2 ± 294.2 186.2 ± 317.6 112.5 ± 203.4 0.86 
Pentanol BMCs (0 Day) -4.4 ± 12.5 -4.3 ± 13.5 -2.4 ± 19.4 0.96 
BMCs (7 Days) 27.8 ± 78.8 -10 ± 29.1 8 ± 18.9 0.61 
BMCs (14 Days) -41.1 ± 75.1 -42.1 ± 61.3 -52.4 ± 86.2 0.61 
Adherent MSCs 19.9 ± 19 20.8 ± 28.9 -23.6 ± 14.1 0.07 
Suspended 
MSCs 
-4.1 ± 5.8 -1.1 ± 14.2 1 ± 5.9 0.79 
DMS/Ethanethiol BMCs (0 Day) -24.7 ± 33.3 -101.8 ± 37.1 -1467.3 ± 1184.2 0.07 
BMCs (7 Days) 539.7 ± 892.9 -14.1 ± 95.4 -1216.4 ± 1120 0.052 
BMCs (14 Days) 308.5 ± 160.5 155.6 ± 565.5 -92.6 ± 445.1 0.61 
Adherent MSCs 1 ± 104.3 24.3 ± 104.1 -627.2 ± 1397.6 0.56 
Suspended 
MSCs 
-123.8 ± 109.2 -141.5 ± 117.9 -31.6 ± 198 0.578 
Hexanal BMCs (0 Day) 32.2 ± 51 24.5 ± 24.2 594.1 ± 654.5 0.19 
BMCs (7 Days) 30.3 ± 59.6 -5.2 ± 16.5 583.5 ± 652.1 0.09 
BMCs (14 Days) 22 ± 38.3 70.1 ± 144 72.4 ± 85.1 0.81 
Adherent MSCs 66.2 ± 119.9 14.1 ± 23.6 113.4 ± 114.8 0.49 
Suspended 
MSCs 
0.1 ± 5.8 -4.4 ± 3.1 0.3 ± 5.7 0.36 
Butyric acid BMCs (0 Day) -7.2 ± 8.4 -1.3 ± 7.4 6 ± 15.6 0.43 
BMCs (7 Days) 4.4 ± 24 -6.9 ± 11.9 5.8 ± 6.4 0.54 
BMCs (14 Days) -18.6 ± 34 -21.8 ± 27.4 -23.1 ± 36.4 0.98 
Adherent MSCs 3.3 ± 3 4.8 ± 7.3 -14.1 ± 6.6 0.01 
Suspended 
MSCs 
-4.6 ± 4 -8.1 ± 14.4 1.5 ± 4.8 0.44 
Pentene BMCs (0 Day) 3.3 ± 4.8 -3.3 ± 10.2 -9.6 ± 3.8 0.32 
BMCs (7 Days) 26.2 ± 61.8 -3.3 ± 22.1 2.3 ± 19.7 0.59 
BMCs (14 Days) -24.7 ± 45.4 -22.3 ± 37.5 -36.2 ± 49.7 0.93 
Adherent MSCs 18.4 ± 18.6 17.9 ± 24.2 -10.4 ± 10.5 0.17 
Suspended 
MSCs 
0.7 ± 5.7 7.9 ± 3 -0.5 ± 1.4 0.04 
Putresceine BMCs (0 Day) -13.2 ± 13 -3.1 ± 12.3 -20.1 ± 21.6 0.46 
BMCs (7 Days) 14 ± 53 -2.3 ± 10.8 -7.4 ± 13 0.68 
BMCs (14 Days) -27.3 ± 52 -21.9 ± 52.3 -28.5 ± 39.6 0.98 
Adherent MSCs 3.2 ± 4.8 8.5 ± 15.6 -10.6 ± 19.3 0.32 
Suspended 
MSCs 
-7 ± 12 1.6 ± 8.4 5.4 ± 6.9 0.26 
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Figure 5. 6. Physioxia effects on the levels of volatile organic compounds in the 
headspace of BMCs media. Bars represent normalised mean values of compounds for 
cells in air oxygen (21% O2) (n=3), intermittent physioxia (2% O2) (n=3) and Physioxia 
(2% O2 WS) (n=3) (X-axis). Error bars represent +/-SD, (*) represent significance at 
(P<0.05) of post-hoc Tukey test and (**) represent significance at (P<0.05) of ANOVA 
test. Y-axis indicates concentration (ppbv) of volatile compounds (a=acetaldehyde, 
b=DMS/ethanethiol). (I= Day 0, II= Day7, III= Day 14)  
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Figure 5. 7. Physioxia effects on the levels of volatile organic compounds in the 
headspace of MSCs media. Bars represent normalised mean values of compounds for 
BMCs at day 0 in air oxygen (21% O2) (n=3), intermittent physioxia (2% O2) (n=3) and 
Physioxia (2% O2 WS) (n=3) (X-axis). Error bars represent +/-SD. Y-axis indicates 
concentration (ppbv) of volatile compounds (a=acetaldehyde, b=DMS/ethanethiol). 
(I=adherent MSCs, II=suspended MSCs). 
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5.4.1 Quantification of VOCs present in the headspace of hMSCs and osteo-
induced hMSCs across time-course of differentiation 
A total of 9 volatile compounds (acetaldehyde, ethanol, butanol, pentanol, 
DMS/Ethanethiol, hexanal, butyric acid, pentene, putresceine) in the headspace of 
media of hMSCs and osteo-induced hMSCs cultured in 21% O2, 2% O2 and 2% O2 WS 
were analysed using MIM mode of the SIFT-MS (Table 5.6, 5.7, 5.8).and (Figure 5.8). 
Following normalisation of incubated media with cells to incubated media without 
cells a t-test was performed for all volatile organic compounds of both hMSCs and 
osteo-induced hMSCs to assess for any differences in the concentration of volatile 
compounds between them at each time-point throughout the differentiation.  
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Table 5. 6. Summary of mean ± SD for those VOCs that were detected in the headspace of 
hMSCs and osteo-induced hMSCs media over time-course of differentiation in air oxygen 
(21% O2). The concentrations are measured in part per billion by volume (ppbv). The P-
values were calculated by t-test. 
VOCs Cells (7 Days) 
(Mean ± SD) 
P-
value 
(14 Days) 
(Mean ± SD) 
P-
value 
(21 Days) 
(Mean ± SD) 
P-
value 
Acetaldehyde Undiff 24 ± 66.5 0.58 192.3 ± 74.9 0.17 393.6 ± 407.4 0.16 
Diff -7.6 ± 28 63.6 ± 117.7 133.2 ± 194.6 
Ethanol Undiff 115.2 ± 1017 0.09 1409 ± 388.3 0.10 221.4 ± 
1278.1 
0.67 
Diff 1512.4 ± 719 684.2 ± 
578.7 
-111.6 ± 
453.1 
Butanol Undiff -9.7 ± 37.8 0.99 -26 ± 53.1 0.33 -9.8 ± 34.3 0.26 
Diff -9.6 ± 40.1 -52.9 ± 44.5 28.6 ± 9.4 
Pentanol Undiff -5.3 ± 5.1 0.58 17.5 ± 4.4 0.60 7 ± 1.6 0.74 
Diff -0.7 ± 7.8 13.1 ± 8.2 4.5 ± 13.1 
DMS/Ethanethiol Undiff 88.4 ± 99.2 0.95 85.5 ± 43.7 0.17 328.1 ± 178.9 0.02 
Diff 93 ± 49.9 -16.2 ± 96.6 215.8 ± 186.9 
Hexanal Undiff -4.5 ± 17.1 0.21 -19.4 ± 38.6 0.64 0.5 ± 12.7 0.79 
Diff -34.2 ± 15 -28.8 ± 22 -6.5 ± 30.1 
Butyric acid Undiff -1.7 ± 3.2 0.96 9 ± 3.2 0.68 1.7 ± 6.9 0.25 
Diff -1.5 ± 7.8 9.9 ± 2.8 -4.8 ± 0.3 
Pentene Undiff -4 ± 3.7 0.51 9.4 ± 6.9 0.49 5.9 ± 7.9 0.70 
Diff 1 ± 9.2 3.3 ± 5.9 10.6 ± 14.5 
Putresceine Undiff -5.2 ± 6.1 0.04 3.6 ± 6.4 0.83 16 ± 13.6 0.56 
Diff 1.6 ± 3.6 2.5 ± 2.2 9.9 ± 11 
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Table 5. 7. Summary of mean ± SD for those VOCs that were detected in the headspace of 
hMSCs and osteo-induced hMSCs media over time-course of differentiation in intermittent 
physioxia (2% O2). The concentrations are measured in part per billion by volume (ppbv). 
The p-values were calculated by t-test. 
VOCs Cells (7 Days) 
(Mean ± SD) 
P-
value 
(14 Days) 
(Mean ± SD) 
P-
value 
(21 Days) 
(Mean ± SD) 
P-
value 
Acetaldehyde Undiff 10.7 ± 21.5 0.35 -5.6 ± 12.7 0.67 -65.5 ± 33.8 0.85 
Diff 21.8 ± 31.1 0.9 ± 16.3 -71.4 ± 24.4 
Ethanol Undiff -50.1 ± 222.5 0.20 52.1 ± 267 0.11 -286.2 ± 
186.5 
0.51 
Diff 96.3 ± 251.1 449.9 ± 
106.2 
20.1 ± 485.6 
Butanol Undiff -135.5 ± 4.7 0.95 -53.3 ± 17.7 0.87 -26.9 ± 67.5 0.14 
Diff -134 ± 44.6 -51.2 ± 17 -76.6 ± 34 
Pentanol Undiff 6.5 ± 8 0.85 -7.9 ± 17.3 0.81 -6.8 ± 14 0.57 
Diff 5.5 ± 2.7 -4.6 ± 4.2 -17.2 ± 20.3 
DMS/Ethanethiol Undiff 21.5 ±  0.93 -54.2 ±22.3 0.80 27.5 ± 28.3 0.20 
Diff -20 ± 44.5 -42.3 ± 60.8 45.6 ± 37.7 
Hexanal Undiff -20.5 ± 22.2 0.66 -1.9 ± 9.2 0.67 -8.1 ± 15.3 0.18 
Diff -29.7 ± 15.7 3 ± 10.5 4.6 ± 8.1 
Butyric acid Undiff 5.3 ± 5.7 0.47 4.3 ± 4.3 0.80 -8.6 ± 6.5 0.94 
Diff 1.4 ± 4.9 3.5 ± 0.29 -9.6 ± 16.4 
Pentene Undiff 1.1 ± 4.1 0.52 -14 ± 14.6 0.72 2.2 ± 8.6 0.18 
Diff 4.5 ± 3.4 -9.4 ± 4.5 -8.3 ± 4 
Putresceine Undiff 9.4 ± 8.2 0.49 3.9 ± 4.8 0.09 -26.8 ± 5.1 0.64 
Diff 4.6 ± 4.3 8.7 ± 2.5 -22.6 ± 9.2 
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Table 5. 8. Summary of mean ± SD for those VOCs that were detected in the headspace of 
hMSCs and osteo-induced hMSCs media over time-course of differentiation in air oxygen 
(21% O2). The concentrations are measured in part per billion by volume (ppbv). The P-
values were calculated by t-test. 
VOCs Cells (7 Days) 
(Mean ± SD) 
P-
value 
(14 Days) 
(Mean ± SD) 
P-
value 
(21 Days) 
(Mean ± SD) 
P-
value 
Acetaldehyde Undiff -60.4 ± 36.8 0.49 -272.2 ± 403.5 0.75 -158.9 ± 132.2 0.06 
Diff -84.2 ± 13.4 -340.8 ± 77.3 -22.3 ± 116.6 
Ethanol Undiff -631.2 ± 149.4 0.51 -996.5 ± 394.6 0.08 -264.6 ± 551.9 0.28 
Diff -557.3 ± 83.5 -297.1 ± 157.3 363.9 ± 280.2 
Butanol Undiff 38 ± 45.9 0.69 -21.3 ± 29.4 0.13 29.8 ± 73.4 0.69 
Diff 50.5 ± 14 -56.5 ± 25.4 -5.6 ± 61.7 
Pentanol Undiff 8.9 ± 13.3 0.42 12 ± 10.7 0.56 -3.9 ± 47.6 0.88 
Diff 4.3 ± 9.4 7.2 ± 11.2 -7.3 ± 18.3 
DMS/Ethanethiol Undiff 44.2 ± 9 0.001 -47.3 ± 285.6 0.78 -110.5 ± 89.9 0.04 
Diff -2.1 ± 10.3 -97.4 ± 24.9 16.8 ± 77.3 
Hexanal Undiff 9.8 ± 4.9 0.60 -5.5 ± 19 0.47 -12.1 ± 9.3 0.77 
Diff 6 ± 9.2 -11.8 ± 7 -7.8 ± 13.6 
Butyric acid Undiff 7.8 ± 10.3 0.97 5.1 ± 3.4 0.58 -1.6 ± 43 0.46 
Diff 7.7 ± 6.4 2.7 ± 9.3 -20 ± 9.3 
Pentene Undiff 1 ± 4.3 0.12 7.5 ± 8.2 0.78 -2.6 ± 4.3 0.13 
Diff -4 ± 5.3 4.8 ± 8.9 14.5 ± 11 
Putresceine Undiff 8.1 ± 13 0.98 -3.6 ± 4.7 0.33 16.1 ± 9.3 0.77 
Diff 8.3 ± 6.6 -9.8 ± 4.3 19.2 ± 8 
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Figure 5. 8. Mean values of volatile organic compounds detected in the headspace of 
undifferentiated and osteo-induced hMSCs media during differentiation. Diamonds 
and squares represent normalised mean values of compounds for undifferentiated hMSCs 
(n=3) and osteo-induced hMSCs (n=3), respectively. Error bars represent +/-SD, asterisks 
represent significance at (P<0.05) between undifferentiated cells and osteo-induced cells. 
X-axis indicates time-course (days) of differentiation, and Y-axis indicates concentration 
(ppbv) of volatile compounds. (a=acetaldehyde, b=DMS/ethanethiol). (I= 21% O2, II=2% 
O2, III= 2% O2 WS). 
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5.5 Discussion: 
In this chapter a further understanding of the cells behaviour can be derived from the 
targeted analytical approach (MIM mode) of SIFT-MS technique to measure the 
concentration of different classes of volatile organic compounds and to investigate the 
biochemical pathways and metabolic changes caused by environment oxygen and 
induction to differentiate. 
Short chain aldehyde, i.e., acetaldehyde, present in the headspace of cell culture media 
were quantified using SIFT-MS. There is a significant decrease in the mean concentration 
of acetaldehyde in 21% O2 condition when comparing with 2% O2 condition for HSEF2-
hESCs and ZK2012L-hiPSCs, while in SHEF1-hESCs an equivalent level is observed in 
both conditions as shown in figure 4.10. Acetaldehyde has previously been detected in the 
exhaled human breath (Turner et al., 2006) and in the culture of human lung cancer cell 
line (Sule-suso et al., 2009; Smith et al., 2003). Until recently, it was believed that 
acetaldehyde in human cells is a metabolite predominantly from ethanol oxidation by the 
alcohol dehydrogenase enzyme (Shin et al., 2009), although other studies have also 
demonstrated that human blood cells metabolise ethanol to acetaldehyde or metabolise it 
further to acetate in an alcohol dehydrogenase-independent manner (Shin et al., 2009), 
which can be further metabolised through TCA to produce energy, or these compounds can 
accumulate in cells (Hernandez et al., 2016). In general, acetaldehyde formation from 
SHEF1-hESCs in both oxygen conditions was equivalent indicating that ADH was not 
affect by the oxygen condition, while increasing its level significantly in 2% O2 as 
compared with 21% O2 for SHEF2-hESCs and ZK2012L-hiPSCs was evidence of elevated 
ADH activity in 2% O2. Actually, increases in acetate level but not acetaldehyde can be 
noticed in human plasma after ethanol intake (Hernandez et al., 2016).  
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VOCs discriminating between air oxygen (21% O2) and physioxic (2% O2) 
undifferentiated pluripotent stem cells have been identified in vitro. A combination of two 
classes of compounds (alcohols and aldehyde), ethanol and acetaldehyde, was able to 
discriminate between physioxic (2% O2) and air oxygen (21% O2) undifferentiated 
pluripotent stem cells. Acetaldehyde was previously identified by Chippendale and 
colleagues utilising SIFT-MS, in a model to study the volatile metabolites of the 
intracellular acetaldehyde dehydrogenase reaction (Chippendale et al., 2012). Crucially, it 
was observed that the hPSCs, specifically the ADH and CYP2E1 present within the cells, 
metabolised ethanol and effectively removed it from the media. When the ADH and 
CYP2E1 enzymes inhibitor 4-methylpyrazole (4-MP) was in the media of cell culture the 
headspace ethanol increased whereas acetaldehyde reduced, seemingly because the 4-MP 
concentration was sufficient to inhibit ADH and CYP2E1 oxidizing ethanol to 
acetaldehyde according to the reaction scheme outlined in Figure 4.11. Moreover, various 
studies have documented that human embryonic stem cells revealed similar changes in 
metabolite use in response to environmental oxygen (Christensen et al., 2014; Forristal et 
al., 2013; Turner et al., 2014). 
Acetaldehyde was correlated with the differentiation of hPSCs. The activity of the 
metabolic pathways for releasing or consuming of acetaldehyde were reduced or activated, 
respectively, at the onset of differentiation. This finding suggests correlation of 
acetaldehyde metabolism with the loss of stemness associated with spontaneous 
differentiation of hPSCs in 21% and 2% O2.  
 
Human mesenchymal stem cells represent an interesting source of adult stem cells for cell-
based therapies and tissue engineering. The effects of different environmental oxygen 
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concentration on hMSCs have been studied previously, usually comparing air oxygen 
tension to a single oxygen concentration of physioxia. The controversial effects of 
physioxic condition on proliferation and differentiation of MSCs have been noted 
previously, these effects depend on several parameters; including oxygen level, species 
source of MSCs derived, different tissues, cell density, exposure time to physioxia (Das et 
al., 2010; Tsai et al., 2012). Under the experimental setting in this chapter, the metabolites 
were sampled and analysed at different time points during MSCs isolation while 
comparing between air oxygen (21% O2) condition and two physioxic conditions (2% O2 
and 2% O2 WS). In addition, the metabolites of osteogenic induction of MSCs in vitro 
were analysed at different time points during the differentiation. 
Acetaldehyde at day 0 was consumed by bone marrow cells in all studied groups, but was 
the most consumed in 2% O2 WS. Acetaldehyde was consumed at day 7 in intermittent and 
uninterrupted physioxia, whereas it was released in 21% O2. At day 14 cells in 2% O2 WS 
consumed acetaldehyde, while it was released in 21% and 2% O2, but was released more in 
21% O2 than in 2% O2. For adherent MSCs acetaldehyde was consumed in 2% O2 WS, 
while it was released in 21% O2 and 2% O2. Conversely, for suspended MSCs, 
acetaldehyde was changed, being consumed in 21% and 2% O2 while released in 2% O2 
WS. The changes in acetaldehyde level among different oxygen environments indicate the 
changes in metabolic pathways of acetaldehyde. 
 
Throughout the time-course of osteo-induction of MSCs the acetaldehyde level in 21% O2 
increased and the difference between MSCs and osteo-induced MSCs increased as well. 
For both MSCs and osteo-induced MSCs in 2% O2 acetaldehyde was changed along the 
time-course, being released at an early time-point and consumed at a late time-point. 
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Acetaldehyde in 2% O2 WS was consumed in a fluctuating manner by both cells during the 
time-course. Indeed, it was shown that, in undifferentiated MSCs, lower consumption 
occurs at early and middle time-points but higher consumption occurs at a later time-point 
as compared with osteo-induced MSCs. 
 
During the SIFT-MS measurements, several compounds aside from acetaldehyde were also 
measured during the analysis. Dimethyl sulphide and/or ethanethiol belong to volatile 
sulphur compounds were identified and detected in the headspace of cell culture samples. 
The production of sulphur-containing compounds in humans is attributed to the 
metabolisation of the sulphur-containing amino acids methionine and cysteine in the 
transamination pathway (Mochalski et al., 2013). Dimethyl sulphide can be produced via 
methylation of methanethiol by thiol S-methyl transferase (Tangerman, 2009). The origin 
of ethanethiol is currently unknown. The results of these experiments showed that SHEF1-
hESCs produced are equivalent amount of dimethyl sulphide and/or ethanethiol in both 
oxygen conditions, whereas SHEF2-hESCs and ZK2012L-hiPSCs produced more 
dimethyl sulphide and/or ethanethiol in 21% O2 than in 2% O2. Thus environmental 
oxygen influences the amount of detected dimethyl sulphide and/or ethanethiol for both 
SHEF2-hESCs and ZK2012L-hiPSCs. Thus, the explanation for high level of dimethyl 
sulphide production may be an increase in enzyme thiol S-methyl transferase activity in 
21% O2. 
Dimethyl sulphide and/or ethanethiol were correlated with the differentiation of hPSCs. 
The activity of the metabolic pathways for releasing or consuming dimethyl sulphide 
and/or ethanethiol were reduced or activated, respectively, at the beginning of 
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differentiation. This finding suggests correlation of DMS and/or ethanethiol levels with the 
loss of stemness associated with spontaneous differentiation in 21% and 2% O2.  
DMS and/or ethanethiol at day 0 was consumed by bone marrow cells in all three groups, 
but the highest consumption was seen in 2% O2 WS and the lowest consumption was in 
21% O2. DMS and/or ethanethiol at day 7 was released in 21% O2, whereas it was 
consumed in both physioxia groups (2% O2 and 2% O2 WS), with more consumption in 
2% O2 WS than in 2% O2. At day 14 cells consumed DMS and/or ethanethiol in 2% O2 
WS with release in 21% O2 and 2% O2, more so in 21% O2 than 2% O2. For adherent 
MSCs DMS and/or ethanethiol was consumed in 2% O2 WS with release in the other two 
groups. For suspended MSCs DMS and/or ethanethiol was consumed in all three groups, 
but consumption was lower in 2% O2 WS than in 21% O2 and 2% O2. The changes in 
DMS and/or ethanethiol level among different oxygen environment may indicates the 
changes in metabolic pathways’ rate of DMS and/or ethanethiol. 
Throughout the time-course of osteo-induction of MSCs the DMS and/or ethanethiol level 
in 21% O2 fluctuated and the difference between MSCs and osteo-induced MSCs increased 
at middle and late time-points. For both MSCs and osteo-induced MSCs in 2% O2 DMS 
and/or ethanethiol fluctuated along the time-course. DMS and/or ethanethiol in 2% O2 WS 
was changed in a fluctuating manner for osteo-induced MSCs during the time-course, 
while undifferentiated MSCs showed release it at early time-point and consumption at 
middle and late time-point. Indeed, it was shown that there are significant differences 
between undifferentiated MSCs and osteo-induced MSCs at early and late time-points. 
Further work would be needed to clarify whether proliferation changes or if changes to 
metabolism could be behind the change in DMS and/or ethanethiol levels. 
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In conclusion, analysis of volatile organic compounds seems promising in comparing the 
metabolic pathway of stem cells in normoxic versus physioxic conditions in vitro. 
Furthermore, it seems that VOCs can be used as a distinguishing characteristic profile in 
the characterisation of stem cells and their progenitor cells. 
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Chapter 6-Discussion
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6.1 Discussion: 
Stem cells present great potential in the regeneration of diseased or damaged tissue. In 
order to best exploit them, knowledge of self-renewal is of special interest over 
differentiation (Avior et al., 2016). Recent advances in metabolomics analysis will increase 
our understanding of stem cell self-renewal and differentiation status. Metabolomics has 
also been utilised to highlight differences in the metabolic profile of different stem cells. 
Given the differential responses of stem cells to differentiation under normoxic and 
hypoxic conditions, it would seem appropriate to characterise the metabolic profile of stem 
cells under a variety of oxygen conditions, to facilitate understanding the metabolism of 
stem cells self-renewal and differentiation status.  
This study has revealed for the first time the utility of a novel, non-invasive sampling 
method using SIFT-MS for the analysis of two hESC lines and one hiPSC line cultured in 
two oxygen tensions. Volatile organic compound profile differentiation was achieved 
between hPSCs cultured in air oxygen (21% O2) and physioxia (2% O2) (p<0.05).  
Each metabolite profile reflects the compounds in the headspace of culture media of cells 
cultured in different oxygen levels. Therefore, OPLS-DA showed 21% O2 samples 
separated from 2% O2 samples, indicating that the environmental conditions affect the 
overall metabolic profile of hPSCs. The environmental oxygen affects the metabolic 
profile of different cells. The metabolic profile of cells gives an indication of the cellular 
activity and can be thought of as a snapshot of cellular state when cultured in physioxic 
condition. Variables (m/z) unique to each sampling area were identified, with evidence of 
important variables from VIP values ≥1. Although variable (m/z) cannot be defined as 
specific biomarker, most variables attributed to more than one volatile organic species. The 
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alterations in the overall metabolite profile rather than individual metabolite or a specific 
metabolic pathway will give a global snapshot of the metabolic status of hPSCs. 
Key stages in ethanol metabolism are oxidation catalysed by alcohol dehydrogenase 
(ADH) and cytochrome P450 2E1 (CYP2E1) (Manzo-Avalos et al., 2010). Based on the 
SIFT-MS results presented here, ethanol levels were higher for hPSCs in 21% O2 than 
those in 2%, while acetaldehyde levels were higher for cells in 2% than those in 21% O2. 
Both ADH and CYP2E1 convert ethanol into acetaldehyde (Tuma and Casey, 2003). The 
presence of ADH and CYP2E1 in hPSCs, cultured in physioxia (2% O2) and air oxygen 
(21% O2), used in this study has been confirmed by RT-PCR. It is possible that 4-methyl 
pyrazole (4-MP) inhibits the action of these enzymes (Zimatkin et al., 2006). The 
combined inhibition of ADH and CYP2E1 has affected the activity of these enzymes 
leading to decreased acetaldehyde levels and increased ethanol levels in the media, 
although SHEF2 in 21% O2 did not decrease the acetaldehyde level. Thus, ethanol and/or 
acetaldehyde compounds are proposed to be volatile biomarkers to discriminate between 
hPSCs cultured in physioxia and air oxygen conditions. 
Stem cell separation techniques rely on the expression of specific surface proteins. As a 
result, isolation of MSCs requires the combination of several antibodies (Dominici et al., 
2006). Although previous report has indicated that MSCs are reside within the hypoxic 
niches in the bone marrow (Eliasson and Jonsson, 2010), this characteristic has not been 
exploited for identification of unique metabolic properties of MSCs. 
Considering the varying of the environmental oxygen, the metabolic impacts of oxygen on 
bone marrow cells (BMCs) and mesenchymal stem cells (MSCs) was evaluated. This 
demonstrated that SIFT-MS metabolomics can discriminate responses of BMCs and MSCs 
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exposed to different environmental oxygen. Current techniques for assessment and 
comparison of oxygen rely on the study of the metabolome of BMCs and MSCs.  
Each metabolite profile reflects the compounds in the headspace of culture media of cells 
cultured in different oxygen conditions. Therefore, OPLS-DA showed 21% O2 samples 
separated from 2% O2 samples, indicating that the environmental conditions affect the 
overall metabolic profile of BMCs and MSCs. Variables (m/z) unique to each sampling 
area were identified, with evidence of important variables from VIP values ≥1. Due to 
limitation of the SIFT-MS technique most variables (m/z) cannot be defined as specific 
biomarker because most variables are attributable to more than one volatile organic 
species. The changes in the overall metabolite profile rather than individual metabolite or a 
specific metabolic pathway will give a global snapshot of the metabolic profile of BMCs 
and MSCs. 
 
The occurrence of metabolic changes was investigated over the 21 days of osteo-induction. 
The multivariate analysis of metabolite of MSCs during osteo-induction detected changes 
of metabolite according to MSCs differentiation. Metabolomics examination of hMSCs 
during the differentiation course yielded a large amount of data. Variables (m/z) unique to 
each sampling area were identified, with evidence of important variables from VIP values 
≥1. Although variable (m/z) cannot be defined as specific biomarker, most variables 
attributed to more than one volatile organic species. The changes in the overall metabolite 
profile rather than individual metabolite or a specific metabolic pathway will give a global 
snapshot of the metabolic status of MSCs and osteo-induced MSCs. 
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Further investigation showed that many variables (m/z) were downregulated and 
upregulated during the time-course of differentiation. These putative metabolites were 
taken forward to narrow down the focus of the analysis.  
Utilising of metabolomics profiles as biomarkers of MSCs during the time-course of 
osteogenic differentiation was also monitored by Surrati et al. (Surrati et al., 2016) who 
used LC-MS. Nevertheless, that approach is limited due to the fact that extracellular 
metabolites give only a rough approximation of intracellular metabolism.  
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Chapter 7-Conclusions 
and future works
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7.1 Conclusions: 
The research work presented in this thesis employed a non-invasive online technique for 
monitoring human cell cultures; particularly those clinically relevant to the field of 
regenerative medicine. The series of metabolomics experiment carried out is based, is 
Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS), which is capable of rapidly and 
accurately measuring the concentration of trace compounds in the headspace of cell 
cultures media to parts per billion by volume (ppbv) levels. The potential and power of the 
SIFT-MS technique in the field of medicine, particularly in breath analysis, has been 
demonstrated by numerous previous studies (Spanel et al., 2011). 
In the metabolomics approach a combination of both supervised and unsupervised methods 
for spectra data analysis have been demonstrated. PCA was employed first to build up a 
picture of sample variances and determine the outlier samples. Definitive PCA models 
have then been used for a supervised method, OPLS-DA, for the identification of samples. 
SIFT-MS was used for the analysis of the headspace above hPSCs cultured in physioxia 
(2% O2) and air oxygen (21% O2) conditions to investigate how changes to this oxygen 
environment affected VOCs above the cells. Differences were observed between the SIFT-
MS spectra obtained from the headspace cell cultures and the culture media alone, and 
between cell cultures of 2% O2 and 21% O2. A subset of variables and proposed 
compounds found to be the most responsible for the variation between the two conditions 
for each hPSCs has been identified. In addition, only acetaldehyde and DMS and/or 
ethanethiol were found to be changed significantly. The influence of the intracellular 
alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP 2E1) on the observed 
acetaldehyde change was investigated in hPSCs (hESCs and hiPSCs) by adding the ADH 
and CYP2E1 inhibitor 4-methyl pyrazole (4-MP) to the culture media and observing the 
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increase in the concentration of ethanol and decrease in the concentration of acetaldehyde 
in the headspace of treated cells when compared with non-treated cells. Indeed the 
application of the ADH and CYP2E1 inhibitor compound did not change the acetaldehyde 
level for SHEF2-hESCs in 21% O2, in some cases causing the acetaldehyde level to 
increase above the treated cells as a result of catalase mediated oxidation of ethanol to 
acetaldehyde, a reaction which was not affected by 4-MP. The same chapter continued to 
investigate VOCs above hPSCs throughout spontaneous differentiation. This measurement 
was conducted before and during the differentiation of hPSCs. The findings were then 
exploited for the purpose of monitoring the level of compounds (biomarkers) in the gas 
phase above the cell culture media of hPSCs and their progenitors. The cultures were 
monitored at four time-points of the differentiation time-course with the concentration of 
acetaldehyde and DMS and/or ethanethiol seen to rise in undifferentiated cells and then 
decline from the first time-point onwards. In addition, the metabolite profiles of the cells 
were investigated over the time-course of 20 days. The OPLS-DA provided a separation of 
the cells culture media at different time-points and control media. A subset of variables and 
proposed compounds were found to be the most responsible for the variation between 
samples for each hPSC and condition. 
SIFT-MS was applied for the analysis of the bone marrow cells over the time course of 
MSCs isolation in three environmental oxygen as well as isolated hMSCs from bone 
marrow cells in those conditions. The cultures were monitored at each time-point of the 
isolation time-course showing changes in the levels of VOCs between cells in different 
culture conditions. The OPLS-DA provided a separation of the cells culture media at each 
time-point and for each control media. A subset of variables and proposed compounds 
were found to be the most responsible for the variation between samples for each time-
point over the time-course of isolation.  
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SIFT-MS was applied to the study of VOCs from hMSCs at different time-points during 
hMSCs osteo-induction in vitro. The OPLS-DA analysis from MSCs in undifferentiated 
and osteo-induced state provided clear separation between media samples from 
undifferentiated and osteo-induced cultures at day 14 and 21 in intermittent physioxia (2% 
O2) and uninterrupted physioxia (2% O2 WS) but not in air oxygen (21% O2). A subset of 
variables and proposed compounds were found to be the most responsible for the variation 
between samples for each time-point over the time-course of differentiation. Individual 
OPLS-DA score plots revealed the metabolic profile of MSCs and osteo-induced MSCs 
during the time-course of differentiation. 
7.2 Future works: 
Studies described in this thesis have been conducted with small number of samples as 
compared to large scale metabolomics studies. Using a large number of samples would 
minimise the variation, which could potentially otherwise mask the detection of 
meaningful compounds change linked to the environmental condition and stem cell state. 
However, SIFT-MS used for on-line and real-time detection and quantification of volatile 
compounds without the need for modification of biological samples in headspace analysis, 
offers immediate analyses. Though GC/LC-MS will remain important techniques for 
volatile compounds analysis, extensive sample preparation is required before analysis. This 
limits their potential applications within the biological setting and prevents a bio-sample 
being analysed in its natural state. The limitations of the SIFT-MS technique are the 
relatively small number of volatile compounds that can be measured in real-time while; 
isomeric separation is not feasible. Further combined GC-MS and SIFT-MS experiments to 
study VOCs above stem cells culture will surely be beneficial in the investigation of 
biomarkers. 
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In conclusion, the thesis has answered a majority of the aims for each chapter. This study 
employed SIFT-MS as a non-invasive and economical technique, confirming the power of 
SIFT-MS to study the VOCs in the headspace of stem cells and their progenitors. 
Combined SIFT-MS and stable isotope probing could be used in the future to quantify 
intracellular metabolites involved at specific stages of differentiation and to investigate 
specific pathways identified by this study.
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Appendices 
Appendix 1. Scores plot from OPLS-DA discrimination of SIFT-MS spectra of 
incubated and unincubated culture media. a) DMEM score plot. b) KO-DMEM score 
plot. c) Essential 8 Medium score plot. d) DMEM/F12 score plot. for each score plot X-
axis, t[2] and Y-axis, t[1], indicate the second and first principal component, respectively. 
Ellipses represent the 95% confidence intervals for each OPLS-DA score plot. The 
unincubated media group (n=3), unincubated hypoxic conditioned media group (n=3) are 
shown as circles and squares, respectively. The 21% O2 incubated media group (n=3), 2% 
O2 incubated media group (n=3), and 2% O2 incubated hypoxic conditioned media group 
(n=3) are shown as triangles, inverted triangles and diamonds, respectively.  
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Appendix 2. Tables of quantified VOCs in the headspace of cell culture media 
VOCs Media Unincubated 
media 
(Mean ± SD) 
21% O2 
Incubated media 
(Mean ± SD) 
2% O2 Incubated 
media 
(Mean ± SD) 
21% 
O2 Vs. 
Control 
(P-
Value) 
2% O2 
Vs. 
Control 
(P-
Value) 
Acetone DMEM 82 ± 48 22.8 ± 0.4 23.6 ± 0.6 0.44 0.66 
KO DMEM 321.4 ± 37.2 46.7 ± 0.8 45.3 ± 5.5 0.006 0.006 
E8M 25 ± 3.1 25.9 ± 5.7 17.5 ± 2.9 0.63 0.02 
DMEM/F12 35.9 ± 7 32.2 ± 1.4 27 ± 12.3 0.4 0.5 
Acetaldehyde DMEM 245.5 ± 55.1 104.1 ± 0.8 102.6 ± 2.5 0.85 0.04 
KO DMEM 589.8 ± 95 94.2 ± 16.1 69.6 ± 10 0.009 0.01 
E8M 119.1 ± 42.8 69.2 ± 14.3 51.3 ± 38.5 0.09 0.01 
DMEM/F12 346.1 ± 33.1 146.3 ± 11.7 62.1 ± 34.1 0.01 0.01 
Ethanol DMEM 1043.6 ±121.3 37516.5 ± 1982.1 29282.9 ± 10587.5 0.001 0.04 
KO DMEM 1148.3 ± 365.2 29059.9 ± 13370.2 11565.6 ± 6427.8 0.07 0.11 
E8M 1191.3 ± 764.5 27816.8 ± 12992 10125.3 ± 6508.9 0.06 0.11 
DMEM/F12 1713.3 ± 182.9 53935.4 ± 9604.7 43696.5 ± 18681.1 0.01 0.06 
Butanol DMEM 131.2 ± 93.9 114.1 ± 72.9 132.4 ± 100.8 0.86 0.98 
KO DMEM 2.5 ± 2.8 39.9 ± 69.1 2.5 ± 4.3 0.46 0.96 
E8M 7.1 ± 12.3 42.4 ± 65 0 ± 0 0.48 0.42 
DMEM/F12 136.8 ± 35.1 311.2 ± 70.8 266.6 ± 258.7 0.08 0.43 
Pentanol DMEM 14.4 ± 6.5 20.1 ± 4.2 17.4 ± 2.7 0.11 0.62 
KO DMEM 19.7 ± 3.6 21.9 ± 14.5 17.5 ± 9.1 0.76 0.58 
E8M 8.2 ± 2.2 19.7 ± 12.9 10.6 ± 6.2 0.2 0.41 
DMEM/F12 4.9 ± 4.8 29.3 ± 5.5 22.6 ± 18.5 0.001 0.16 
DMS/Ethanethiol DMEM 352.4 ± 162.4 260.1 ± 112 160.7 ± 8.5 0.47 0.16 
KO DMEM 402.1 ± 39.3 95.6 ± 30 81.6 ± 21.8 0.001 0.001 
E8M 95.2 ± 15.2 78.2 ± 9.5 62.3 ± 26.3 0.04 0.04 
DMEM/F12 282.5 ± 15.3 157.9 ± 35.1 81.7 ± 22 0.01 0.004 
Hexanal DMEM 12.9 ± 3.9 217.5 ± 44.8 110.4 ± 23.7 0.01 0.01 
KO DMEM 20.5 ± 3.8 464.9 ± 393.4 190.7 ± 166 0.18 0.21 
E8M 20.2 ± 16.8 455.1 ± 392.6 162.2 ± 144.7 0.18 0.19 
DMEM/F12 15.4 ± 7.3 735 ± 74.5 639 ± 466.6 0.004 0.14 
Butyric acid DMEM 5.1 ± 3.5 14.2 ± 3.5 10.8 ± 3.4 0.14 0.11 
KO DMEM 6.9 ± 3.1 12.9 ± 9.9 10.7 ± 4.9 0.28 0.35 
E8M 3.1 ± 2 11.6 ± 8.7 6.3 ± 4.5 0.25 0.34 
DMEM/F12 1.2 ± 0.4 23.2 ± 7.7 16.4 ± 18.3 0.03 0.28 
Pentene DMEM 10.3 ± 4.5 6.3 ± 5.3 7.4 ± 4.6 0.2 0.5 
KO DMEM 14.2 ± 2.6 9.8 ± 5.3 7.3 ± 5.4 0.21 0.12 
E8M 5.6 ± 3.2 8.8 ± 4.6 4.6 ± 2 0.09 0.64 
DMEM/F12 4.1 ± 5 6.3 ± 3.4 6.6 ± 1 0.67 0.5 
Putresceine DMEM 9.1 ± 5.9 13.2 ± 11.2 5.2 ± 5.9 0.71 0.62 
KO DMEM 7.4 ± 0.78 6.8 ± 2.3 6.3 ± 4.1 0.66 0.69 
E8M 2.4 ± 1.5 6.4 ± 4 5.5 ± 2.3 0.28 0.15 
DMEM/F12 1.8 ± 1.9 10.2 ± 3.8 15.6 ± 22.1 0.02 0.41 
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VOCs Media Unincubated media 
(Mean ± SD) 
2% O2 Incubated 
media (Mean ± SD) 
2% O2 Vs. 
Control (P-
Value) 
Acetone HOC DMEM 35.8 ± 2 39.4 ± 11.7 0.64 
HOC KO DMEM 342.8 ± 81.8 114.6 ± 17.9 0.03 
HOC E8M 32.1 ± 4.4 30.8 ± 11.9 0.81 
HOC DMEM/F12 29.3 ± 9.5 32 ± 7.6 0.51 
Acetaldehyde HOC DMEM 351.1 ± 61.6 99.5 ± 26.4 0.01 
HOC KO DMEM 859.6 ± 52.9 263.1 ± 24.2 0.004 
HOC E8M 222.1 ± 33.2 95.5 ± 33.4 0.01 
HOC DMEM/F12 249.9 ± 44.4 55.9 ± 34 0.03 
Ethanol HOC DMEM 2102.1 ± 772.9 32010.5 ± 5626.8 0.008 
HOC KO DMEM 2157.1 ± 396.7 14421.1 ± 3262.7 0.02 
HOC E8M 2946.4 ± 764.9 17820.4 ± 4923.7 0.03 
HOC DMEM/F12 1448.4 ± 28.8 49735.3 ± 22978.6 0.06 
Butanol HOC DMEM 108.8 ± 22.2 164 ± 68.7 0.35 
HOC KO DMEM 61.8 ± 48.6 77.2 ± 13.5 0.52 
HOC E8M 63.1 ± 5.1 58.5 ± 36.4 0.82 
HOC DMEM/F12 50.1 ± 37.2 340.3 ± 296.8 0.22 
Pentanol HOC DMEM 20.5 ± 9.5 25.4 ± 4.8 0.55 
HOC KO DMEM 31.3 ± 3.7 32 ± 13 0.93 
HOC E8M 20 ± 6.6 26.1 ± 10.3 0.13 
HOC DMEM/F12 9.8 ± 4.3 34 ± 10.8 0.02 
DMS/Ethanethiol HOC DMEM 275.3 ± 57.1 142.7 ± 27.6 0.05 
HOC KO DMEM 476.4 ± 17 153 ± 39.2 0.001 
HOC E8M 173 ± 33.3 78.5 ± 20.6 0.09 
HOC DMEM/F12 223.6 ± 15 105.1 ± 24.4 0.006 
Hexanal HOC DMEM 22.9 ± 6.5 218.9 ± 18.5 0.005 
HOC KO DMEM 24.5 ± 13.1 91.6 ± 38.8 0.04 
HOC E8M 28.5 ± 18.6 105 ± 33.1 0.06 
HOC DMEM/F12 16.6 ± 5.3 571.1 ± 299.9 0.08 
Butyric acid HOC DMEM 9.9 ± 3.8 13.5 ± 2.8 0.25 
HOC KO DMEM 15.1 ± 2.3 14.9 ± 9.1 0.97 
HOC E8M 17.1 ± 5.2 21.9 ± 11.7 0.32 
HOC DMEM/F12 4.7 ± 4.4 14.7 ± 6.9 0.02 
Pentene HOC DMEM 11.7 ± 6.4 13.1 ± 3.9 0.82 
HOC KO DMEM 17.8 ± 3 18.8 ± 4.5 0.46 
HOC E8M 2.9 ± 1.5 4.2 ± 3.9 0.69 
HOC DMEM/F12 5.6 ± 2.3 21.4 ± 4.5 0.02 
Putresceine HOC DMEM 6.2 ± 4 3.8 ± 3.3 0.6 
HOC KO DMEM 12.5 ± 4.2 16.5 ± 15.1 0.65 
HOC E8M 29 ± 22.5 9.5 ± 12.8 0.32 
HOC DMEM/F12 6.6 ± 5.7 6.2 ± 4.1 0.94 
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